BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W, Tian DS. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 2020;71:762-8. [PMID: 32161940 DOI: 10.1093/cid/ciaa248] [Cited by in Crossref: 1664] [Cited by in F6Publishing: 1812] [Article Influence: 832.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang C, Peng C, Ning L, Qiu X, Wu K, Yang N, Jin B, Zhao Y, Zheng F. Development and Validation of a Nomogram to Assist Monitoring Nosocomial SARS-CoV-2 Infection of Hospitalized Patients. JIR 2022;Volume 15:1471-81. [DOI: 10.2147/jir.s351509] [Reference Citation Analysis]
2 Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J Neuroimmunol 2020;350:577436. [PMID: 33212316 DOI: 10.1016/j.jneuroim.2020.577436] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
3 Griffin DE. Are T cells helpful for COVID-19: the relationship between response and risk. J Clin Invest 2020;130:6222-4. [PMID: 32976117 DOI: 10.1172/JCI142081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 He F, Quan Y, Lei M, Liu R, Qin S, Zeng J, Zhao Z, Yu N, Yang L, Cao J. Clinical features and risk factors for ICU admission in COVID-19 patients with cardiovascular diseases. Aging Dis 2020;11:763-9. [PMID: 32765943 DOI: 10.14336/AD.2020.0622] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Pallotto C, Suardi LR, Esperti S, Tarquini R, Grifoni E, Meini S, Valoriani A, Di Martino S, Cei F, Sisti E, Piani F, Botta A, Salomoni E, Baragli F, Blanc P. Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study. Infect Dis (Lond) 2020;52:675-7. [PMID: 32543971 DOI: 10.1080/23744235.2020.1778178] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
6 Chen YM, Zheng Y, Yu Y, Wang Y, Huang Q, Qian F, Sun L, Song ZG, Chen Z, Feng J, An Y, Yang J, Su Z, Sun S, Dai F, Chen Q, Lu Q, Li P, Ling Y, Yang Z, Tang H, Shi L, Jin L, Holmes EC, Ding C, Zhu TY, Zhang YZ. Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage. EMBO J 2020;39:e105896. [PMID: 33140861 DOI: 10.15252/embj.2020105896] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
7 Lu S, Zhao Y, Yu W, Yang Y, Gao J, Wang J, Kuang D, Yang M, Yang J, Ma C, Xu J, Qian X, Li H, Zhao S, Li J, Wang H, Long H, Zhou J, Luo F, Ding K, Wu D, Zhang Y, Dong Y, Liu Y, Zheng Y, Lin X, Jiao L, Zheng H, Dai Q, Sun Q, Hu Y, Ke C, Liu H, Peng X. Comparison of nonhuman primates identified the suitable model for COVID-19. Signal Transduct Target Ther 2020;5:157. [PMID: 32814760 DOI: 10.1038/s41392-020-00269-6] [Cited by in Crossref: 62] [Cited by in F6Publishing: 69] [Article Influence: 31.0] [Reference Citation Analysis]
8 Del Turco S, Vianello A, Ragusa R, Caselli C, Basta G. COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge? Thromb Res 2020;196:143-51. [PMID: 32871306 DOI: 10.1016/j.thromres.2020.08.039] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
9 Tang L, Yin Z, Hu Y, Mei H. Controlling Cytokine Storm Is Vital in COVID-19. Front Immunol 2020;11:570993. [PMID: 33329533 DOI: 10.3389/fimmu.2020.570993] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
10 Yang H, Xu Y, Li Z, Yan L, Wang J, Liao P. The Clinical Implication of Dynamic Hematological Parameters in COVID-19: A Retrospective Study in Chongqing, China. Int J Gen Med 2021;14:4073-80. [PMID: 34354369 DOI: 10.2147/IJGM.S321292] [Reference Citation Analysis]
11 Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021;17:46-64. [PMID: 33077917 DOI: 10.1038/s41581-020-00357-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 42.5] [Reference Citation Analysis]
12 Yonas E, Alwi I, Pranata R, Huang I, Lim MA, Yamin M, Nasution SA, Setiati S, Virani SS. Elevated interleukin levels are associated with higher severity and mortality in COVID 19 - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 2020;14:2219-30. [PMID: 33395783 DOI: 10.1016/j.dsx.2020.11.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
13 Mahroum N, Alghory A, Kiyak Z, Alwani A, Seida R, Alrais M, Shoenfeld Y. Ferritin - from iron, through inflammation and autoimmunity, to COVID-19. J Autoimmun 2022;126:102778. [PMID: 34883281 DOI: 10.1016/j.jaut.2021.102778] [Reference Citation Analysis]
14 Wang LL, Yang JW, Xu JF. Coronavirus (SARS-CoV-2) causes lung inflammation and injury. Clin Microbiol Infect 2021:S1198-743X(21)00674-1. [PMID: 34861410 DOI: 10.1016/j.cmi.2021.11.022] [Reference Citation Analysis]
15 Furci F, Caminati M, Senna G, Gangemi S. The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19. Clin Mol Allergy 2021;19:19. [PMID: 34719394 DOI: 10.1186/s12948-021-00159-4] [Reference Citation Analysis]
16 Mishra KP, Singh M, Saraswat D, Ganju L, Varshney R. Dysfunctional State of T Cells or Exhaustion During Chronic Viral Infections and COVID-19: A Review. Viral Immunol 2022. [PMID: 35325564 DOI: 10.1089/vim.2022.0002] [Reference Citation Analysis]
17 Zhang L, Li T, Chen L, Wu F, Xia W, Huang M, Guo Z, Song L, Yin H, Zhang Y, Yu Y, Cai S, Lu Z, Rong S, Bao W. Association of sleep quality before and after SARS-CoV-2 infection with clinical outcomes in hospitalized patients with COVID-19 in China. EXCLI J 2021;20:894-906. [PMID: 34121976 DOI: 10.17179/excli2021-3451] [Reference Citation Analysis]
18 Derruau S, Bouchet J, Nassif A, Baudet A, Yasukawa K, Lorimier S, Prêcheur I, Bloch-Zupan A, Pellat B, Chardin H, Jung S, On Behalf Of Task Force Covid-Collège National des EnseignantS En Biologie Orale Cnesbo-France. COVID-19 and Dentistry in 72 Questions: An Overview of the Literature. J Clin Med 2021;10:779. [PMID: 33669185 DOI: 10.3390/jcm10040779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Serrano OK, Kutzler HL, Rochon C, Radojevic JA, Lawlor MT, Hammond JA, Gluck J, Feingold AD, Jaiswal A. Incidental COVID-19 in a heart-kidney transplant recipient with malnutrition and recurrent infections: Implications for the SARS-CoV-2 immune response. Transpl Infect Dis 2020;22:e13367. [PMID: 32533615 DOI: 10.1111/tid.13367] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
20 Cañas CA. The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals. Med Hypotheses 2020;145:110345. [PMID: 33080459 DOI: 10.1016/j.mehy.2020.110345] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
21 Meng L, Xu J, Zhang J, Zhang K, Shang P, Li Q, Li Y, Wang L, Cai B. Monitoring peripheral neutrophil and T-lymphocyte subsets could assist in differentiating the severity and disease progression of coronavirus disease 2019. Aging (Albany NY) 2021;13:7723-32. [PMID: 33741750 DOI: 10.18632/aging.202701] [Reference Citation Analysis]
22 Moreno-Torres V, de Mendoza C, de la Fuente S, Sánchez E, Martínez-Urbistondo M, Herráiz J, Gutiérrez A, Gutiérrez Á, Hernández C, Callejas A, Maínez C, Royuela A, Cuervas-Mons V; Puerta de Hierro COVID-19 working group. Bacterial infections in patients hospitalized with COVID-19. Intern Emerg Med 2021. [PMID: 34406633 DOI: 10.1007/s11739-021-02824-7] [Reference Citation Analysis]
23 Jurado Hernández JL, Álvarez Orozco IF. COVID-19 in Children: Respiratory Involvement and Some Differences With the Adults. Front Pediatr 2021;9:622240. [PMID: 33855003 DOI: 10.3389/fped.2021.622240] [Reference Citation Analysis]
24 Sanjay S, Mutalik D, Gowda S, Mahendradas P, Kawali A, Shetty R. "Post Coronavirus Disease (COVID-19) Reactivation of a Quiescent Unilateral Anterior Uveitis". SN Compr Clin Med 2021;:1-5. [PMID: 34124585 DOI: 10.1007/s42399-021-00985-2] [Reference Citation Analysis]
25 [DOI: 10.1101/2020.07.29.20164293] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
26 Knoll R, Schultze JL, Schulte-Schrepping J. Monocytes and Macrophages in COVID-19. Front Immunol 2021;12:720109. [PMID: 34367190 DOI: 10.3389/fimmu.2021.720109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Zhang B, Liu S, Tan T, Huang W, Dong Y, Chen L, Chen Q, Zhang L, Zhong Q, Zhang X, Zou Y, Zhang S. Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Chest. 2020;158:e9-e13. [PMID: 32243945 DOI: 10.1016/j.chest.2020.03.039] [Cited by in Crossref: 223] [Cited by in F6Publishing: 216] [Article Influence: 111.5] [Reference Citation Analysis]
28 Kalra RS, Dhanjal JK, Meena AS, Kalel VC, Dahiya S, Singh B, Dewanjee S, Kandimalla R. COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications. Front Aging Neurosci 2021;13:662786. [PMID: 34149397 DOI: 10.3389/fnagi.2021.662786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Wang H, Zhang Y, Mo P, Liu J, Wang H, Wang F, Zhao Q. Neutrophil to CD4+ lymphocyte ratio as a potential biomarker in predicting virus negative conversion time in COVID-19. Int Immunopharmacol 2020;85:106683. [PMID: 32531713 DOI: 10.1016/j.intimp.2020.106683] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
30 Ali A, Noman M, Guo Y, Liu X, Zhang R, Zhou J, Zheng Y, Zhang XE, Qi Y, Chen X, Men D. Myoglobin and C-reactive protein are efficient and reliable early predictors of COVID-19 associated mortality. Sci Rep 2021;11:5975. [PMID: 33727641 DOI: 10.1038/s41598-021-85426-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Bunders MJ, Altfeld M. Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions. Immunity 2020;53:487-95. [PMID: 32853545 DOI: 10.1016/j.immuni.2020.08.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
32 Lagier JC, Million M, Gautret P, Colson P, Cortaredona S, Giraud-Gatineau A, Honoré S, Gaubert JY, Fournier PE, Tissot-Dupont H, Chabrière E, Stein A, Deharo JC, Fenollar F, Rolain JM, Obadia Y, Jacquier A, La Scola B, Brouqui P, Drancourt M, Parola P, Raoult D; IHU COVID-19 Task force. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis 2020;36:101791. [PMID: 32593867 DOI: 10.1016/j.tmaid.2020.101791] [Cited by in Crossref: 130] [Cited by in F6Publishing: 116] [Article Influence: 65.0] [Reference Citation Analysis]
33 Demaret J, Lefèvre G, Vuotto F, Trauet J, Duhamel A, Labreuche J, Varlet P, Dendooven A, Stabler S, Gachet B, Bauer J, Prevost B, Bocket L, Alidjinou EK, Lambert M, Yelnik C, Meresse B, Dubuquoy L, Launay D, Dubucquoi S, Montaigne D, Woitrain E, Maggiotto F, Bou Saleh M, Top I, Elsermans V, Jeanpierre E, Dupont A, Susen S, Brousseau T, Poissy J, Faure K, Labalette M; Lille Covid Research Network (LICORNE). Severe SARS-CoV-2 patients develop a higher specific T-cell response. Clin Transl Immunology 2020;9:e1217. [PMID: 33376594 DOI: 10.1002/cti2.1217] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
34 Khalirakhmanov AF, Idrisova KF, Gaifullina RF, Zinchenko SV, Litvinov RI, Sharafeev AZ, Kiyasov AP, Rizvanov AA. Pathogenesis, Diagnosis, and Treatment of Hemostatic Disorders in COVID-19 Patients. Acta Naturae 2021;13:79-84. [PMID: 34377558 DOI: 10.32607/actanaturae.11182] [Reference Citation Analysis]
35 Conticini E, Frediani B, Caro D. Can Atmospheric Pollution Be Considered a Co-Factor in Extremely High Level of SARS-CoV-2 Lethality in Northern Italy? Environ Pollut. 2020;261:114465. [PMID: 32268945 DOI: 10.1016/j.envpol.2020.114465] [Cited by in Crossref: 370] [Cited by in F6Publishing: 283] [Article Influence: 185.0] [Reference Citation Analysis]
36 Malek RJ, Bill CA, Vines CM. Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19. Biomed Pharmacother 2021;144:112276. [PMID: 34624681 DOI: 10.1016/j.biopha.2021.112276] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Neidleman J, Luo X, George AF, McGregor M, Yang J, Yun C, Murray V, Gill G, Greene WC, Vasquez J, Lee S, Ghosn E, Lynch K, Roan NR. Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19. medRxiv 2021:2021. [PMID: 33532792 DOI: 10.1101/2021.01.22.21250054] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Khan M, Shah N, Mushtaq H, Jehanzeb V. Profiling Laboratory Biomarkers Associated with COVID-19 Disease Progression: A Single-Center Experience. Int J Microbiol 2021;2021:6643333. [PMID: 33628256 DOI: 10.1155/2021/6643333] [Reference Citation Analysis]
39 Zahedi M, Yousefi M, Abounoori M, Malekan M, Tajik F, Heydari K, Mortazavi P, Ghahramani S, Ghazaeian M, Sheydaee F, Nasirzadeh A, Alizadeh-Navaei R. The Interrelationship between Liver Function Test and the Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Iran J Med Sci 2021;46:237-55. [PMID: 34305236 DOI: 10.30476/ijms.2021.87555.1793] [Reference Citation Analysis]
40 Pasha SB, Swi A, Hammoud GM. Gastrointestinal and hepatic manifestations of COVID-19 infection: Lessons for practitioners. World J Meta-Anal 2020; 8(5): 348-374 [DOI: 10.13105/wjma.v8.i5.348] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Webb BJ, Peltan ID, Jensen P, Hoda D, Hunter B, Silver A, Starr N, Buckel W, Grisel N, Hummel E, Snow G, Morris D, Stenehjem E, Srivastava R, Brown SM. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. Lancet Rheumatol 2020;2:e754-63. [PMID: 33015645 DOI: 10.1016/S2665-9913(20)30343-X] [Cited by in Crossref: 83] [Cited by in F6Publishing: 48] [Article Influence: 41.5] [Reference Citation Analysis]
42 Jannelli E, Castelli A, Ferranti Calderoni E, Annunziata S, Maccario G, Ivone A, Pasta G, Mosconi M. Fractures in Patients With COVID-19 Infection: Early Prognosis and Management. A Case Series of 20 Patients in a Single Institution in Lombardy, Northern Italy. J Orthop Trauma 2020;34:e389-97. [PMID: 32947590 DOI: 10.1097/BOT.0000000000001905] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Mondello C, Roccuzzo S, Malfa O, Sapienza D, Gualniera P, Ventura Spagnolo E, Di Nunno N, Salerno M, Pomara C, Asmundo A. Pathological Findings in COVID-19 as a Tool to Define SARS-CoV-2 Pathogenesis. A Systematic Review. Front Pharmacol 2021;12:614586. [PMID: 33867981 DOI: 10.3389/fphar.2021.614586] [Reference Citation Analysis]
44 Muttineni R, Kammili N, Bingi TC, Rao M R, Putty K, Dholaniya PS, Puli RK, Pakalapati S, S S, K S, Doodipala MR, Upadhyay AA, Bosinger SE, Amara RR, Kondapi AK. Clinical and whole genome characterization of SARS-CoV-2 in India. PLoS One 2021;16:e0246173. [PMID: 33529260 DOI: 10.1371/journal.pone.0246173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
45 Mol MBA, Strous MTA, van Osch FHM, Vogelaar FJ, Barten DG, Farchi M, Foudraine NA, Gidron Y. Heart-rate-variability (HRV), predicts outcomes in COVID-19. PLoS One 2021;16:e0258841. [PMID: 34710127 DOI: 10.1371/journal.pone.0258841] [Reference Citation Analysis]
46 Swain S, Ray A, Sarda R, Vyas S, Singh G, Jorwal P, Kodan P, Khanna P, Xess I, Sinha S, Wig N, Trikha A. COVID-19-associated subacute invasive pulmonary aspergillosis. Mycoses 2021. [PMID: 34541719 DOI: 10.1111/myc.13369] [Reference Citation Analysis]
47 Fenizia C, Biasin M, Cetin I, Vergani P, Mileto D, Spinillo A, Gismondo MR, Perotti F, Callegari C, Mancon A, Cammarata S, Beretta I, Nebuloni M, Trabattoni D, Clerici M, Savasi V. Analysis of SARS-CoV-2 vertical transmission during pregnancy. Nat Commun 2020;11:5128. [PMID: 33046695 DOI: 10.1038/s41467-020-18933-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 76] [Article Influence: 42.5] [Reference Citation Analysis]
48 Bhatti SI, Mindikoglu AL. The impact of dawn to sunset fasting on immune system and its clinical significance in Covid-19 pandemic. Metabol Open 2021;:100162. [PMID: 34977523 DOI: 10.1016/j.metop.2021.100162] [Reference Citation Analysis]
49 Kam YW, Ahmed MY, Amrun SN, Lee B, Refaie T, Elgizouli K, Fong SW, Renia L, Ng LF. Systematic analysis of disease-specific immunological signatures in patients with febrile illness from Saudi Arabia. Clin Transl Immunology 2020;9:e1163. [PMID: 32864128 DOI: 10.1002/cti2.1163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
50 Fouladseresht H, Ghamar Talepoor A, Eskandari N, Norouzian M, Ghezelbash B, Beyranvand MR, Nejadghaderi SA, Carson-chahhoud K, Kolahi A, Safiri S. Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities. Front Immunol 2022;12:785946. [DOI: 10.3389/fimmu.2021.785946] [Reference Citation Analysis]
51 Kiremitler NB, Kemerli MZ, Kayaci N, Karagoz S, Pekdemir S, Sarp G, Sanduvac S, Onses MS, Yilmaz E. Nanostructures for the Prevention, Diagnosis, and Treatment of SARS-CoV-2: A Review. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.2c00181] [Reference Citation Analysis]
52 Schweizer TA, Mairpady Shambat S, Vulin C, Hoeller S, Acevedo C, Huemer M, Gomez‐mejia A, Chang C, Baum J, Hertegonne S, Hitz E, Scheier TC, Hofmaenner DA, Buehler PK, Moch H, Schuepbach RA, Brugger SD, Zinkernagel AS. Blunted sFasL signalling exacerbates TNF‐driven neutrophil necroptosis in critically ill COVID‐19 patients. Clin & Trans Imm 2021;10. [DOI: 10.1002/cti2.1357] [Reference Citation Analysis]
53 Kaya A, Yıldız Kaya S. A case of reactivation of hepatitis B presenting with exudative ascites. Trop Doct 2021;:494755211064412. [PMID: 34927481 DOI: 10.1177/00494755211064412] [Reference Citation Analysis]
54 Li Y, Zhao W, Liu J, Chen Z, Lv Q, Zhang Z. Immunotherapy Summary for Cytokine Storm in COVID-19. Front Pharmacol 2021;12:731847. [PMID: 34603047 DOI: 10.3389/fphar.2021.731847] [Reference Citation Analysis]
55 Fathi M, Vakili K, Sayehmiri F, Mohamadkhani A, Hajiesmaeili M, Rezaei-Tavirani M, Eilami O. The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study. PLoS One 2021;16:e0246190. [PMID: 33592019 DOI: 10.1371/journal.pone.0246190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
56 Welzel T, Samba SD, Klein R, van den Anker JN, Kuemmerle-Deschner JB. COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment. J Clin Med 2021;10:605. [PMID: 33562758 DOI: 10.3390/jcm10040605] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
57 Testino G, Vignoli T, Patussi V, Allosio P, Amendola MF, Aricò S, Baselice A, Balbinot P, Campanile V, Fanucchi T, Greco G, Macciò L, Meneguzzi C, Mioni D, Palmieri VO, Parisi M, Renzetti D, Rossin R, Gandin C, Bottaro LC, Bernardi M, Addolorato G, Lungaro L, Zoli G, Scafato E, Caputo F. Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA). Dig Dis Sci 2021. [PMID: 34142284 DOI: 10.1007/s10620-021-07006-1] [Reference Citation Analysis]
58 Gulic T, Blagojevic Zagorac G. COVID-19 and pregnancy: are they friends or enemies? Horm Mol Biol Clin Investig 2021;42:57-62. [PMID: 33567179 DOI: 10.1515/hmbci-2020-0054] [Reference Citation Analysis]
59 [DOI: 10.1101/2021.03.31.21254699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
60 Bossù P, Toppi E, Sterbini V, Spalletta G. Implication of Aging Related Chronic Neuroinflammation on COVID-19 Pandemic. J Pers Med 2020;10:E102. [PMID: 32858874 DOI: 10.3390/jpm10030102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
61 Gautier T, David-Le Gall S, Sweidan A, Tamanai-Shacoori Z, Jolivet-Gougeon A, Loréal O, Bousarghin L. Next-Generation Probiotics and Their Metabolites in COVID-19. Microorganisms 2021;9:941. [PMID: 33925715 DOI: 10.3390/microorganisms9050941] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
62 Liu D, Cui P, Zeng S, Wang S, Feng X, Xu S, Li R, Gao Y, Yu R, Wang Y, Yuan Y, Li H, Jiao X, Chi J, Liu J, Yu Y, Zheng X, Song C, Jin N, Gong W, Liu X, Cai G, Li C, Gao Q. Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study. EClinicalMedicine 2020;25:100471. [PMID: 32840491 DOI: 10.1016/j.eclinm.2020.100471] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
63 Minami T, Iwata Y, Wada T. Renal complications in coronavirus disease 2019: a systematic review. Inflamm Regen 2020;40:31. [PMID: 33317643 DOI: 10.1186/s41232-020-00140-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
64 Kali SK, Dröge P, Murugan P. Interferon β, an enhancer of the innate immune response against SARS-CoV-2 infection. Microb Pathog 2021;158:105105. [PMID: 34311016 DOI: 10.1016/j.micpath.2021.105105] [Reference Citation Analysis]
65 Khalid A, Ali Jaffar M, Khan T, Abbas Lail R, Ali S, Aktas G, Waris A, Javaid A, Ijaz N, Muhammad N. Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis. Hematology 2021;26:529-42. [PMID: 34334100 DOI: 10.1080/16078454.2021.1950898] [Reference Citation Analysis]
66 Tabassum T, Rahman A, Araf Y, Ullah MA, Hosen MJ. Prospective selected biomarkers in COVID-19 diagnosis and treatment. Biomark Med 2021;15:1435-49. [PMID: 34538093 DOI: 10.2217/bmm-2021-0038] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Prasad N, Gopalakrishnan N, Sahay M, Gupta A, Agarwal SK; COVID-19 Working Group of Indian Society of Nephrology. Epidemiology, Genomic Structure, the Molecular Mechanism of Injury, Diagnosis and Clinical Manifestations of Coronavirus Infection: An Overview. Indian J Nephrol 2020;30:143-54. [PMID: 33013059 DOI: 10.4103/ijn.IJN_191_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
68 Wei LL, Wang WJ, Chen DX, Xu B. Dysregulation of the immune response affects the outcome of critical COVID-19 patients. J Med Virol 2020;92:2768-76. [PMID: 32543740 DOI: 10.1002/jmv.26181] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
69 Shah A, Shah M, Kaidawala Z, Desphande R. Corona, Acute Ischemic Stroke, Malignant Cerebral Edema, and Hemo-adsorption: A Case Report. Indian Journal of Critical Care Medicine 2022;26:235-8. [DOI: 10.5005/jp-journals-10071-24116] [Reference Citation Analysis]
70 Zhang J, Rao X, Li Y, Zhu Y, Liu F, Guo G, Luo G, Meng Z, De Backer D, Xiang H, Peng Z. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Ann Intensive Care 2021;11:5. [PMID: 33420963 DOI: 10.1186/s13613-020-00792-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 28.0] [Reference Citation Analysis]
71 Samsonova M, Mikhalyova L, Zairatyants O, Varyasin V, Bykanova A, Mishnev O, Berezovsky Y, Tishkevitch O, Gomzikova E, Chernyayev A, Khovanskaya T. Lung Pathology of COVID-19 in Moscow. Arkh patol 2020;82:32. [DOI: 10.17116/patol20208204132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
72 Zeng Q, Li YZ, Dong SY, Chen ZT, Gao XY, Zhang H, Huang G, Xu Y. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension. Front Immunol 2020;11:596684. [PMID: 33362779 DOI: 10.3389/fimmu.2020.596684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Li Q, Cao Y, Chen L, Wu D, Yu J, Wang H, He W, Chen L, Dong F, Chen W, Chen W, Li L, Ran Q, Liu Q, Ren W, Gao F, Chen Z, Gale RP, Hu Y. Hematological features of persons with COVID-19. Leukemia 2020;34:2163-72. [PMID: 32528042 DOI: 10.1038/s41375-020-0910-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 18.5] [Reference Citation Analysis]
74 Zhu A, Chen Z, Wang Y, Zeng Q, Sun J, Zhuang Z, Li F, Zhao J, Zhao J, Zhong N. Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice. Fundamental Research 2021;1:124-30. [DOI: 10.1016/j.fmre.2021.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
75 Botta C, Indrieri A, Garofalo E, Biamonte F, Bruni A, Pasqua P, Cesario F, Costanzo FS, Longhini F, Mendicino F. COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine Storm. Front Oncol 2020;10:599502. [PMID: 33489899 DOI: 10.3389/fonc.2020.599502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
76 Low ZY, Yip AJW, Sharma A, Lal SK. SARS coronavirus outbreaks past and present-a comparative analysis of SARS-CoV-2 and its predecessors. Virus Genes 2021;57:307-17. [PMID: 34061288 DOI: 10.1007/s11262-021-01846-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Bagheri A, Moezzi SMI, Mosaddeghi P, Nadimi Parashkouhi S, Fazel Hoseini SM, Badakhshan F, Negahdaripour M. Interferon-inducer antivirals: Potential candidates to combat COVID-19. Int Immunopharmacol 2021;91:107245. [PMID: 33348292 DOI: 10.1016/j.intimp.2020.107245] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
78 Lozahic C, Maddock H, Sandhu H. Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19. Front Cardiovasc Med 2021;8:634291. [PMID: 33969006 DOI: 10.3389/fcvm.2021.634291] [Reference Citation Analysis]
79 Taher A, Lashgari M, Sedighi L, Rahimi-Bashar F, Poorolajal J, Mehrpooya M. A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome. Pharmacol Rep 2021. [PMID: 34114174 DOI: 10.1007/s43440-021-00296-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
80 Beydoğan E, Yürük Atasoy P. The relationship between CRP at admission and thorax CT findings in patients diagnosed with COVID-19. Int J Clin Pract 2021;:e14962. [PMID: 34624163 DOI: 10.1111/ijcp.14962] [Reference Citation Analysis]
81 De Virgiliis F, Di Giovanni S. Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19. Nat Rev Neurol 2020;16:645-52. [PMID: 32843733 DOI: 10.1038/s41582-020-0402-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
82 [DOI: 10.1101/2020.05.04.075911] [Cited by in Crossref: 61] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
83 Bonam SR, Kaveri SV, Sakuntabhai A, Gilardin L, Bayry J. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients. Cell Rep Med. 2020;1:100016. [PMID: 32562483 DOI: 10.1016/j.xcrm.2020.100016] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 27.0] [Reference Citation Analysis]
84 Lewis TC, Adhikari S, Tatapudi V, Holub M, Kunichoff D, Troxel AB, Montgomery RA, Sterman DH. A Propensity-Matched Cohort Study of Tocilizumab in Patients With Coronavirus Disease 2019. Crit Care Explor 2020;2:e0283. [PMID: 33225307 DOI: 10.1097/CCE.0000000000000283] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
85 Alhalabi M, Eddin KA, Ali F, Abbas A. SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report. Medicine (Baltimore) 2022;101:e28722. [PMID: 35089243 DOI: 10.1097/MD.0000000000028722] [Reference Citation Analysis]
86 Cheng L, Li H, Li L, Liu C, Yan S, Chen H, Li Y. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal 2020;34:e23618. [PMID: 33078400 DOI: 10.1002/jcla.23618] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 19.5] [Reference Citation Analysis]
87 Roomi S, Ullah W, Farooq S, Saeed R, Haq S, Ashfaq AA. Is therapeutic anticoagulation improving renal outcomes in COVID-19? J Community Hosp Intern Med Perspect 2020;10:306-9. [PMID: 32850085 DOI: 10.1080/20009666.2020.1785995] [Reference Citation Analysis]
88 Stradner MH, Dejaco C, Zwerina J, Fritsch-Stork RD. Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic. Front Med (Lausanne) 2020;7:562142. [PMID: 33154972 DOI: 10.3389/fmed.2020.562142] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
89 Feng R, Wang B, Ma Z, Guo X, Li H, Tang Y, Meng H, Yu H, Peng C, Chu G, Wang X, Teng Y, Zhang Q, Zhu T, Tong Z, Zhao H, Lu H, Qi X. Dynamic change of serum albumin level can predict the prognosis of COVID-19 patients with hypoalbuminemia. J Med Virol 2021. [PMID: 34750829 DOI: 10.1002/jmv.27439] [Reference Citation Analysis]
90 Zhu Y, Zhong J, Dong L. Epidemiology and Clinical Management of Rheumatic Autoimmune Diseases in the COVID-19 Pandemic: A Review. Front Med (Lausanne) 2021;8:725226. [PMID: 34490312 DOI: 10.3389/fmed.2021.725226] [Reference Citation Analysis]
91 Zhang YY, Li BR, Ning BT. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections. Front Immunol 2020;11:2033. [PMID: 32922406 DOI: 10.3389/fimmu.2020.02033] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
92 Dyavar SR, Singh R, Emani R, Pawar GP, Chaudhari VD, Podany AT, Avedissian SN, Fletcher CV, Salunke DB. Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options. Biomed Pharmacother 2021;141:111794. [PMID: 34153851 DOI: 10.1016/j.biopha.2021.111794] [Reference Citation Analysis]
93 Goerlich E, Minhas AS, Mukherjee M, Sheikh FH, Gilotra NA, Sharma G, Michos ED, Hays AG. Multimodality Imaging for Cardiac Evaluation in Patients with COVID-19. Curr Cardiol Rep 2021;23:44. [PMID: 33721125 DOI: 10.1007/s11886-021-01483-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
94 Gao YM, Xu G, Wang B, Liu BC. Cytokine storm syndrome in coronavirus disease 2019: A narrative review. J Intern Med 2021;289:147-61. [PMID: 32696489 DOI: 10.1111/joim.13144] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 26.5] [Reference Citation Analysis]
95 Khoshkam Z, Aftabi Y, Stenvinkel P, Paige Lawrence B, Rezaei MH, Ichihara G, Fereidouni S. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection. J Adv Res 2021;31:49-60. [PMID: 33520309 DOI: 10.1016/j.jare.2020.12.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
96 Zheng KL, Xu Y, Guo YF, Diao L, Kong XY, Wan XJ, Zhao F, Ning FZ, Wang LB, Qiao F, Zhao JM, Zhou JH, Zhong YQ, Wu SX, Chen Y, Jin G, Dong YC. Efficacy and safety of tocilizumab in COVID-19 patients. Aging (Albany NY) 2020;12:18878-88. [PMID: 33031060 DOI: 10.18632/aging.103988] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
97 Sauerhering L, Kupke A, Meier L, Dietzel E, Hoppe J, Gruber AD, Gattenloehner S, Witte B, Fink L, Hofmann N, Zimmermann T, Goesmann A, Nist A, Stiewe T, Becker S, Herold S, Peteranderl C. Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus via interferon-λ in vitro and in mice. Eur Respir J 2020;56:1901826. [PMID: 32616594 DOI: 10.1183/13993003.01826-2019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
98 Qi Y, Jia JA, Li H, Wan N, Zhang S, Ma X. Lymphocyte-monocyte-neutrophil index: a predictor of severity of coronavirus disease 2019 patients produced by sparse principal component analysis. Virol J 2021;18:115. [PMID: 34088324 DOI: 10.1186/s12985-021-01561-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Alavi Darazam I, Shokouhi S, Pourhoseingholi MA, Naghibi Irvani SS, Mokhtari M, Shabani M, Amirdosara M, Torabinavid P, Golmohammadi M, Hashemi S, Azimi A, Jafarazadeh Maivan MH, Rezaei O, Zali A, Hajiesmaeili M, Shabanpour Dehbsneh H, Hoseyni Kusha A, Taleb Shoushtari M, Khalili N, Soleymaninia A, Gachkar L, Khoshkar A. Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial. Sci Rep 2021;11:8059. [PMID: 33850184 DOI: 10.1038/s41598-021-86859-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
100 Peritore AF, D'Amico R, Siracusa R, Cordaro M, Fusco R, Gugliandolo E, Genovese T, Crupi R, Di Paola R, Cuzzocrea S, Impellizzeri D. Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach. Int J Mol Sci 2021;22:5533. [PMID: 34073872 DOI: 10.3390/ijms22115533] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Soni B, Kabra R, Singh S. Quantitative Insight into Immunopathology of SARS-CoV-2 Infection. J Interferon Cytokine Res 2021;41:244-57. [PMID: 34280026 DOI: 10.1089/jir.2020.0156] [Reference Citation Analysis]
102 D'Marco L, Puchades MJ, Romero-Parra M, Gimenez-Civera E, Soler MJ, Ortiz A, Gorriz JL. Coronavirus disease 2019 in chronic kidney disease. Clin Kidney J 2020;13:297-306. [PMID: 32699615 DOI: 10.1093/ckj/sfaa104] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
103 Vere G, Alam MR, Farrar S, Kealy R, Kessler BM, O’brien DP, Pinto-fernández A. Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19. Biomolecules 2022;12:300. [DOI: 10.3390/biom12020300] [Reference Citation Analysis]
104 Liu J, Liu Z, Jiang W, Wang J, Zhu M, Song J, Wang X, Su Y, Xiang G, Ye M, Li J, Zhang Y, Shen Q, Li Z, Yao D, Song Y, Yu K, Luo Z, Ye L. Clinical predictors of COVID-19 disease progression and death: Analysis of 214 hospitalised patients from Wuhan, China. Clin Respir J 2021;15:293-309. [PMID: 33090710 DOI: 10.1111/crj.13296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
105 Emadi-Baygi M, Ehsanifard M, Afrashtehpour N, Norouzi M, Joz-Abbasalian Z. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities. Front Immunol 2021;12:778913. [PMID: 34912345 DOI: 10.3389/fimmu.2021.778913] [Reference Citation Analysis]
106 Felsenstein S, Herbert JA, McNamara PS, Hedrich CM. COVID-19: Immunology and treatment options. Clin Immunol. 2020;215:108448. [PMID: 32353634 DOI: 10.1016/j.clim.2020.108448] [Cited by in Crossref: 254] [Cited by in F6Publishing: 222] [Article Influence: 127.0] [Reference Citation Analysis]
107 Mosaddeghi P, Shahabinezhad F, Dorvash M, Goodarzi M, Negahdaripour M. Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19. Hum Vaccin Immunother 2021;17:1650-61. [PMID: 33185497 DOI: 10.1080/21645515.2020.1833577] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
108 Fakhry AbdelMassih A, Ghaly R, Amin A, Gaballah A, Kamel A, Heikal B, Menshawey E, Ismail HA, Hesham H, Attallah J, Eshak K, Moursi M, Khaled-Ibn-ElWalid M, Tawfik M, Tarek M, Mohy-El-Din M, Habib M, Hafez N, Bahnan O, Ismail P, Senoussy S, Ghaly S, Farah S, Hozaien R, Adel V, Khaled M. Obese communities among the best predictors of COVID-19-related deaths. Cardiovasc Endocrinol Metab 2020;9:102-7. [PMID: 32803143 DOI: 10.1097/XCE.0000000000000218] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
109 Arastehfar A, Carvalho A, van de Veerdonk FL, Jenks JD, Koehler P, Krause R, Cornely OA, S Perlin D, Lass-Flörl C, Hoenigl M. COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment. J Fungi (Basel) 2020;6:E91. [PMID: 32599813 DOI: 10.3390/jof6020091] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 41.5] [Reference Citation Analysis]
110 Soliz J, Schneider-Gasser EM, Arias-Reyes C, Aliaga-Raduan F, Poma-Machicao L, Zubieta-Calleja G, Furuya WI, Trevizan-Baú P, Dhingra RR, Dutschmann M. Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19? Respir Physiol Neurobiol 2020;279:103476. [PMID: 32522574 DOI: 10.1016/j.resp.2020.103476] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
111 Mulchandani R, Lyngdoh T, Kakkar AK. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis. Eur J Clin Invest 2021;51:e13429. [PMID: 33058143 DOI: 10.1111/eci.13429] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
112 Brinati D, Campagner A, Ferrari D, Locatelli M, Banfi G, Cabitza F. Detection of COVID-19 Infection from Routine Blood Exams with Machine Learning: A Feasibility Study. J Med Syst 2020;44:135. [PMID: 32607737 DOI: 10.1007/s10916-020-01597-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 25.0] [Reference Citation Analysis]
113 Chidambaram V, Tun NL, Haque WZ, Majella MG, Sivakumar RK, Kumar A, Hsu AT, Ishak IA, Nur AA, Ayeh SK, Salia EL, Zil-E-Ali A, Saeed MA, Sarena APB, Seth B, Ahmadzada M, Haque EF, Neupane P, Wang KH, Pu TM, Ali SMH, Arshad MA, Wang L, Baksh S, Karakousis PC, Galiatsatos P. Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis.PLoS One. 2020;15:e0241541. [PMID: 33206661 DOI: 10.1371/journal.pone.0241541] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
114 Sherren PB, Ostermann M, Agarwal S, Meadows CIS, Ioannou N, Camporota L. COVID-19-related organ dysfunction and management strategies on the intensive care unit: a narrative review. Br J Anaesth 2020;125:912-25. [PMID: 32988604 DOI: 10.1016/j.bja.2020.08.050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
115 [DOI: 10.1101/2020.05.06.20092833] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
116 Tian J, Yuan X, Xiao J, Zhong Q, Yang C, Liu B, Cai Y, Lu Z, Wang J, Wang Y, Liu S, Cheng B, Wang J, Zhang M, Wang L, Niu S, Yao Z, Deng X, Zhou F, Wei W, Li Q, Chen X, Chen W, Yang Q, Wu S, Fan J, Shu B, Hu Z, Wang S, Yang XP, Liu W, Miao X, Wang Z. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol 2020;21:893-903. [PMID: 32479790 DOI: 10.1016/S1470-2045(20)30309-0] [Cited by in Crossref: 174] [Cited by in F6Publishing: 133] [Article Influence: 87.0] [Reference Citation Analysis]
117 Zhong P, Xu J, Yang D, Shen Y, Wang L, Feng Y, Du C, Song Y, Wu C, Hu X, Sun Y. COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduct Target Ther 2020;5:256. [PMID: 33139693 DOI: 10.1038/s41392-020-00373-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
118 Huang W, Berube J, McNamara M, Saksena S, Hartman M, Arshad T, Bornheimer SJ, O'Gorman M. Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis. Cytometry A 2020;97:772-6. [PMID: 32542842 DOI: 10.1002/cyto.a.24172] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 24.0] [Reference Citation Analysis]
119 Reddy RK, Charles WN, Sklavounos A, Dutt A, Seed PT, Khajuria A. The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. J Med Virol 2021;93:1045-56. [PMID: 32749705 DOI: 10.1002/jmv.26389] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 27.5] [Reference Citation Analysis]
120 Pillat MM, Krüger A, Guimarães LMF, Lameu C, de Souza EE, Wrenger C, Ulrich H. Insights in Chloroquine Action: Perspectives and Implications in Malaria and COVID-19. Cytometry A 2020;97:872-81. [PMID: 32686260 DOI: 10.1002/cyto.a.24190] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
121 Eslamijouybari M, Heydari K, Maleki I, Moosazadeh M, Hedayatizadeh-Omran A, Vahedi L, Ghasemian R, Sharifpour A, Alizadeh-Navaei R. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19 Patients and Control Group and Relationship with Disease Prognosis. Caspian J Intern Med 2020;11:531-5. [PMID: 33425271 DOI: 10.22088/cjim.11.0.531] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
122 Gao ZW, Wang X, Lin F, Dong K. The correlation between SARS-CoV-2 infection and rheumatic disease. Autoimmun Rev. 2020;19:102557. [PMID: 32371101 DOI: 10.1016/j.autrev.2020.102557] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
123 Azouz NP, Klingler AM, Callahan V, Akhrymuk IV, Elez K, Raich L, Henry BM, Benoit JL, Benoit SW, Noé F, Kehn-Hall K, Rothenberg ME. Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2. bioRxiv 2020:2020. [PMID: 33052338 DOI: 10.1101/2020.05.04.077826] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
124 Bi X, Liu W, Ding X, Liang S, Zheng Y, Zhu X, Quan S, Yi X, Xiang N, Du J, Lyu H, Yu D, Zhang C, Xu L, Ge W, Zhan X, He J, Xiong Z, Zhang S, Li Y, Xu P, Zhu G, Wang D, Zhu H, Chen S, Li J, Zhao H, Zhu Y, Liu H, Xu J, Shen B, Guo T. Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19. Cell Rep 2022;38:110271. [PMID: 35026155 DOI: 10.1016/j.celrep.2021.110271] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Asghar MS, Haider Kazmi SJ, Khan NA, Akram M, Hassan M, Rasheed U, Ahmed Khan S. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country. Cureus 2020;12:e9575. [PMID: 32913691 DOI: 10.7759/cureus.9575] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
126 Wang M, Luo L, Bu H, Xia H. One case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4+ T-cell count. Int J Infect Dis. 2020;96:148-150. [PMID: 32335339 DOI: 10.1016/j.ijid.2020.04.060] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 22.0] [Reference Citation Analysis]
127 Berber I, Cagasar O, Sarici A, Berber NK, Aydogdu I, Ulutas O, Yildirim A, Bag HGG, Delen LA. Peripheral Blood Smear Findings of COVID-19 Patients Provide İnformation about the Severity of the Disease and the Duration of Hospital Stay. Mediterr J Hematol Infect Dis 2021;13:e2021009. [PMID: 33489048 DOI: 10.4084/MJHID.2021.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
128 Luo Z, Chen W, Xiang M, Wang H, Xiao W, Xu C, Li Y, Min J, Tu Q. The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial. Eur J Integr Med 2021;42:101305. [PMID: 33552315 DOI: 10.1016/j.eujim.2021.101305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
129 Trombetta A, Comar M, Tommasini A, Canton M, Campisciano G, Zanotta N, Cason C, Maso G, Risso FM. SARS-CoV-2 Infection and Inflammatory Response in a Twin Pregnancy. Int J Environ Res Public Health 2021;18:3075. [PMID: 33802696 DOI: 10.3390/ijerph18063075] [Reference Citation Analysis]
130 Satış H, Özger HS, Aysert Yıldız P, Hızel K, Gulbahar Ö, Erbaş G, Aygencel G, Guzel Tunccan O, Öztürk MA, Dizbay M, Tufan A. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19. Cytokine 2021;137:155302. [PMID: 33002740 DOI: 10.1016/j.cyto.2020.155302] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
131 Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis 2020;14:1753466620937175. [PMID: 32615866 DOI: 10.1177/1753466620937175] [Cited by in Crossref: 110] [Cited by in F6Publishing: 107] [Article Influence: 55.0] [Reference Citation Analysis]
132 Çölkesen F, Kepenek Kurt E, Vatansev H, Korkmaz C, Çölkesen F, Yücel F, Yıldız E, Evcen R, Aykan FS, Kılınç M, Aytekin G, Feyzioğlu B, Doğan M, Arslan Ş, Teke T, Keleş S, Reisli İ. Memory B cells and serum immunoglobulins are associated with disease severity and mortality in patients with COVID-19. Postgrad Med J 2022:postgradmedj-2021-140540. [PMID: 35046114 DOI: 10.1136/postgradmedj-2021-140540] [Reference Citation Analysis]
133 Jamal M, Bangash HI, Habiba M, Lei Y, Xie T, Sun J, Wei Z, Hong Z, Shao L, Zhang Q. Immune dysregulation and system pathology in COVID-19. Virulence 2021;12:918-36. [PMID: 33757410 DOI: 10.1080/21505594.2021.1898790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
134 Cisneros IE, Cunningham KA. Covid-19 interface with drug misuse and substance use disorders. Neuropharmacology 2021;198:108766. [PMID: 34454912 DOI: 10.1016/j.neuropharm.2021.108766] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Ulugerger Avci G, Bektan Kanat B, Suzan V, Can G, Korkmazer B, Karaali R, Tabak F, Borekci S, Aygun G, Yavuzer H, Doventas A. Clinical outcomes of geriatric patients with COVID-19: review of one-year data. Aging Clin Exp Res. [DOI: 10.1007/s40520-021-02047-y] [Reference Citation Analysis]
136 Baeten P, Van Zeebroeck L, Kleinewietfeld M, Hellings N, Broux B. Improving the Efficacy of Regulatory T Cell Therapy. Clin Rev Allergy Immunol 2021. [PMID: 34224053 DOI: 10.1007/s12016-021-08866-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
137 Serrano M, Espinosa G, Lalueza A, Bravo-Gallego LY, Diaz-Simón R, Garcinuño S, Gil-Etayo J, Moises J, Naranjo L, Prieto-González S, Ruiz-Ortiz E, Sánchez B, Moreno-Castaño AB, Díaz-Pedroche C, Viñas-Gomis O, Cervera R, Serrano A; APS-COVID 19 Study Group/European Forum on Antiphospholipid Antibodies. Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019. ACR Open Rheumatol 2021;3:267-76. [PMID: 33738987 DOI: 10.1002/acr2.11245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
138 Yuksel A, Karadogan D, Gurkan CG, Akyil FT, Toreyin ZN, Marim F, Arikan H, Eyuboglu TS, Emiralioglu N, Serifoglu I, Develi E, Celik S, Sertcelik UO, Gursoy TR, Elversli MF, Oncel A, Er B, Firincioglulari A, Gunaydin FE, Ozakinci H, Ozcelik N, Esendagli D, Aydin A, Kose N, Ercelik M, Gulhan PY, Yildiz E, Irmak I, Kara BY, Gurz S, Karakas FG, Akgun M. Unclear Issues Regarding COVID-19. Eurasian J Med 2020;52:191-6. [PMID: 32612430 DOI: 10.5152/eurasianjmed.2020.20092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
139 [DOI: 10.1101/2020.04.08.031807] [Cited by in Crossref: 39] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
140 Nguyen Y, Corre F, Honsel V, Curac S, Zarrouk V, Burtz CP, Weiss E, Moyer JD, Gauss T, Grégory J, Bert F, Trichet C, Peoc'h K, Vilgrain V, Rebours V, Fantin B, Galy A. A nomogram to predict the risk of unfavourable outcome in COVID-19: a retrospective cohort of 279 hospitalized patients in Paris area. Ann Med 2020;52:367-75. [PMID: 32723107 DOI: 10.1080/07853890.2020.1803499] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
141 Angelopoulou A, Alexandris N, Konstantinou E, Mesiakaris K, Zanidis C, Farsalinos K, Poulas K. Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19. Environ Res. 2020;188:109858. [PMID: 32846644 DOI: 10.1016/j.envres.2020.109858] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
142 Noroozi R, Branicki W, Pyrc K, Łabaj PP, Pospiech E, Taheri M, Ghafouri-Fard S. Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions. Cytokine 2020;133:155143. [PMID: 32460144 DOI: 10.1016/j.cyto.2020.155143] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 17.0] [Reference Citation Analysis]
143 Esmaeilzadeh A, Rostami S, Yeganeh PM, Tahmasebi S, Ahmadi M. Recent advances in antibody-based immunotherapy strategies for COVID-19. J Cell Biochem 2021. [PMID: 34160093 DOI: 10.1002/jcb.30017] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
144 Vale AJM, Fernandes ACL, Guzen FP, Pinheiro FI, de Azevedo EP, Cobucci RN. Susceptibility to COVID-19 in Pregnancy, Labor, and Postpartum Period: Immune System, Vertical Transmission, and Breastfeeding. Front Glob Womens Health 2021;2:602572. [PMID: 34816177 DOI: 10.3389/fgwh.2021.602572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
145 Chen H, Qin L, Wu S, Xu W, Gao R, Zhang X. Clinical characteristics and laboratory features of COVID-19 in high altitude areas: A retrospective cohort study. PLoS One 2021;16:e0249964. [PMID: 34003821 DOI: 10.1371/journal.pone.0249964] [Reference Citation Analysis]
146 Hazeldine J, Lord JM. Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19? Front Immunol 2020;11:573662. [PMID: 33123152 DOI: 10.3389/fimmu.2020.573662] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
147 Juneja D, Savio RD, Srinivasan S, Pandit RA, Ramasubban S, Reddy PK, Singh M, Gopal PB, Chaudhry D, Govil D, Dixit S, Samavedam S. Basic Critical Care for Management of COVID-19 Patients: Position Paper of Indian Society of Critical Care Medicine, Part-I. Indian J Crit Care Med 2020;24:S244-53. [PMID: 33354048 DOI: 10.5005/jp-journals-10071-23601] [Reference Citation Analysis]
148 Cheng WT, Ke YH, Yang GY, Sun H, Chen Y, Ying RY, Zeng XH, Shen D, Tang KJ, Xu K, Yu F. Analysis of clinical features of COVID-19 in cancer patients. Acta Oncol 2020;59:1393-6. [PMID: 32857662 DOI: 10.1080/0284186X.2020.1810313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
149 Wang Z, Chen J, Zhu C, Liu L, Qi T, Shen Y, Zhang Y, Xu L, Li T, Qian Z, Steinhart CR, Lu H. Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients. Front Immunol 2021;12:568789. [PMID: 34149679 DOI: 10.3389/fimmu.2021.568789] [Reference Citation Analysis]
150 Khan F, van den Akker T, Hussein S, Marcellino BK, Khattar P, Glicksberg BS, Nadkarni GN, Firpo-Betancourt A, El Jamal SM. Activation of cytotoxic T cell population and inversion of CD4:CD8 ratio as manifestations of cellular immune response in SARS-COV-2 infection. J Hematop 2020;:1-3. [PMID: 32837599 DOI: 10.1007/s12308-020-00405-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
151 Singh S, Chakravarty T, Chen P, Akhmerov A, Falk J, Friedman O, Zaman T, Ebinger JE, Gheorghiu M, Marbán L, Marbán E, Makkar RR. Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series. Basic Res Cardiol 2020;115:36. [PMID: 32399655 DOI: 10.1007/s00395-020-0795-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
152 Savić D, Alsheikh TM, Alhaj AK, Lazovic L, Alsarraf L, Bosnjakovic P, Yousef W. Ruptured cerebral pseudoaneurysm in an adolescent as an early onset of COVID-19 infection: case report. Acta Neurochir (Wien) 2020;162:2725-9. [PMID: 32720013 DOI: 10.1007/s00701-020-04510-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
153 Polycarpou A, Howard M, Farrar CA, Greenlaw R, Fanelli G, Wallis R, Klavinskis LS, Sacks S. Rationale for targeting complement in COVID-19. EMBO Mol Med 2020;12:e12642. [PMID: 32559343 DOI: 10.15252/emmm.202012642] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 21.0] [Reference Citation Analysis]
154 Luo XH, Zhu Y, Mao J, Du RC. T cell immunobiology and cytokine storm of COVID-19. Scand J Immunol 2021;93:e12989. [PMID: 33113222 DOI: 10.1111/sji.12989] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
155 Iannaccone G, Scacciavillani R, Del Buono MG, Camilli M, Ronco C, Lavie CJ, Abbate A, Crea F, Massetti M, Aspromonte N. Weathering the Cytokine Storm in COVID-19: Therapeutic Implications. Cardiorenal Med 2020;10:277-87. [PMID: 32599589 DOI: 10.1159/000509483] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 12.5] [Reference Citation Analysis]
156 Yağcı S, Serin E, Acicbe Ö, Zeren Mİ, Odabaşı MS. The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID-19. Int J Lab Hematol 2021;43 Suppl 1:142-51. [PMID: 33554466 DOI: 10.1111/ijlh.13479] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
157 Calvet J, Gratacós J, Amengual MJ, Llop M, Navarro M, Moreno A, Berenguer-Llergo A, Serrano A, Orellana C, Cervantes M. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study. Viruses 2020;12:E1277. [PMID: 33182268 DOI: 10.3390/v12111277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
158 Reza Bagheri S, Abdi A, Benson J, Naghdi N, Eden SV, Arjmand M, Amini Z, Lawton MT, Alimohammadi E. The significant impact of Coronavirus disease 2019 (COVID-19) on in-hospital mortality of elderly patients with moderate to severe traumatic brain injury: A retrospective observational study. J Clin Neurosci 2021;93:241-6. [PMID: 34656255 DOI: 10.1016/j.jocn.2021.09.029] [Reference Citation Analysis]
159 Tong M, Xiong Y, Zhu C, Xu H, Zheng Q, Jiang Y, Zou L, Xiao X, Chen F, Yan X, Hu C, Zhu Y. Serum surfactant protein D in COVID-19 is elevated and correlated with disease severity. BMC Infect Dis 2021;21:737. [PMID: 34344306 DOI: 10.1186/s12879-021-06447-3] [Reference Citation Analysis]
160 Young BE, Fong SW, Chan YH, Mak TM, Ang LW, Anderson DE, Lee CY, Amrun SN, Lee B, Goh YS, Su YCF, Wei WE, Kalimuddin S, Chai LYA, Pada S, Tan SY, Sun L, Parthasarathy P, Chen YYC, Barkham T, Lin RTP, Maurer-Stroh S, Leo YS, Wang LF, Renia L, Lee VJ, Smith GJD, Lye DC, Ng LFP. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet 2020;396:603-11. [PMID: 32822564 DOI: 10.1016/S0140-6736(20)31757-8] [Cited by in Crossref: 189] [Cited by in F6Publishing: 109] [Article Influence: 94.5] [Reference Citation Analysis]
161 Cappello F, Gammazza AM, Dieli F, de Macario, Macario AJ. Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis. J Clin Med 2020;9:E2038. [PMID: 32610587 DOI: 10.3390/jcm9072038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
162 Ma X, Ng M, Xu S, Xu Z, Qiu H, Liu Y, Lyu J, You J, Zhao P, Wang S, Tang Y, Cui H, Yu C, Wang F, Shao F, Sun P, Tang Z. Development and validation of prognosis model of mortality risk in patients with COVID-19. Epidemiol Infect 2020;148:e168. [PMID: 32746957 DOI: 10.1017/S0950268820001727] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
163 Ferreira-Santos D, Maranhão P, Monteiro-Soares M; COVIDcids. Identifying common baseline clinical features of COVID-19: a scoping review. BMJ Open 2020;10:e041079. [PMID: 32938604 DOI: 10.1136/bmjopen-2020-041079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
164 Hügle B, Krumrey-Langkammerer M, Haas JP. Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication. Pediatr Rheumatol Online J 2021;19:163. [PMID: 34844609 DOI: 10.1186/s12969-021-00653-8] [Reference Citation Analysis]
165 Ghahramani S, Tabrizi R, Lankarani KB, Kashani SMA, Rezaei S, Zeidi N, Akbari M, Heydari ST, Akbari H, Nowrouzi-Sohrabi P, Ahmadizar F. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020;25:30. [PMID: 32746929 DOI: 10.1186/s40001-020-00432-3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 27.5] [Reference Citation Analysis]
166 Ahmed-Hassan H, Sisson B, Shukla RK, Wijewantha Y, Funderburg NT, Li Z, Hayes D Jr, Demberg T, Liyanage NPM. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections. Front Immunol 2020;11:1979. [PMID: 32973803 DOI: 10.3389/fimmu.2020.01979] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
167 Cagnazzo F, Arquizan C, Derraz I, Dargazanli C, Lefevre PH, Riquelme C, Gaillard N, Mourand I, Gascou G, Bonafe A, Costalat V. Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature. J Neurol 2021;268:2656-65. [PMID: 33125542 DOI: 10.1007/s00415-020-10285-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
168 Manenti L, Maggiore U, Fiaccadori E, Meschi T, Antoni AD, Nouvenne A, Ticinesi A, Cerundolo N, Prati B, Delsante M, Gandoflini I, Donghi L, Gentile M, Farina MT, Oliva V, Zambrano C, Regolisti G, Palmisano A, Caminiti C, Cocchi E, Ferrari C, Riella LV, Cravedi P, Peruzzi L. Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study. PLoS One 2021;16:e0248276. [PMID: 33760858 DOI: 10.1371/journal.pone.0248276] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
169 [DOI: 10.1101/2020.05.13.20101345] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
170 Koralnik IJ, Tyler KL. COVID-19: A Global Threat to the Nervous System. Ann Neurol. 2020;88:1-11. [PMID: 32506549 DOI: 10.1002/ana.25807] [Cited by in Crossref: 150] [Cited by in F6Publishing: 130] [Article Influence: 75.0] [Reference Citation Analysis]
171 Hasanvand A. COVID-19 and the role of cytokines in this disease. Inflammopharmacology 2022. [PMID: 35505267 DOI: 10.1007/s10787-022-00992-2] [Reference Citation Analysis]
172 Perricone C, Bartoloni E, Gerli R. Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19. Reumatologia 2020;58:261-4. [PMID: 33227067 DOI: 10.5114/reum.2020.100088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
173 Zhou X, Ye Q. Cellular Immune Response to COVID-19 and Potential Immune Modulators. Front Immunol 2021;12:646333. [PMID: 33995364 DOI: 10.3389/fimmu.2021.646333] [Reference Citation Analysis]
174 Demeester S, Demuyser T, Fauconnier C, Heestermans R, Orlando C, Depreter B, Jochmans K. Routine haematology parameters in COVID‐19 patients and clinical outcome: A Belgian single‐centre study. Int J Lab Hem 2020;42. [DOI: 10.1111/ijlh.13313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
175 Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, Deng G. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int J Infect Dis 2020;96:467-74. [PMID: 32425643 DOI: 10.1016/j.ijid.2020.05.055] [Cited by in Crossref: 137] [Cited by in F6Publishing: 120] [Article Influence: 68.5] [Reference Citation Analysis]
176 Zahran AM, Zahran ZAM, Mady YH, Mahran EEMO, Rashad A, Makboul A, Nasif KA, Abdelmaksoud AA, El-Badawy O. Differential alterations in peripheral lymphocyte subsets in COVID-19 patients: upregulation of double-positive and double-negative T cells. Multidiscip Respir Med 2021;16:758. [PMID: 34221400 DOI: 10.4081/mrm.2021.758] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
177 Fratta Pasini AM, Stranieri C, Cominacini L, Mozzini C. Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications. Antioxidants (Basel) 2021;10:272. [PMID: 33578849 DOI: 10.3390/antiox10020272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
178 Patterson BK, Seethamraju H, Dhody K, Corley MJ, Kazempour K, Lalezari JP, Pang AP, Sugai C, Francisco EB, Pise A, Rodrigues H, Ryou M, Wu HL, Webb GM, Park BS, Kelly S, Pourhassan N, Lelic A, Kdouh L, Herrera M, Hall E, Aklin E, Ndhlovu L, Sacha JB. Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19. medRxiv 2020:2020. [PMID: 32511656 DOI: 10.1101/2020.05.02.20084673] [Cited by in Crossref: 28] [Cited by in F6Publishing: 4] [Article Influence: 14.0] [Reference Citation Analysis]
179 Dos Santos ACM, Dos Santos BRC, Dos Santos BB, de Moura EL, Ferreira JM, Dos Santos LKC, Oliveira SP, Dias RBF, Pereira E Silva AC, de Farias KF, de Souza Figueiredo EVM. Genetic polymorphisms as multi-biomarkers in severe acute respiratory syndrome (SARS) by coronavirus infection: A systematic review of candidate gene association studies. Infect Genet Evol 2021;93:104846. [PMID: 33933633 DOI: 10.1016/j.meegid.2021.104846] [Reference Citation Analysis]
180 Zarrilli G, Angerilli V, Businello G, Sbaraglia M, Traverso G, Fortarezza F, Rizzo S, De Gaspari M, Basso C, Calabrese F, Dei Tos AP, Fassan M. The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury. Int J Mol Sci 2021;22:974. [PMID: 33478107 DOI: 10.3390/ijms22020974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
181 Zahran AM, El-Badawy O, Ali WA, Mahran ZG, Mahran EEMO, Rayan A. Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer. PLoS One 2021;16:e0246806. [PMID: 33617530 DOI: 10.1371/journal.pone.0246806] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Feizollahi P, matin S, Roghani SA, Mostafaei S, Safarzadeh E, Taghadosi M. Evaluation serum levels of Insulin Growth Factor-1 (IGF-1) and its association with clinical parameters in severe COVID-19. Inflammopharmacol. [DOI: 10.1007/s10787-021-00908-6] [Reference Citation Analysis]
183 Beura SK, Panigrahi AR, Yadav P, Singh SK. Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective. Front Pharmacol 2021;12:658273. [PMID: 33981235 DOI: 10.3389/fphar.2021.658273] [Reference Citation Analysis]
184 López-Collazo E, Avendaño-Ortiz J, Martín-Quirós A, Aguirre LA. Immune Response and COVID-19: A mirror image of Sepsis. Int J Biol Sci 2020;16:2479-89. [PMID: 32792851 DOI: 10.7150/ijbs.48400] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
185 Chatterjee S, Datey A, Sengupta S, Ghosh A, Jha A, Walia S, Singh S, Suranjika S, Bhattacharya G, Laha E, Keshry SS, Ray A, Pani SS, Suryawanshi AR, Dash R, Senapati S, Beuria TK, Syed GH, Prasad P, Raghav SK, Devadas S, Swain RK, Chattopadhyay S, Parida A. Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India. Front Cell Infect Microbiol 2021;11:725035. [PMID: 34993157 DOI: 10.3389/fcimb.2021.725035] [Reference Citation Analysis]
186 Safavi F, Nath A. Silencing of immune activation with methotrexate in patients with COVID-19. J Neurol Sci 2020;415:116942. [PMID: 32471659 DOI: 10.1016/j.jns.2020.116942] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
187 Lv Z, Wang W, Qiao B, Cui X, Feng Y, Chen L, Ma Q, Liu X. The prognostic value of general laboratory testing in patients with COVID-19. J Clin Lab Anal 2021;35:e23668. [PMID: 33314316 DOI: 10.1002/jcla.23668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
188 Ghannam M, Alshaer Q, Al-Chalabi M, Zakarna L, Robertson J, Manousakis G. Neurological involvement of coronavirus disease 2019: a systematic review. J Neurol 2020;267:3135-53. [PMID: 32561990 DOI: 10.1007/s00415-020-09990-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 18.0] [Reference Citation Analysis]
189 Mazur-Bialy AI, Kołomańska-Bogucka D, Tim S, Opławski M. Pregnancy and Childbirth in the COVID-19 Era-The Course of Disease and Maternal-Fetal Transmission. J Clin Med 2020;9:E3749. [PMID: 33233369 DOI: 10.3390/jcm9113749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
190 Mussa BM, Srivastava A, Verberne AJM. COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond. Viruses 2021;13:498. [PMID: 33802995 DOI: 10.3390/v13030498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
191 Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, Choi B, Nam SK, Sa M, Kwon JS, Jeong SJ, Lee HK, Park SH, Choi JY, Kim SH, Jung I, Shin EC. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci Immunol. 2020;5. [PMID: 32651212 DOI: 10.1126/sciimmunol.abd1554] [Cited by in Crossref: 255] [Cited by in F6Publishing: 227] [Article Influence: 127.5] [Reference Citation Analysis]
192 Xia G, Qin B, Ma C, Zhu Y, Zheng Q. High-dose vitamin C ameliorates cardiac injury in COVID-19 pandemic: a retrospective cohort study. Aging (Albany NY) 2021;13:20906-14. [PMID: 34499050 DOI: 10.18632/aging.203503] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Sarcinelli MA, Martins da Silva T, Artico Silva AD, Ferreira de Carvalho Patricio B, Mendes de Paiva FC, Santos de Lima R, Leal da Silva M, Antunes Rocha HV. The pulmonary route as a way to drug repositioning in COVID-19 therapy. J Drug Deliv Sci Technol 2021;63:102430. [PMID: 33649708 DOI: 10.1016/j.jddst.2021.102430] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Van Zeebroeck L, Arroyo Hornero R, Côrte-Real BF, Hamad I, Meissner TB, Kleinewietfeld M. Fast and Efficient Genome Editing of Human FOXP3+ Regulatory T Cells. Front Immunol 2021;12:655122. [PMID: 34408743 DOI: 10.3389/fimmu.2021.655122] [Reference Citation Analysis]
195 Alefishat E, Jelinek HF, Mousa M, Tay GK, Alsafar HS. Immune response to SARS-CoV-2 Variants: A focus on severity, susceptibility, and preexisting immunity. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.01.007] [Reference Citation Analysis]
196 Theodoropoulos G, Albanis K, Wangpaichitr M. Perspective on the treatment of non-small cell lung cancer in the context of potential SARS-CoV-2 infection during the pandemic. J Curr Sci Technol 2021;11. [PMID: 33791600 DOI: 10.14456/jcst.2021.15] [Reference Citation Analysis]
197 Khaksarinejad R, Arabpour Z, RezaKhani L, Parvizpour F, Rasmi Y. Biomarker based biosensors: An opportunity for diagnosis of COVID-19. Rev Med Virol 2022;:e2356. [PMID: 35478470 DOI: 10.1002/rmv.2356] [Reference Citation Analysis]
198 Yang H, Xi X, Wang W, Gu B. Immune Response, Viral Shedding Time, and Clinical Characterization in COVID-19 Patients With Gastrointestinal Symptoms. Front Med (Lausanne) 2021;8:593623. [PMID: 34222268 DOI: 10.3389/fmed.2021.593623] [Reference Citation Analysis]
199 Bchetnia M, Girard C, Duchaine C, Laprise C. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status. J Infect Public Health.  2020. [PMID: 32778421 DOI: 10.1016/j.jiph.2020.07.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
200 Baracy M Jr, Afzal F, Szpunar SM, Tremp M, Grace K, Liovas M, Aslam MF. Coronavirus disease 2019 (COVID-19) and the risk of hypertensive disorders of pregnancy: a retrospective cohort study. Hypertens Pregnancy 2021;40:226-35. [PMID: 34428127 DOI: 10.1080/10641955.2021.1965621] [Reference Citation Analysis]
201 Ribeiro DE, Oliveira-Giacomelli Á, Glaser T, Arnaud-Sampaio VF, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry 2021;26:1044-59. [PMID: 33328588 DOI: 10.1038/s41380-020-00965-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
202 Coleman MJ, Zimmerly KM, Yang XO. Accumulation of CD28null Senescent T-Cells Is Associated with Poorer Outcomes in COVID19 Patients. Biomolecules 2021;11:1425. [PMID: 34680058 DOI: 10.3390/biom11101425] [Reference Citation Analysis]
203 Laaribi I, Mimouni H, Bouayed Z, El Aidouni G, Berrichi S, Bahouh C, Bkiyar H, Housni B. Bilateral spontaneous pneumothorax in critically-ill COVID-19 infants: About two cases. Ann Med Surg (Lond) 2022;73:103172. [PMID: 34904055 DOI: 10.1016/j.amsu.2021.103172] [Reference Citation Analysis]
204 Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and Multiorgan Response. Curr Probl Cardiol 2020;45:100618. [PMID: 32439197 DOI: 10.1016/j.cpcardiol.2020.100618] [Cited by in Crossref: 286] [Cited by in F6Publishing: 268] [Article Influence: 143.0] [Reference Citation Analysis]
205 Gao Y, Chen Y, Liu M, Niu M, Song Z, Yan M, Tian J. Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis. Epidemiol Infect 2021;149:e66. [PMID: 33583450 DOI: 10.1017/S0950268821000376] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
206 [DOI: 10.1101/2020.04.20.20065953] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
207 Spiering AE, de Vries TJ. Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19. Front Immunol 2021;12:756262. [PMID: 34858409 DOI: 10.3389/fimmu.2021.756262] [Reference Citation Analysis]
208 Firth A, Prathapan P. Azithromycin: The First Broad-spectrum Therapeutic. Eur J Med Chem 2020;207:112739. [PMID: 32871342 DOI: 10.1016/j.ejmech.2020.112739] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
209 Wiggill TM, Mayne ES, Vaughan JL, Louw S. Overview of the Haematological Effects of COVID-19 Infection. Adv Exp Med Biol 2021;1321:163-72. [PMID: 33656722 DOI: 10.1007/978-3-030-59261-5_14] [Reference Citation Analysis]
210 Açıksarı G, Koçak M, Çağ Y, Altunal LN, Atıcı A, Çelik FB, Bölen F, Açıksarı K, Çalışkan M. Prognostic Value of Inflammatory Biomarkers in Patients with Severe COVID-19: A Single-Center Retrospective Study. Biomark Insights 2021;16:11772719211027022. [PMID: 34248354 DOI: 10.1177/11772719211027022] [Reference Citation Analysis]
211 Huang X, He C, Hua X, Kan A, Sun S, Wang J, Li S. Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients. Int J Biol Sci 2020;16:2464-76. [PMID: 32760213 DOI: 10.7150/ijbs.48639] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
212 Hussain S, Baxi H, Chand Jamali M, Nisar N, Hussain MS. Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidence. Diabetes Metab Syndr 2020;14:1595-602. [PMID: 32862098 DOI: 10.1016/j.dsx.2020.08.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
213 Homayounieh F, Zhang EW, Babaei R, Karimi Mobin H, Sharifian M, Mohseni I, Kuo A, Arru C, Kalra MK, Digumarthy SR. Clinical and imaging features predict mortality in COVID-19 infection in Iran. PLoS One 2020;15:e0239519. [PMID: 32970733 DOI: 10.1371/journal.pone.0239519] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
214 Muyayalo KP, Huang DH, Zhao SJ, Xie T, Mor G, Liao AH. COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes. Am J Reprod Immunol 2020;84:e13304. [PMID: 32662111 DOI: 10.1111/aji.13304] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
215 Adil MS, Verma A, Rudraraju M, Narayanan SP, Somanath PR. Akt-independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS-CoV2 infection. J Cell Physiol 2021;236:6597-606. [PMID: 33624300 DOI: 10.1002/jcp.30343] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Drakoulis N, Porter AL, Tsatsakis A, Spandidos DA. Contributing factors common to COVID‑19 and gastrointestinal cancer. Oncol Rep 2022;47:16. [PMID: 34779496 DOI: 10.3892/or.2021.8227] [Reference Citation Analysis]
217 Tsuchiya A, Takeuchi S, Iwasawa T, Kumagai M, Sato T, Motegi S, Ishii Y, Koseki Y, Tomiyoshi K, Natsui K, Takeda N, Yoshida Y, Yamazaki F, Kojima Y, Watanabe Y, Kimura N, Tominaga K, Kamimura H, Takamura M, Terai S. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases. Inflamm Regen. 2020;40:14. [PMID: 32582401 DOI: 10.1186/s41232-020-00121-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
218 Udovicic I, Stanojevic I, Djordjevic D, Zeba S, Rondovic G, Abazovic T, Lazic S, Vojvodic D, To K, Abazovic D, Khan W, Surbatovic M. Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19. J Clin Med 2021;10:5815. [PMID: 34945111 DOI: 10.3390/jcm10245815] [Reference Citation Analysis]
219 Ali AM, Kunugi H. Approaches to Nutritional Screening in Patients with Coronavirus Disease 2019 (COVID-19). Int J Environ Res Public Health 2021;18:2772. [PMID: 33803339 DOI: 10.3390/ijerph18052772] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
220 Teimury A, Mahmoodi Khaledi E. Current Options in the Treatment of COVID-19: A Review. Risk Manag Healthc Policy 2020;13:1999-2010. [PMID: 33116980 DOI: 10.2147/RMHP.S265030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
221 Banerjee A, Ray S, Vorselaars B, Kitson J, Mamalakis M, Weeks S, Baker M, Mackenzie LS. Use of Machine Learning and Artificial Intelligence to predict SARS-CoV-2 infection from Full Blood Counts in a population. Int Immunopharmacol 2020;86:106705. [PMID: 32652499 DOI: 10.1016/j.intimp.2020.106705] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 16.5] [Reference Citation Analysis]
222 Farahani M, Niknam Z, Mohammadi Amirabad L, Amiri-Dashatan N, Koushki M, Nemati M, Danesh Pouya F, Rezaei-Tavirani M, Rasmi Y, Tayebi L. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. Biomed Pharmacother 2022;145:112420. [PMID: 34801852 DOI: 10.1016/j.biopha.2021.112420] [Reference Citation Analysis]
223 Kaftan AN, Hussain MK, Algenabi AA, Naser FH, Enaya MA. Predictive Value of C-reactive Protein, Lactate Dehydrogenase, Ferritin and D-dimer Levels in Diagnosing COVID-19 Patients: a Retrospective Study. Acta Inform Med 2021;29:45-50. [PMID: 34012213 DOI: 10.5455/aim.2021.29.45-50] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
224 Wang F, Qu M, Zhou X, Zhao K, Lai C, Tang Q, Xian W, Chen R, Li X, Li Z, He Q, Liu L. The timeline and risk factors of clinical progression of COVID-19 in Shenzhen, China. J Transl Med 2020;18:270. [PMID: 32620125 DOI: 10.1186/s12967-020-02423-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
225 Vassallo M, Manni S, Pini P, Blanchouin E, Ticchioni M, Seitz-Polski B, Puchois A, Sindt A, Lotte L, Fauque P, Durant J. Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation. Int J Infect Dis 2020;101:174-9. [PMID: 33002623 DOI: 10.1016/j.ijid.2020.09.1438] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
226 Chakrabarty K, Shetty R, Argulwar S, Das D, Ghosh A. Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019. Cytotherapy 2021:S1465-3249(21)00776-3. [PMID: 34656419 DOI: 10.1016/j.jcyt.2021.08.003] [Reference Citation Analysis]
227 Behl T, Kaur I, Bungau S, Kumar A, Uddin MS, Kumar C, Pal G, Sahil, Shrivastava K, Zengin G, Arora S. The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions. Life Sci 2020;257:118075. [PMID: 32653522 DOI: 10.1016/j.lfs.2020.118075] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 20.5] [Reference Citation Analysis]
228 Ong SWX, Tan WYT, Chan YH, Fong SW, Renia L, Ng LF, Leo YS, Lye DC, Young BE. Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019. Clin Transl Immunology 2020;9:e1159. [PMID: 32728438 DOI: 10.1002/cti2.1159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
229 Buicu AL, Cernea S, Benedek I, Buicu CF, Benedek T. Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity. J Clin Med 2021;10:1545. [PMID: 33916917 DOI: 10.3390/jcm10081545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
230 Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, O'Mahony L, Gao Y, Nadeau K, Akdis CA. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy 2020;75:1564-81. [PMID: 32396996 DOI: 10.1111/all.14364] [Cited by in Crossref: 346] [Cited by in F6Publishing: 306] [Article Influence: 173.0] [Reference Citation Analysis]
231 Khamis F, Al-Zakwani I, Al Hashmi S, Al Dowaiki S, Al Bahrani M, Pandak N, Al Khalili H, Memish Z. Therapeutic plasma exchange in adults with severe COVID-19 infection. Int J Infect Dis 2020;99:214-8. [PMID: 32585284 DOI: 10.1016/j.ijid.2020.06.064] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 20.0] [Reference Citation Analysis]
232 Yu Z, Ellahi R, Nutini A, Sohail A, Sait SM. Modeling and simulations of CoViD-19 molecular mechanism induced by cytokines storm during SARS-CoV2 infection. J Mol Liq 2021;327:114863. [PMID: 33281252 DOI: 10.1016/j.molliq.2020.114863] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
233 Lionetto L, Ulivieri M, Capi M, De Bernardini D, Fazio F, Petrucca A, Pomes LM, De Luca O, Gentile G, Casolla B, Curto M, Salerno G, Schillizzi S, Torre MS, Santino I, Rocco M, Marchetti P, Aceti A, Ricci A, Bonfini R, Nicoletti F, Simmaco M, Borro M. Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study. Biochim Biophys Acta Mol Basis Dis 2021;1867:166042. [PMID: 33338598 DOI: 10.1016/j.bbadis.2020.166042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
234 Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S. Mesenchymal stem cells and COVID-19: What they do and what they can do. World J Stem Cells 2021; 13(9): 1318-1337 [PMID: 34630865 DOI: 10.4252/wjsc.v13.i9.1318] [Reference Citation Analysis]
235 Cossio M, Gilardino RE. Would the Use of Artificial Intelligence in COVID-19 Patient Management Add Value to the Healthcare System? Front Med (Lausanne) 2021;8:619202. [PMID: 33585525 DOI: 10.3389/fmed.2021.619202] [Reference Citation Analysis]
236 Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. IJMS 2022;23:3636. [DOI: 10.3390/ijms23073636] [Reference Citation Analysis]
237 Lei F, Liu YM, Zhou F, Qin JJ, Zhang P, Zhu L, Zhang XJ, Cai J, Lin L, Ouyang S, Wang X, Yang C, Cheng X, Liu W, Li H, Xie J, Wu B, Luo H, Xiao F, Chen J, Tao L, Cheng G, She ZG, Zhou J, Wang H, Lin J, Luo P, Fu S, Ye P, Xiao B, Mao W, Liu L, Yan Y, Chen G, Huang X, Zhang BH, Yuan Y. Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China. Hepatology. 2020;72:389-398. [PMID: 32359177 DOI: 10.1002/hep.31301] [Cited by in Crossref: 131] [Cited by in F6Publishing: 139] [Article Influence: 65.5] [Reference Citation Analysis]
238 Wenzhong L, Hualan L. COVID-19: captures iron and generates reactive oxygen species to damage the human immune system. Autoimmunity 2021;54:213-24. [PMID: 33899609 DOI: 10.1080/08916934.2021.1913581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
239 Najjar S, Najjar A, Chong DJ, Pramanik BK, Kirsch C, Kuzniecky RI, Pacia SV, Azhar S. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation 2020;17:231. [PMID: 32758257 DOI: 10.1186/s12974-020-01896-0] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 30.0] [Reference Citation Analysis]
240 Rea IM, Alexander HD. Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing. Ageing Res Rev 2021;73:101494. [PMID: 34688926 DOI: 10.1016/j.arr.2021.101494] [Reference Citation Analysis]
241 Chen H, Liu W, Wang Y, Liu D, Zhao L, Yu J. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients. EBioMedicine 2021;70:103500. [PMID: 34311326 DOI: 10.1016/j.ebiom.2021.103500] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
242 Tian M, Li H, Yan T, Dai Y, Dong L, Wei H, Song X, Dong J, Cheng F, Li W. Clinical features of patients undergoing hemodialysis with COVID-19. Semin Dial 2021;34:57-65. [PMID: 33118200 DOI: 10.1111/sdi.12928] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
243 Formica V, Minieri M, Bernardini S, Ciotti M, D'Agostini C, Roselli M, Andreoni M, Morelli C, Parisi G, Federici M, Paganelli C, Legramante JM. Complete blood count might help to identify subjects with high probability of testing positive to SARS-CoV-2. Clin Med (Lond) 2020;20:e114-9. [PMID: 32620590 DOI: 10.7861/clinmed.2020-0373] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
244 Di Renzo GC, Giardina I. Coronavirus disease 2019 in pregnancy: consider thromboembolic disorders and thromboprophylaxis. Am J Obstet Gynecol 2020;223:135. [PMID: 32333857 DOI: 10.1016/j.ajog.2020.04.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 15.0] [Reference Citation Analysis]
245 Uncini A, Vallat JM, Jacobs BC. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. J Neurol Neurosurg Psychiatry 2020;91:1105-10. [PMID: 32855289 DOI: 10.1136/jnnp-2020-324491] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 27.0] [Reference Citation Analysis]
246 Chiappalupi S, Salvadori L, Vukasinovic A, Donato R, Sorci G, Riuzzi F. Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives. Life Sci 2021;272:119251. [PMID: 33636175 DOI: 10.1016/j.lfs.2021.119251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
247 Graham JB, Swarts JL, Leist SR, Schäfer A, Menachery VD, Gralinski LE, Jeng S, Miller DR, Mooney MA, McWeeney SK, Ferris MT, de Villena FP, Heise MT, Baric RS, Lund JM. Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection. bioRxiv 2020:2020. [PMID: 32995791 DOI: 10.1101/2020.09.21.306837] [Reference Citation Analysis]
248 Oroojalian F, Haghbin A, Baradaran B, Hemmat N, Shahbazi MA, Baghi HB, Mokhtarzadeh A, Hamblin MR. Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials. Int J Biol Macromol 2020;165:18-43. [PMID: 32991900 DOI: 10.1016/j.ijbiomac.2020.09.204] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
249 LaSalle TJ, Gonye ALK, Freeman SS, Kaplonek P, Gushterova I, Kays KR, Manakongtreecheep K, Tantivit J, Rojas-Lopez M, Russo BC, Sharma N, Thomas MF, Lavin-Parsons KM, Lilly BM, Mckaig BN, Charland NC, Khanna HK, Lodenstein CL, Margolin JD, Blaum EM, Lirofonis PB, Sonny A, Bhattacharyya RP, Parry BA, Goldberg MB, Alter G, Filbin MR, Villani AC, Hacohen N, Sade-Feldman M. Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with disease severity in hospitalized COVID-19 patients. bioRxiv 2021:2021. [PMID: 34642692 DOI: 10.1101/2021.10.04.463121] [Reference Citation Analysis]
250 de Dios E, Rios-Navarro C, Perez-Sole N, Gavara J, Marcos-Garces V, Rodríguez E, Carratalá A, Forner MJ, Navarro J, Blasco ML, Bondia E, Signes-Costa J, Vila JM, Forteza MJ, Chorro FJ, Bodi V. Similar Clinical Course and Significance of Circulating Innate and Adaptive Immune Cell Counts in STEMI and COVID-19. J Clin Med 2020;9:E3484. [PMID: 33126723 DOI: 10.3390/jcm9113484] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
251 Lonati C, Gatti S, Catania A. Activation of Melanocortin Receptors as a Potential Strategy to Reduce Local and Systemic Reactions Induced by Respiratory Viruses. Front Endocrinol (Lausanne) 2020;11:569241. [PMID: 33362713 DOI: 10.3389/fendo.2020.569241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
252 Aydin A, Cebi G, Demirtas ZE, Erkus H, Kucukay A, Ok M, Sakalli L, Alpdagtas S, Gunduz O, Ustundag CB. Combating COVID-19 with tissue engineering: a review. Emergent Mater 2020;:1-21. [PMID: 33235976 DOI: 10.1007/s42247-020-00138-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
253 Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020;14:395-403. [PMID: 32334395 DOI: 10.1016/j.dsx.2020.04.018] [Cited by in Crossref: 317] [Cited by in F6Publishing: 291] [Article Influence: 158.5] [Reference Citation Analysis]
254 Sanchez-Gonzalez MA, Moskowitz D, Issuree PD, Yatzkan G, Rizvi SAA, Day K. A Pathophysiological Perspective on COVID-19's Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation. Infect Chemother 2020;52:335-44. [PMID: 32537960 DOI: 10.3947/ic.2020.52.3.335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
255 Hosseini A, Hashemi V, Shomali N, Asghari F, Gharibi T, Akbari M, Gholizadeh S, Jafari A. Innate and adaptive immune responses against coronavirus. Biomed Pharmacother 2020;132:110859. [PMID: 33120236 DOI: 10.1016/j.biopha.2020.110859] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
256 Santos AF, Póvoa P, Paixão P, Mendonça A, Taborda-Barata L. Changes in Glycolytic Pathway in SARS-COV 2 Infection and Their Importance in Understanding the Severity of COVID-19. Front Chem 2021;9:685196. [PMID: 34568275 DOI: 10.3389/fchem.2021.685196] [Reference Citation Analysis]
257 Shang L, Shao M, Guo Q, Shi J, Zhao Y, Xiaokereti J, Tang B. Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis. Arch Med Res 2020;51:700-9. [PMID: 32811670 DOI: 10.1016/j.arcmed.2020.07.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
258 Gao J, Huang X, Gu H, Lou L, Xu Z. Predictive criteria of severe cases in COVID-19 patients of early stage: A retrospective observational study. J Clin Lab Anal 2020;34:e23562. [PMID: 32893398 DOI: 10.1002/jcla.23562] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
259 Tahaghoghi-Hajghorbani S, Zafari P, Masoumi E, Rajabinejad M, Jafari-Shakib R, Hasani B, Rafiei A. The role of dysregulated immune responses in COVID-19 pathogenesis. Virus Res 2020;290:198197. [PMID: 33069815 DOI: 10.1016/j.virusres.2020.198197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
260 Ahmadi E, Bagherpour Z, Zarei E, Omidkhoda A. Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function. Pathology - Research and Practice 2022;231:153782. [DOI: 10.1016/j.prp.2022.153782] [Reference Citation Analysis]
261 Tahmasebi S, Saeed BQ, Temirgalieva E, Yumashev AV, El-Esawi MA, Navashenaq JG, Valizadeh H, Sadeghi A, Aslani S, Yousefi M, Jadidi-Niaragh F, Adigozalou J, Ahmadi M, Roshangar L. Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2. Life Sci 2021;276:119437. [PMID: 33789145 DOI: 10.1016/j.lfs.2021.119437] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
262 Estrada E. Cascading from SARS-CoV-2 to Parkinson's Disease through Protein-Protein Interactions. Viruses 2021;13:897. [PMID: 34066091 DOI: 10.3390/v13050897] [Reference Citation Analysis]
263 Goncharov NV, Vasilyev KA, Kudryavtsev IV, Avdonin PP, Belinskaia DA, Stukova MA, Shamova OV, Avdonin PV. Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1). J Evol Biochem Phys 2022;58:230-46. [DOI: 10.1134/s0022093022010203] [Reference Citation Analysis]
264 Shi MJ, Lv JG, Lin L, Guo JY. Trends in Coronavirus Disease 2019 Hospitalization and Prognosis: Gender Effect. Curr Med Sci 2021;41:312-7. [PMID: 33877547 DOI: 10.1007/s11596-021-2348-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Alhalaili B, Popescu IN, Kamoun O, Alzubi F, Alawadhia S, Vidu R. Nanobiosensors for the Detection of Novel Coronavirus 2019-nCoV and Other Pandemic/Epidemic Respiratory Viruses: A Review. Sensors (Basel) 2020;20:E6591. [PMID: 33218097 DOI: 10.3390/s20226591] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
266 Talotta R, Robertson E. Autoimmunity as the comet tail of COVID-19 pandemic. World J Clin Cases 2020; 8(17): 3621-3644 [PMID: 32953841 DOI: 10.12998/wjcc.v8.i17.3621] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 13] [Article Influence: 12.5] [Reference Citation Analysis]
267 Li D, Chen Y, Liu H, Jia Y, Li F, Wang W, Wu J, Wan Z, Cao Y, Zeng R. Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study. Signal Transduct Target Ther. 2020;5:62. [PMID: 32371949 DOI: 10.1038/s41392-020-0163-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 18.0] [Reference Citation Analysis]
268 Yoo SJ, Qi X, Inui S, Kim H, Jeong YJ, Lee KH, Lee YK, Lee BY, Kim JY, Jin KN, Lim JK, Kim YH, Kim KB, Jiang Z, Shao C, Lei J, Zou S, Pan H, Gu Y, Zhang G, Goo JM, Yoon SH. Deep Learning-Based Automatic CT Quantification of Coronavirus Disease 2019 Pneumonia: An International Collaborative Study. J Comput Assist Tomogr 2022. [PMID: 35405709 DOI: 10.1097/RCT.0000000000001303] [Reference Citation Analysis]
269 Hosseinimehr SJ. Does NF-κB Signaling Pathway Play a Crucial Role in Pneumonia Induced by SARS-COV-2 Virus Causing COVID-19? Eurasian J Med 2021;53:67-8. [PMID: 33716535 DOI: 10.5152/eurasianjmed.2020.20174] [Reference Citation Analysis]
270 Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? J Clin Med. 2020;9. [PMID: 32403217 DOI: 10.3390/jcm9051417] [Cited by in Crossref: 185] [Cited by in F6Publishing: 191] [Article Influence: 92.5] [Reference Citation Analysis]
271 Jeyaraman M, Muthu S, Bapat A, Jain R, Sushmitha ES, Gulati A, Channaiah Anudeep T, Dilip SJ, Jha NK, Kumar D, Kesari KK, Ojha S, Dholpuria S, Gupta G, Dureja H, Chellappan DK, Singh SK, Dua K, Jha SK. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon 2021;7:e07635. [PMID: 34312598 DOI: 10.1016/j.heliyon.2021.e07635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
272 Agwa SHA, Kamel MM, Elghazaly H, Abd Elsamee AM, Hafez H, Girgis SA, Ezz Elarab H, Ebeid FSE, Sayed SM, Sherif L, Matboli M. Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients. Genes (Basel) 2021;12:830. [PMID: 34071309 DOI: 10.3390/genes12060830] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
273 Norouzi M, Miar P, Norouzi S, Nikpour P. Nervous System Involvement in COVID-19: a Review of the Current Knowledge. Mol Neurobiol 2021;58:3561-74. [PMID: 33765290 DOI: 10.1007/s12035-021-02347-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
274 Rana AK, Rahmatkar SN, Kumar A, Singh D. Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Cytokine Growth Factor Rev. 2021;58:92-101. [PMID: 32948440 DOI: 10.1016/j.cytogfr.2020.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
275 Dong M, Zhang J, Ma X, Tan J, Chen L, Liu S, Xin Y, Zhuang L. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother 2020;131:110678. [PMID: 32861070 DOI: 10.1016/j.biopha.2020.110678] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 19.5] [Reference Citation Analysis]
276 Zantah M, Dominguez Castillo E, Townsend R, Dikengil F, Criner GJ. Pneumothorax in COVID-19 disease- incidence and clinical characteristics. Respir Res. 2020;21:236. [PMID: 32938445 DOI: 10.1186/s12931-020-01504-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
277 Konig MF, Powell M, Staedtke V, Bai RY, Thomas DL, Fischer N, Huq S, Khalafallah AM, Koenecke A, Xiong R, Mensh B, Papadopoulos N, Kinzler KW, Vogelstein B, Vogelstein JT, Athey S, Zhou S, Bettegowda C. Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists. J Clin Invest 2020;130:3345-7. [PMID: 32352407 DOI: 10.1172/JCI139642] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 21.5] [Reference Citation Analysis]
278 Poulas K, Farsalinos K, Zanidis C. Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy. Front Immunol 2020;11:1373. [PMID: 32612613 DOI: 10.3389/fimmu.2020.01373] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
279 [DOI: 10.1101/2020.03.24.20042655] [Cited by in Crossref: 64] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
280 Atzori L, Ferreli C, Mateeva V, Vassileva S, Rongioletti F. Clinicopathologic features between different viral epidemic outbreaks involving the skin. Clin Dermatol 2021;39:405-17. [PMID: 34517998 DOI: 10.1016/j.clindermatol.2021.04.002] [Reference Citation Analysis]
281 Castelo-Branco L, Fregni F. Home-Based Transcranial Direct Current Stimulation (tDCS) to Prevent and Treat Symptoms Related to Stress: A Potential Tool to Remediate the Behavioral Consequences of the COVID-19 Isolation Measures? Front Integr Neurosci 2020;14:46. [PMID: 33071764 DOI: 10.3389/fnint.2020.00046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
282 Yan X, Wang S, Ma P, Yang B, Si D, Liu G, Liu L, Ding M, Yang W, Li J, Sun H, Yang P. Cardiac injury is associated with inflammation in geriatric COVID-19 patients. J Clin Lab Anal 2021;35:e23654. [PMID: 33210392 DOI: 10.1002/jcla.23654] [Reference Citation Analysis]
283 Samsami M, Fatemi A, Jalili Khoshnoud R, Kohansal K, Hussen BM, Soghala S, Taheri M, Ghafouri-Fard S. Abnormal Transcript Levels of Cytokines Among Iranian COVID-19 Patients. J Mol Neurosci 2021. [PMID: 34855144 DOI: 10.1007/s12031-021-01941-4] [Reference Citation Analysis]
284 Russo V, Bottino R, Carbone A, Rago A, Papa AA, Golino P, Nigro G. COVID-19 and Heart: From Clinical Features to Pharmacological Implications. J Clin Med 2020;9:E1944. [PMID: 32580344 DOI: 10.3390/jcm9061944] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
285 de Cáceres C, Martínez R, Bachiller P, Marín L, García JM. The effect of tocilizumab on cytokine release syndrome in COVID-19 patients. Pharmacol Rep 2020;72:1529-37. [PMID: 33165762 DOI: 10.1007/s43440-020-00186-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
286 Braga CL, Silva-Aguiar RP, Battaglini D, Peruchetti DB, Robba C, Pelosi P, Rocco PRM, Caruso-Neves C, Silva PL. The renin-angiotensin-aldosterone system: Role in pathogenesis and potential therapeutic target in COVID-19. Pharmacol Res Perspect 2020;8:e00623. [PMID: 32658389 DOI: 10.1002/prp2.623] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
287 Ikeda S, Misumi T, Izumi S, Sakamoto K, Nishimura N, Ro S, Fukunaga K, Okamori S, Tachikawa N, Miyata N, Shinkai M, Shinoda M, Miyazaki Y, Iijima Y, Izumo T, Inomata M, Okamoto M, Yamaguchi T, Iwabuchi K, Masuda M, Takoi H, Oyamada Y, Fujitani S, Mineshita M, Ishii H, Nakagawa A, Yamaguchi N, Hibino M, Tsushima K, Nagai T, Ishikawa S, Ishikawa N, Kondoh Y, Yamazaki Y, Gocho K, Nishizawa T, Tsuzuku A, Yagi K, Shindo Y, Takeda Y, Yamanaka T, Ogura T. Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study. Sci Rep 2021;11:10727. [PMID: 34021229 DOI: 10.1038/s41598-021-90246-y] [Reference Citation Analysis]
288 Siska PJ, Decking SM, Babl N, Matos C, Bruss C, Singer K, Klitzke J, Schön M, Simeth J, Köstler J, Siegmund H, Ugele I, Paulus M, Dietl A, Kolodova K, Steines L, Freitag K, Peuker A, Schönhammer G, Raithel J, Graf B, Geismann F, Lubnow M, Mack M, Hau P, Bohr C, Burkhardt R, Gessner A, Salzberger B, Wagner R, Hanses F, Hitzenbichler F, Heudobler D, Lüke F, Pukrop T, Herr W, Wolff D, Spang R, Poeck H, Hoffmann P, Jantsch J, Brochhausen C, Lunz D, Rehli M, Kreutz M, Renner K. Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone. J Clin Invest 2021;131:e148225. [PMID: 34779418 DOI: 10.1172/JCI148225] [Reference Citation Analysis]
289 Asghar MS, Khan NA, Haider Kazmi SJ, Ahmed A, Hassan M, Jawed R, Akram M, Rasheed U, Memon GM, Ahmed MU, Tahniyat U, Tirmizi SB. Hematological parameters predicting severity and mortality in COVID-19 patients of Pakistan: a retrospective comparative analysis. J Community Hosp Intern Med Perspect 2020;10:514-20. [PMID: 33194120 DOI: 10.1080/20009666.2020.1816276] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
290 Taghiloo S, Aliyali M, Abedi S, Mehravaran H, Sharifpour A, Zaboli E, Eslami-Jouybari M, Ghasemian R, Vahedi-Larijani L, Hossein-Nattaj H, Amjadi O, Rezazadeh H, Ajami A, Asgarian-Omran H. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics. J Med Virol 2021;93:1589-98. [PMID: 32910458 DOI: 10.1002/jmv.26505] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
291 [DOI: 10.1101/2020.04.28.20073767] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
292 Torre A, Aliberti S, Castellotti PF, Cirillo DM, Grisolia A, Mangioni D, Marchetti G, Rossotti R, Santus P, Besozzi G, Villa S, Codecasa LR; Milan TB-COVID-19 study group. Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy. Respir Med 2020;175:106204. [PMID: 33186846 DOI: 10.1016/j.rmed.2020.106204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
293 Kiselevskiy M, Shubina I, Chikileva I, Sitdikova S, Samoylenko I, Anisimova N, Kirgizov K, Suleimanova A, Gorbunova T, Varfolomeeva S. Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence? Pharmaceuticals (Basel) 2020;13:E166. [PMID: 32722596 DOI: 10.3390/ph13080166] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
294 Balzanelli MG, Distratis P, Dipalma G, Vimercati L, Catucci O, Amatulli F, Cefalo A, Lazzaro R, Palazzo D, Aityan SK, Pricolo G, Prudenzano A, D'Errico P, Laforgia R, Pezzolla A, Tomassone D, Inchingolo AD, Pham VH, Iacobone D, Materi GM, Scarano A, Lorusso F, Inchingolo F, Nguyen KCD, Isacco CG. Immunity Profiling of COVID-19 Infection, Dynamic Variations of Lymphocyte Subsets, a Comparative Analysis on Four Different Groups. Microorganisms 2021;9:2036. [PMID: 34683357 DOI: 10.3390/microorganisms9102036] [Reference Citation Analysis]
295 Schrijver B, Assmann JLJC, van Gammeren AJ, Vermeulen RCH, Portengen L, Heukels P, Langerak AW, Dik WA, van der Velden VHJ, Ermens TAAM. Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome. Eur Cytokine Netw 2020;31:154-67. [PMID: 33648924 DOI: 10.1684/ecn.2020.0456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
296 Sidhom JW, Baras AS. Deep learning identifies antigenic determinants of severe SARS-CoV-2 infection within T-cell repertoires. Sci Rep 2021;11:14275. [PMID: 34253751 DOI: 10.1038/s41598-021-93608-8] [Reference Citation Analysis]
297 Váncsa S, Hegyi PJ, Zádori N, Szakó L, Vörhendi N, Ocskay K, Földi M, Dembrovszky F, Dömötör ZR, Jánosi K, Rakonczay Z Jr, Hartmann P, Horváth T, Erőss B, Kiss S, Szakács Z, Németh D, Hegyi P, Pár G. Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review. Front Med (Lausanne) 2020;7:572115. [PMID: 33282888 DOI: 10.3389/fmed.2020.572115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
298 De La Flor JC, Valga F, Marschall A, Monzon T, Albarracín C, Ruiz E, Rodeles M. Targeting Cytokine Storm in COVID-19: A Role of Online Hemodiafiltration with Asymmetric Cellulose Triacetate in Maintenance Hemodialysis Patients-A Report of 10 Cases. Case Rep Nephrol 2021;2021:5575928. [PMID: 33747583 DOI: 10.1155/2021/5575928] [Reference Citation Analysis]
299 Filosto M, Cotti Piccinelli S, Gazzina S, Foresti C, Frigeni B, Servalli MC, Sessa M, Cosentino G, Marchioni E, Ravaglia S, Briani C, Castellani F, Zara G, Bianchi F, Del Carro U, Fazio R, Filippi M, Magni E, Natalini G, Palmerini F, Perotti AM, Bellomo A, Osio M, Scopelliti G, Carpo M, Rasera A, Squintani G, Doneddu PE, Bertasi V, Cotelli MS, Bertolasi L, Fabrizi GM, Ferrari S, Ranieri F, Caprioli F, Grappa E, Broglio L, De Maria G, Leggio U, Poli L, Rasulo F, Latronico N, Nobile-Orazio E, Padovani A, Uncini A. Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions. J Neurol Neurosurg Psychiatry 2021;92:751-6. [PMID: 33158914 DOI: 10.1136/jnnp-2020-324837] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
300 Farley M, Zuberi J. COVID-19 Precipitating Status Epilepticus in a Pediatric Patient. Am J Case Rep 2020;21:e925776. [PMID: 32730234 DOI: 10.12659/AJCR.925776] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
301 Gadotti AC, de Castro Deus M, Telles JP, Wind R, Goes M, Garcia Charello Ossoski R, de Padua AM, de Noronha L, Moreno-Amaral A, Baena CP, Tuon FF. IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection. Virus Res 2020;289:198171. [PMID: 32979474 DOI: 10.1016/j.virusres.2020.198171] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 9.5] [Reference Citation Analysis]
302 Möhn N, Pul R, Kleinschnitz C, Prüss H, Witte T, Stangel M, Skripuletz T. Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS. Front Immunol 2020;11:1059. [PMID: 32477373 DOI: 10.3389/fimmu.2020.01059] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
303 Wong RSY. The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective. SN Compr Clin Med 2020;:1-9. [PMID: 33015553 DOI: 10.1007/s42399-020-00546-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
304 Saleki K, Banazadeh M, Miri NS, Azadmehr A. Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1. Rev Neurosci 2021. [PMID: 34225390 DOI: 10.1515/revneuro-2021-0047] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
305 Sohn KM, Lee SG, Kim HJ, Cheon S, Jeong H, Lee J, Kim IS, Silwal P, Kim YJ, Paik S, Chung C, Park C, Kim YS, Jo EK. COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis. J Korean Med Sci 2020;35:e343. [PMID: 32989935 DOI: 10.3346/jkms.2020.35.e343] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 21.5] [Reference Citation Analysis]
306 Tabassum T, Rahman A, Araf Y, Ullah MA, Hosen MJ. Management of asthma patients during the COVID-19 pandemic: pathophysiological considerations to address the challenges. Beni-Suef Univ J Basic Appl Sci 2022;11. [DOI: 10.1186/s43088-022-00204-4] [Reference Citation Analysis]
307 Zhong M, Sun A, Xiao T, Yao G, Sang L, Zheng X, Zhang J, Jin X, Xu L, Yang W, Wang P, Hu K, Zhang D, Ge J. A Randomized, Single-Blind, Group Sequential, Active-Controlled Study to Evaluate the Clinical Efficacy and Safety of α-Lipoic Acid for Critically Ill Patients With Coronavirus Disease 2019 (COVID-19). Front Med 2022;8:566609. [DOI: 10.3389/fmed.2021.566609] [Reference Citation Analysis]
308 Andrade RM, Marques RS, de Moura TR, de Paiva SM, Gurgel RQ, Martins-Filho PR. Is there a bidirectional interaction between periodontitis and the severity of SARS-CoV-2 infection? EXCLI J 2021;20:1009-10. [PMID: 34267612 DOI: 10.17179/excli2021-3810] [Reference Citation Analysis]
309 Zingaropoli MA, Nijhawan P, Carraro A, Pasculli P, Zuccalà P, Perri V, Marocco R, Kertusha B, Siccardi G, Del Borgo C, Curtolo A, Ajassa C, Iannetta M, Ciardi MR, Mastroianni CM, Lichtner M. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia. Front Immunol 2021;12:627548. [PMID: 33777012 DOI: 10.3389/fimmu.2021.627548] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
310 Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past. Front Immunol 2020;11:1949. [PMID: 32849654 DOI: 10.3389/fimmu.2020.01949] [Cited by in Crossref: 90] [Cited by in F6Publishing: 72] [Article Influence: 45.0] [Reference Citation Analysis]
311 Almqvist J, Granberg T, Tzortzakakis A, Klironomos S, Kollia E, Öhberg C, Martin R, Piehl F, Ouellette R, Ineichen BV. Neurological manifestations of coronavirus infections - a systematic review. Ann Clin Transl Neurol 2020;7:2057-71. [PMID: 32853453 DOI: 10.1002/acn3.51166] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 15.5] [Reference Citation Analysis]
312 Foo SS, Cambou MC, Mok T, Fajardo VM, Jung KL, Fuller T, Chen W, Kerin T, Mei J, Bhattacharya D, Choi Y, Wu X, Xia T, Shin WJ, Cranston J, Aldrovandi G, Tobin N, Contreras D, Ibarrondo FJ, Yang O, Yang S, Garner O, Cortado R, Bryson Y, Janzen C, Ghosh S, Devaskar S, Asilnejad B, Moreira ME, Vasconcelos Z, Soni PR, Gibson LC, Brasil P, Comhair SAA, Arumugaswami V, Erzurum SC, Rao R, Jung JU, Nielsen-Saines K. The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2. Cell Rep Med 2021;2:100453. [PMID: 34723226 DOI: 10.1016/j.xcrm.2021.100453] [Reference Citation Analysis]
313 Venditto VJ, Haydar D, Abdel-Latif A, Gensel JC, Anstead MI, Pitts MG, Creameans J, Kopper TJ, Peng C, Feola DJ. Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19. Front Immunol 2021;12:574425. [PMID: 33643308 DOI: 10.3389/fimmu.2021.574425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
314 Hanan N, Doud RL Jr, Park IW, Jones HP, Mathew SO. The Many Faces of Innate Immunity in SARS-CoV-2 Infection. Vaccines (Basel) 2021;9:596. [PMID: 34199761 DOI: 10.3390/vaccines9060596] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
315 [DOI: 10.1101/2020.06.18.20131326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
316 Ittyachen AM. Covid-19 and leptospirosis: Cytokine storm and the use of steroids. Trop Doct 2021;51:128-30. [PMID: 33236692 DOI: 10.1177/0049475520971425] [Reference Citation Analysis]
317 Sarkar S, Khanna P, Singh AK. The Impact of Neutrophil-Lymphocyte Count Ratio in COVID-19: A Systematic Review and Meta-Analysis. J Intensive Care Med 2021;:8850666211045626. [PMID: 34672824 DOI: 10.1177/08850666211045626] [Reference Citation Analysis]
318 Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci 2021;58:297-310. [PMID: 33347790 DOI: 10.1080/10408363.2020.1860895] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
319 John S, Hussain SI, Piechowski-Jozwiak B, Dibu J, Kesav P, Bayrlee A, Elkambergy H, John TLS, Roser F, Mifsud VA. Clinical characteristics and admission patterns of stroke patients during the COVID 19 pandemic: A single center retrospective, observational study from the Abu Dhabi, United Arab Emirates. Clin Neurol Neurosurg 2020;199:106227. [PMID: 33011516 DOI: 10.1016/j.clineuro.2020.106227] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
320 Mariappan V, S R R, Balakrishna Pillai A. Angiotensin-converting enzyme 2: A protective factor in regulating disease virulence of SARS-COV-2. IUBMB Life 2020;72:2533-45. [PMID: 33031602 DOI: 10.1002/iub.2391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
321 Reddy K, Rogers AJ, McAuley DF. Delving beneath the surface of hyperinflammation in COVID-19. Lancet Rheumatol 2020;2:e578-9. [PMID: 32864626 DOI: 10.1016/S2665-9913(20)30304-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
322 Ognibene A, Lorubbio M, Magliocca P, Tripodo E, Vaggelli G, Iannelli G, Feri M, Scala R, Tartaglia AP, Galano A, Pancrazzi A, Tacconi D. Elevated monocyte distribution width in COVID-19 patients: The contribution of the novel sepsis indicator. Clin Chim Acta 2020;509:22-4. [PMID: 32504637 DOI: 10.1016/j.cca.2020.06.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
323 Bonny V, Maillard A, Mousseaux C, Plaçais L, Richier Q. [COVID-19: Pathogenesis of a multi-faceted disease]. Rev Med Interne 2020;41:375-89. [PMID: 32507520 DOI: 10.1016/j.revmed.2020.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
324 Kang SH, Kim SW, Kim AY, Cho KH, Park JW, Do JY. Association between Chronic Kidney Disease or Acute Kidney Injury and Clinical Outcomes in COVID-19 Patients. J Korean Med Sci 2020;35:e434. [PMID: 33372426 DOI: 10.3346/jkms.2020.35.e434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
325 Kong M, Zhang H, Cao X, Mao X, Lu Z. Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19. Epidemiol Infect 2020;148:e139. [PMID: 32641174 DOI: 10.1017/S0950268820001557] [Cited by in Crossref: 50] [Cited by in F6Publishing: 27] [Article Influence: 25.0] [Reference Citation Analysis]
326 Zhang HJ, Qi GQ, Gu X, Zhang XY, Fang YF, Jiang H, Zhao YJ. Lymphocyte blood levels that remain low can predict the death of patients with COVID-19. Medicine (Baltimore) 2021;100:e26503. [PMID: 34260527 DOI: 10.1097/MD.0000000000026503] [Reference Citation Analysis]
327 Feng Y, Huang J, Wu J, Xu Y, Chen B, Jiang L, Xiang H, Peng Z, Wang X. Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: A pilot study. Cell Prolif. 2020;53:e12947. [PMID: 33205469 DOI: 10.1111/cpr.12947] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
328 Alberca RW, Andrade MMS, Branco ACCC, Pietrobon AJ, Pereira NZ, Fernandes IG, Oliveira LM, Teixeira FME, Beserra DR, de Oliveira EA, Gozzi-Silva SC, Ramos YÁL, de Brito CA, Arnone M, Orfali RL, Aoki V, Duarte AJDS, Sato MN. Frequencies of CD33+CD11b+HLA-DR-CD14-CD66b+ and CD33+CD11b+HLA-DR-CD14+CD66b- Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19. Front Med (Lausanne) 2020;7:580677. [PMID: 33178720 DOI: 10.3389/fmed.2020.580677] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
329 He F, Luo Q, Lei M, Fan L, Shao X, Hu K, Qin S, Yu N, Cao J, Yang L. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review. Clin Rheumatol 2020;39:2803-10. [PMID: 32725351 DOI: 10.1007/s10067-020-05230-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
330 Palasiewicz K, Umar S, Romay B, Zomorrodi RK, Shahrara S. Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein. Eur J Immunol 2021;51:2330-40. [PMID: 34107055 DOI: 10.1002/eji.202049159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
331 [DOI: 10.1101/2020.07.17.209304] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
332 Zheng S, Baak JP, Li S, Xiao W, Ren H, Yang H, Gan Y, Wen C. Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW. Phytomedicine 2020;79:153336. [PMID: 32949888 DOI: 10.1016/j.phymed.2020.153336] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
333 Ok F, Erdogan O, Durmus E, Carkci S, Canik A. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients. J Med Virol 2021;93:786-93. [PMID: 32662893 DOI: 10.1002/jmv.26300] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
334 Zheng C, Kar I, Chen CK, Sau C, Woodson S, Serra A, Abboud H. Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination. CNS Drugs 2020;34:879-96. [PMID: 32780300 DOI: 10.1007/s40263-020-00756-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
335 Aguadero V, Nuez E, García-miralles C, Sole-enrech G, Cano-corres R. Prognostic value of serum lactate dehydrogenase in hospitalized patients with Covid-19. Revista Romana de Medicina de Laborator 2021;29:131-41. [DOI: 10.2478/rrlm-2021-0016] [Reference Citation Analysis]
336 Posada-Vergara MP, Alzate-Ángel JC, Martínez-Buitrago E. COVID-19 and VIH. Colomb Med (Cali) 2020;51:e4327. [PMID: 33012892 DOI: 10.25100/cm.v51i2.4327] [Reference Citation Analysis]
337 Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, Klimko N, Lass-Flörl C, Oladele RO, Vinh DC, Zhu LP, Böll B, Brüggemann R, Gangneux JP, Perfect JR, Patterson TF, Persigehl T, Meis JF, Ostrosky-Zeichner L, White PL, Verweij PE, Cornely OA; European Confederation of Medical Mycology., International Society for Human Animal Mycology., Asia Fungal Working Group., INFOCUS LATAM/ISHAM Working Group., ISHAM Pan Africa Mycology Working Group., European Society for Clinical Microbiology., Infectious Diseases Fungal Infection Study Group., ESCMID Study Group for Infections in Critically Ill Patients., Interregional Association of Clinical Microbiology and Antimicrobial Chemotherapy., Medical Mycology Society of Nigeria., Medical Mycology Society of China Medicine Education Association., Infectious Diseases Working Party of the German Society for Haematology and Medical Oncology., Association of Medical Microbiology., Infectious Disease Canada. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis 2021;21:e149-62. [PMID: 33333012 DOI: 10.1016/S1473-3099(20)30847-1] [Cited by in Crossref: 69] [Cited by in F6Publishing: 54] [Article Influence: 34.5] [Reference Citation Analysis]
338 [DOI: 10.1101/2020.07.28.20162735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
339 Batum M, Kisabay Ak A, Mavioğlu H. Covid-19 infection-induced neuromyelitis optica: a case report. Int J Neurosci 2020;:1-7. [PMID: 33280477 DOI: 10.1080/00207454.2020.1860036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
340 Wang Y, Zheng J, Islam MS, Yang Y, Hu Y, Chen X. The role of CD4+FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment. Int J Biol Sci 2021;17:1507-20. [PMID: 33907514 DOI: 10.7150/ijbs.59534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
341 Riva G, Nasillo V, Tagliafico E, Trenti T, Luppi M. COVID-19: room for treating T cell exhaustion? Crit Care 2020;24:229. [PMID: 32414395 DOI: 10.1186/s13054-020-02960-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
342 Huang H, Chen S, Li H, Zhou XL, Dai Y, Wu J, Zhang J, Shao L, Yan R, Wang M, Wang J, Tu Y, Ge M. The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan. Aliment Pharmacol Ther. 2020;52:1051-1059. [PMID: 32697870 DOI: 10.1111/apt.15962] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
343 Socolovithc RL, Fumis RRL, Tomazini BM, Pastore L, Galas FRBG, de Azevedo LCP, Costa ELV. Epidemiology, outcomes, and the use of intensive care unit resources of critically ill patients diagnosed with COVID-19 in Sao Paulo, Brazil: A cohort study. PLoS One 2020;15:e0243269. [PMID: 33270741 DOI: 10.1371/journal.pone.0243269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
344 Saresella M, Trabattoni D, Marventano I, Piancone F, La Rosa F, Caronni A, Lax A, Bianchi L, Banfi P, Navarro J, Bolognesi E, Zanzottera M, Guerini FR, Clerici M. NK Cell Subpopulations and Receptor Expression in Recovering SARS-CoV-2 Infection. Mol Neurobiol 2021. [PMID: 34453271 DOI: 10.1007/s12035-021-02517-4] [Reference Citation Analysis]
345 Mostaza JM, García-Iglesias F, González-Alegre T, Blanco F, Varas M, Hernández-Blanco C, Hontañón V, Jaras-Hernández MJ, Martínez-Prieto M, Menéndez-Saldaña A, Cachán ML, Estirado E, Lahoz C; Carlos III COVID Working Group. Clinical course and prognostic factors of COVID-19 infection in an elderly hospitalized population. Arch Gerontol Geriatr 2020;91:104204. [PMID: 32771883 DOI: 10.1016/j.archger.2020.104204] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
346 Torres T, Puig L. Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic. Am J Clin Dermatol 2020;21:307-11. [PMID: 32277351 DOI: 10.1007/s40257-020-00514-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 17.0] [Reference Citation Analysis]
347 Alsagaby SA, Aljouie A, Alshammari TH, Mir SA, Alhumaydhi FA, Al Abdulmonem W, Alshaalan H, Alomaish H, Daghistani R, Alsehawi A, Alharbi NK. Haematological and radiological-based prognostic markers of COVID-19. J Infect Public Health 2021;14:1650-7. [PMID: 34627060 DOI: 10.1016/j.jiph.2021.09.021] [Reference Citation Analysis]
348 Quinaglia T, Shabani M, Breder I, Silber HA, Lima JAC, Sposito AC. Coronavirus disease-19: The multi-level, multi-faceted vasculopathy. Atherosclerosis 2021;322:39-50. [PMID: 33706082 DOI: 10.1016/j.atherosclerosis.2021.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
349 Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res 2020;21:224. [PMID: 32854739 DOI: 10.1186/s12931-020-01479-w] [Cited by in Crossref: 172] [Cited by in F6Publishing: 1] [Article Influence: 86.0] [Reference Citation Analysis]
350 Olwal CO, Nganyewo NN, Tapela K, Djomkam Zune AL, Owoicho O, Bediako Y, Duodu S. Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19. Front Immunol 2021;12:602848. [PMID: 33613574 DOI: 10.3389/fimmu.2021.602848] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
351 Cazzaniga M, Fumagalli LAM, D'angelo L, Cerino M, Bonfanti G, Fumagalli RM, Schiavo G, Lorini C, Lainu E, Terragni S, Chiarelli M, Scarazzati C, Bonato C, Zago M. Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID-19 pneumonia. Int J Clin Pract 2021;75:e14047. [PMID: 33497517 DOI: 10.1111/ijcp.14047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
352 Maillet F, Pourbaix A, le Pluart D, Sirmai L, Postolache SA, Couvelard A, Houhou-Fidouh N, Males L, Deconinck L, Lescure FX. Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments. IDCases 2021;24:e01111. [PMID: 33842207 DOI: 10.1016/j.idcr.2021.e01111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
353 Li Z, Wu J, Zhou J, Yuan B, Chen J, Wu W, Mo L, Qu Z, Zhou F, Dong Y, Huang K, Liu Z, Wang T, Symmes D, Gu J, Sho E, Zhang J, Chen R, Xu Y. A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases. mBio 2021;12:e0254221. [PMID: 34634931 DOI: 10.1128/mBio.02542-21] [Reference Citation Analysis]
354 Abraham RS, Marshall JM, Kuehn HS, Rueda CM, Gibbs A, Guider W, Stewart C, Rosenzweig SD, Wang H, Jean S, Peeples M, King T, Hunt WG, Honegger JR, Ramilo O, Mustillo PJ, Mejias A, Ardura MI, Shimamura M. Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant. J Allergy Clin Immunol 2021;147:532-544.e1. [PMID: 33007327 DOI: 10.1016/j.jaci.2020.09.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
355 Shao Z, Feng Y, Zhong L, Xie Q, Lei M, Liu Z, Wang C, Ji J, Liu H, Gu Z, Hu Z, Su L, Wu M, Liu Z. Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study. Clin Transl Immunology 2020;9:e1192. [PMID: 33082954 DOI: 10.1002/cti2.1192] [Cited by in Crossref: 30] [Cited by in F6Publishing: 38] [Article Influence: 15.0] [Reference Citation Analysis]
356 Jiang WQ, Li XS, Zhong WH, Huang LQ, Lin XJ, Wen MY, Deng YJ, Li X, Zeng HK. Comparison of clinical characteristics in patients with coronavirus disease and influenza A in Guangzhou, China. World J Emerg Med 2021;12:287-92. [PMID: 34512825 DOI: 10.5847/wjem.j.1920-8642.2021.04.006] [Reference Citation Analysis]
357 Zhang Y, Shi F, Wang Y, Meng Y, Zhang Q, Wang K, Zeng P, Diao H. Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19. Front Mol Biosci 2022;9:835590. [DOI: 10.3389/fmolb.2022.835590] [Reference Citation Analysis]
358 Riggioni C, Comberiati P, Giovannini M, Agache I, Akdis M, Alves-Correia M, Antó JM, Arcolaci A, Azkur AK, Azkur D, Beken B, Boccabella C, Bousquet J, Breiteneder H, Carvalho D, De Las Vecillas L, Diamant Z, Eguiluz-Gracia I, Eiwegger T, Eyerich S, Fokkens W, Gao YD, Hannachi F, Johnston SL, Jutel M, Karavelia A, Klimek L, Moya B, Nadeau KC, O'Hehir R, O'Mahony L, Pfaar O, Sanak M, Schwarze J, Sokolowska M, Torres MJ, van de Veen W, van Zelm MC, Wang Y, Zhang L, Jiménez-Saiz R, Akdis CA. A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy 2020;75:2503-41. [PMID: 32535955 DOI: 10.1111/all.14449] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 20.5] [Reference Citation Analysis]
359 Wu J, Shi Y, Pan X, Wu S, Hou R, Zhang Y, Zhong T, Tang H, Du W, Wang L, Wo J, Mu J, Qiu Y, Yang K, Zhang LK, Ye BC, Qi N. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO. Cell Rep 2021;34:108761. [PMID: 33567255 DOI: 10.1016/j.celrep.2021.108761] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 22.0] [Reference Citation Analysis]
360 Peddapalli A, Gehani M, Kalle AM, Peddapalli SR, Peter AE, Sharad S. Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-κB: A Systematic Review. Viruses 2021;13:378. [PMID: 33673529 DOI: 10.3390/v13030378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
361 Faour WH, Choaib A, Issa E, Choueiry FE, Shbaklo K, Alhajj M, Sawaya RT, Harhous Z, Alefishat E, Nader M. Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies. Inflamm Res 2021. [PMID: 34802072 DOI: 10.1007/s00011-021-01520-8] [Reference Citation Analysis]
362 Jorgensen SCJ, Tse CLY, Burry L, Dresser LD. Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID-19. Pharmacotherapy. 2020;40:843-856. [PMID: 32542785 DOI: 10.1002/phar.2438] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 15.0] [Reference Citation Analysis]
363 Golota AS, Kamilova TA, Shneider OV, Vologzhanin DA, Sherbak SG. Pathogenesis of the initial stages of severe COVID-19. Journal of Clinical Practice 2021;12:83-102. [DOI: 10.17816/clinpract71351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
364 Megiorni F, Pontecorvi P, Gerini G, Anastasiadou E, Marchese C, Ceccarelli S. Sex-Related Factors in Cardiovascular Complications Associated to COVID-19. Biomolecules 2022;12:21. [DOI: 10.3390/biom12010021] [Reference Citation Analysis]
365 Deng F, Zhang L, Lyu L, Lu Z, Gao D, Ma X, Guo Y, Wang R, Gong S, Jiang W. [Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19]. Med Clin (Barc). 2021;156:324-331. [PMID: 33422296 DOI: 10.1016/j.medcli.2020.11.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
366 Pramitasuri TI, Laksmidewi AAAP, Putra IBK, Dalimartha FA. Neutrophil Extracellular Traps in Coronavirus Disease-19-Associated Ischemic Stroke: A Novel Avenue in Neuroscience. Exp Neurobiol 2021;30:1-12. [PMID: 33632982 DOI: 10.5607/en20048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
367 Nieto-Fontarigo JJ, Tillgren S, Cerps S, Sverrild A, Hvidtfeldt M, Ramu S, Menzel M, Sander AF, Porsbjerg C, Uller L. Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma. Front Immunol 2021;12:743890. [PMID: 34950134 DOI: 10.3389/fimmu.2021.743890] [Reference Citation Analysis]
368 García-García I, Guerra-García P, Ferreras C, Borobia AM, Carcas AJ, Queiruga-Parada J, Vicario JL, Mirones I, Solano C, Eguizabal C, Soria B, Pérez-Martínez A. A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol. Trials 2021;22:674. [PMID: 34600562 DOI: 10.1186/s13063-021-05625-7] [Reference Citation Analysis]
369 Bottaccioli AG, Lazzari D, Bottaccioli F. Promoting the Resilience of the Italian Population Against SARS-CoV-2. Front Psychiatry 2020;11:560017. [PMID: 33664678 DOI: 10.3389/fpsyt.2020.560017] [Reference Citation Analysis]
370 Gupta AK, Leslie A, Hewitt JN, Kovoor JG, Ovenden CD, Edwards S, Chan JCY, Worthington MG. Cardiac surgery on patients with COVID-19: a systematic review and meta-analysis. ANZ J Surg 2022. [PMID: 35373439 DOI: 10.1111/ans.17667] [Reference Citation Analysis]
371 Lauro R, Irrera N, Eid AH, Bitto A. Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children? Pathogens 2021;10:476. [PMID: 33920011 DOI: 10.3390/pathogens10040476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
372 Ciccullo A, Borghetti A, Zileri Dal Verme L, Tosoni A, Lombardi F, Garcovich M, Biscetti F, Montalto M, Cauda R, Di Giambenedetto S; GEMELLI AGAINST COVID Group. Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line. Int J Antimicrob Agents 2020;56:106017. [PMID: 32437920 DOI: 10.1016/j.ijantimicag.2020.106017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 16.0] [Reference Citation Analysis]
373 Khan H, Patel S, Majumdar A. Role of NRF2 and Sirtuin activators in COVID-19. Clin Immunol 2021;233:108879. [PMID: 34798239 DOI: 10.1016/j.clim.2021.108879] [Reference Citation Analysis]
374 Salvarani C, Dolci G, Massari M, Merlo DF, Cavuto S, Savoldi L, Bruzzi P, Boni F, Braglia L, Turrà C, Ballerini PF, Sciascia R, Zammarchi L, Para O, Scotton PG, Inojosa WO, Ravagnani V, Salerno ND, Sainaghi PP, Brignone A, Codeluppi M, Teopompi E, Milesi M, Bertomoro P, Claudio N, Salio M, Falcone M, Cenderello G, Donghi L, Del Bono V, Colombelli PL, Angheben A, Passaro A, Secondo G, Pascale R, Piazza I, Facciolongo N, Costantini M; RCT-TCZ-COVID-19 Study Group. Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Intern Med 2021;181:24-31. [PMID: 33080005 DOI: 10.1001/jamainternmed.2020.6615] [Cited by in Crossref: 207] [Cited by in F6Publishing: 220] [Article Influence: 207.0] [Reference Citation Analysis]
375 Keflie TS, Biesalski HK. Micronutrients and bioactive substances: Their potential roles in combating COVID-19. Nutrition 2021;84:111103. [PMID: 33450678 DOI: 10.1016/j.nut.2020.111103] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
376 Nasir N, Mahmood F, Habib K, Khanum I, Jamil B. Tocilizumab for COVID-19 Acute Respiratory Distress Syndrome: Outcomes Assessment Using the WHO Ordinal Scale. Cureus 2020;12:e12290. [PMID: 33510989 DOI: 10.7759/cureus.12290] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
377 Fei F, Smith JA, Cao L. Clinical laboratory characteristics in patients with suspected COVID-19: One single-institution experience. J Med Virol 2021;93:1665-71. [PMID: 32946118 DOI: 10.1002/jmv.26527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
378 Gour A, Manhas D, Bag S, Gorain B, Nandi U. Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2. Phytother Res 2021;35:4258-83. [PMID: 33786876 DOI: 10.1002/ptr.7092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
379 Long VS, Ngiam JN, Chew N, Tham SM, Lim ZY, Li T, Cen S, Annadurai JK, Thant SM, Tambyah PA, Santosa A, Teo WZY, Yap ES, Cross GB, Sia CH. Haematological profile of COVID-19 patients from a centre in Singapore. Hematology 2021;26:1007-12. [PMID: 34871520 DOI: 10.1080/16078454.2021.2005311] [Reference Citation Analysis]
380 Norouzi M, Norouzi S, Ruggiero A, Khan MS, Myers S, Kavanagh K, Vemuri R. Type-2 Diabetes as a Risk Factor for Severe COVID-19 Infection. Microorganisms 2021;9:1211. [PMID: 34205044 DOI: 10.3390/microorganisms9061211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
381 Paland N, Pechkovsky A, Aswad M, Hamza H, Popov T, Shahar E, Louria-Hayon I. The Immunopathology of COVID-19 and the Cannabis Paradigm. Front Immunol 2021;12:631233. [PMID: 33643316 DOI: 10.3389/fimmu.2021.631233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
382 Ferreira AC, Soares VC, de Azevedo-Quintanilha IG, Dias SDSG, Fintelman-Rodrigues N, Sacramento CQ, Mattos M, de Freitas CS, Temerozo JR, Teixeira L, Damaceno Hottz E, Barreto EA, Pão CRR, Palhinha L, Miranda M, Bou-Habib DC, Bozza FA, Bozza PT, Souza TML. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discov 2021;7:43. [PMID: 33649297 DOI: 10.1038/s41420-021-00428-w] [Cited by in Crossref: 55] [Cited by in F6Publishing: 1] [Article Influence: 55.0] [Reference Citation Analysis]
383 Chen C, Lin S, Shen C, Hsieh K, Cheng C. Biomarkers during COVID-19: Mechanisms of Change and Implications for Patient Outcomes. Diagnostics 2022;12:509. [DOI: 10.3390/diagnostics12020509] [Reference Citation Analysis]
384 Jiang N, Li Z, Yang B, Jin M, Sun Y, He Y, Liu Y, Wang Y, Si D, Ma P, Zhang J, Liu T, Yu Q. Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients. Biomed Res Int 2021;2021:9101082. [PMID: 33542929 DOI: 10.1155/2021/9101082] [Reference Citation Analysis]
385 Bakouny Z, Hawley JE, Choueiri TK, Peters S, Rini BI, Warner JL, Painter CA. COVID-19 and Cancer: Current Challenges and Perspectives. Cancer Cell 2020;38:629-46. [PMID: 33049215 DOI: 10.1016/j.ccell.2020.09.018] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 22.5] [Reference Citation Analysis]
386 Aricò E, Bracci L, Castiello L, Gessani S, Belardelli F. Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic? Cytokine Growth Factor Rev 2020;54:43-50. [PMID: 32665127 DOI: 10.1016/j.cytogfr.2020.07.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
387 Williams V, Dash N, Suthar R, Mohandoss V, Jaiswal N, Kavitha T, Nallasamy K, Angurana SK. Clinicolaboratory Profile, Treatment, Intensive Care Needs, and Outcome of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: A Systematic Review and Meta-analysis. J Pediatr Intensive Care. [DOI: 10.1055/s-0040-1719173] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
388 Fathi F, Sami R, Mozafarpoor S, Hafezi H, Motedayyen H, Arefnezhad R, Eskandari N. Immune system changes during COVID-19 recovery play key role in determining disease severity. Int J Immunopathol Pharmacol 2020;34:2058738420966497. [PMID: 33076729 DOI: 10.1177/2058738420966497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
389 Sivasubramanian G, Ghanem H, Maison-Fomotar M, Jain R, Libke R. COVID-19-Associated Pulmonary Aspergillosis: A Single-Center Experience in Central Valley, California, January 2020-March 2021. J Fungi (Basel) 2021;7:948. [PMID: 34829235 DOI: 10.3390/jof7110948] [Reference Citation Analysis]
390 Frohman EM, Villemarette-Pittman NR, Melamed E, Cruz RA, Longmuir R, Varkey TC, Steinman L, Zamvil SS, Frohman TC. Part I. SARS-CoV-2 triggered 'PANIC' attack in severe COVID-19. J Neurol Sci 2020;415:116936. [PMID: 32532449 DOI: 10.1016/j.jns.2020.116936] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
391 Xuan W, Jiang X, Huang L, Pan S, Chen C, Zhang X, Zhu H, Zhang S, Yu W, Peng Z, Su D. Predictive Value of Eosinophil Count on COVID-19 Disease Progression and Outcomes, a Retrospective Study of Leishenshan Hospital in Wuhan, China. J Intensive Care Med 2021;:8850666211037326. [PMID: 34550036 DOI: 10.1177/08850666211037326] [Reference Citation Analysis]
392 Huang A, Bange E, Han N, Wileyto EP, Kim J, Gouma S, Robinson J, Greenplate A, Porterfield F, Owoyemi O, Naik K, Zheng C, Galantino M, Weisman A, Ittner C, Kugler E, Baxter A, Weirick M, McAllister C, Babady NE, Kumar A, Widman A, Dewolf S, Boutemine S, Roberts C, Budzik K, Tollett S, Wright C, Perloff T, Sun L, Mathew D, Giles J, Oldridge D, Wu J, Alanio C, Adamski S, Vella L, Kerr S, Cohen J, Oyer R, Massa R, Maillard I, Maxwell K, Maslak P, Vonderheide R, Wolchok JD, Hensley S, Wherry E, Meyer N, DeMichele A, Vardhana S, Mamtani R, Oniyide O, Agyekum R, Dunn T, Jones T, Giannini H, Garfall A, Reilly J. CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer. Res Sq 2021:rs. [PMID: 33564756 DOI: 10.21203/rs.3.rs-162289/v1] [Cited by in Crossref: 9] [Article Influence: 9.0] [Reference Citation Analysis]
393 Hajifathalian K, Kumar S, Newberry C, Shah S, Fortune B, Krisko T, Ortiz-Pujols S, Zhou XK, Dannenberg AJ, Kumar R, Sharaiha RZ. Obesity is Associated with Worse Outcomes in COVID-19: Analysis of Early Data from New York City. Obesity (Silver Spring) 2020;28:1606-12. [PMID: 32470210 DOI: 10.1002/oby.22923] [Cited by in Crossref: 93] [Cited by in F6Publishing: 79] [Article Influence: 46.5] [Reference Citation Analysis]
394 Freeman TL, Swartz TH. Targeting the NLRP3 Inflammasome in Severe COVID-19. Front Immunol 2020;11:1518. [PMID: 32655582 DOI: 10.3389/fimmu.2020.01518] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 49.5] [Reference Citation Analysis]
395 Tsai ST, Lu MK, San S, Tsai CH. The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review. Front Neurol. 2020;11:498. [PMID: 32574246 DOI: 10.3389/fneur.2020.00498] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 18.0] [Reference Citation Analysis]
396 Fernández-Lázaro D, González-Bernal JJ, Sánchez-Serrano N, Navascués LJ, Ascaso-Del-Río A, Mielgo-Ayuso J. Physical Exercise as a Multimodal Tool for COVID-19: Could It Be Used as a Preventive Strategy? Int J Environ Res Public Health 2020;17:E8496. [PMID: 33212762 DOI: 10.3390/ijerph17228496] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
397 Ruscitti P, Conforti A, Cipriani P, Giacomelli R, Tasso M, Costa L, Caso F. Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders. Adv Rheumatol 2021;61:45. [PMID: 34238376 DOI: 10.1186/s42358-021-00204-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
398 Mba IE, Sharndama HC, Osondu-Chuka GO, Okeke OP. Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update. Infect Dis (Lond) 2021;53:559-80. [PMID: 33905282 DOI: 10.1080/23744235.2021.1916071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
399 Kulkarni PG, Sakharkar A, Banerjee T. Understanding the role of nACE2 in neurogenic hypertension among COVID-19 patients. Hypertens Res 2021. [PMID: 34848886 DOI: 10.1038/s41440-021-00800-4] [Reference Citation Analysis]
400 Picchianti Diamanti A, Rosado MM, Pioli C, Sesti G, Laganà B. Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity. Int J Mol Sci 2020;21:E3330. [PMID: 32397174 DOI: 10.3390/ijms21093330] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 22.5] [Reference Citation Analysis]
401 Elneil S, Lalezari JP, Pourhassan NZ. Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab. J Transl Autoimmun 2021;4:100097. [PMID: 33778462 DOI: 10.1016/j.jtauto.2021.100097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
402 Podstawka J, Sinha S, Hiroki CH, Sarden N, Granton E, Labit E, Kim JH, Andonegui G, Lou Y, Snarr BD, Sheppard DC, Rosin NL, Biernaskie J, Yipp BG. Marginating transitional B cells modulate neutrophils in the lung during inflammation and pneumonia. J Exp Med 2021;218:e20210409. [PMID: 34313733 DOI: 10.1084/jem.20210409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
403 Ascierto PA, Fu B, Wei H. IL-6 modulation for COVID-19: the right patients at the right time? J Immunother Cancer 2021;9:e002285. [PMID: 33837054 DOI: 10.1136/jitc-2020-002285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
404 [DOI: 10.1101/2020.04.02.20051565] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
405 Filgueira TO, Castoldi A, Santos LER, de Amorim GJ, de Sousa Fernandes MS, Anastácio WLDN, Campos EZ, Santos TM, Souto FO. The Relevance of a Physical Active Lifestyle and Physical Fitness on Immune Defense: Mitigating Disease Burden, With Focus on COVID-19 Consequences. Front Immunol 2021;12:587146. [PMID: 33613573 DOI: 10.3389/fimmu.2021.587146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
406 Vadasz Z, Brenner B, Toubi E. Immune-Mediated Coagulopathy in COVID-19 Infection. Semin Thromb Hemost 2020;46:838-40. [PMID: 32877959 DOI: 10.1055/s-0040-1714272] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
407 Tomo S, Banerjee M, Sharma P, Garg M. Does dehydroepiandrosterone sulfate have a role in COVID-19 prognosis and treatment? Endocr Regul 2021;55:174-81. [PMID: 34523302 DOI: 10.2478/enr-2021-0019] [Reference Citation Analysis]
408 An PJ, Zhu YZ, Yang LP. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications. Pharmacol Res 2020;159:104946. [PMID: 32450346 DOI: 10.1016/j.phrs.2020.104946] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
409 Luo J, Zhu X, Jian J, Chen X, Yin K. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment. Acta Biochim Biophys Sin (Shanghai) 2021;53:273-82. [PMID: 33428706 DOI: 10.1093/abbs/gmaa176] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
410 Zou H, Yang Y, Dai H, Xiong Y, Wang JQ, Lin L, Chen ZS. Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment. Front Pharmacol 2021;12:732403. [PMID: 34880750 DOI: 10.3389/fphar.2021.732403] [Reference Citation Analysis]
411 Zhao R, Sun Y, Zhang Y, Wang W, Wang S, Wang C, Liu J, Gao L, Hu Z, Fei J, Hou X, Zheng H, Chen L. Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals. Mediators Inflamm 2020;2020:6914878. [PMID: 33061829 DOI: 10.1155/2020/6914878] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
412 Wu D, Wu X, Huang J, Rao Q, Zhang Q, Zhang W. Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patients. BMC Infect Dis 2021;21:631. [PMID: 34210280 DOI: 10.1186/s12879-021-06354-7] [Reference Citation Analysis]
413 Yu HH, Qin C, Chen M, Wang W, Tian DS. D-dimer level is associated with the severity of COVID-19. Thromb Res 2020;195:219-25. [PMID: 32777639 DOI: 10.1016/j.thromres.2020.07.047] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
414 Søreide K, Hallet J, Matthews JB, Schnitzbauer AA, Line PD, Lai PBS, Otero J, Callegaro D, Warner SG, Baxter NN, Teh CSC, Ng-Kamstra J, Meara JG, Hagander L, Lorenzon L. Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services. Br J Surg 2020;107:1250-61. [PMID: 32350857 DOI: 10.1002/bjs.11670] [Cited by in Crossref: 265] [Cited by in F6Publishing: 215] [Article Influence: 132.5] [Reference Citation Analysis]
415 Croft A, Bucca A, Jansen JH, Motzkus C, Herbert A, Wang A, Hunter BR. First-time Diabetic Ketoacidosis in Type 2 Diabetics With Covid-19 Infection: A Novel Case Series. J Emerg Med 2020;59:e193-7. [PMID: 32912646 DOI: 10.1016/j.jemermed.2020.07.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
416 Ren P, Zhu C, He Y, Jiang H, Chen J. Analysis of the dynamic relationship between immune profiles and the clinical features of patients with COVID-19. Ann Transl Med 2021;9:1118. [PMID: 34430559 DOI: 10.21037/atm-21-812] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
417 Zhou Y, Xu J, Hou Y, Leverenz JB, Kallianpur A, Mehra R, Liu Y, Yu H, Pieper AA, Jehi L, Cheng F. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. bioRxiv 2021:2021. [PMID: 33791705 DOI: 10.1101/2021.03.15.435423] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
418 DiPiazza AT, Graham BS, Ruckwardt TJ. T cell immunity to SARS-CoV-2 following natural infection and vaccination. Biochem Biophys Res Commun 2021;538:211-7. [PMID: 33190827 DOI: 10.1016/j.bbrc.2020.10.060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
419 Nawar T, Morjaria S, Kaltsas A, Patel D, Perez-Johnston R, Daniyan AF, Mailankody S, Parameswaran R. Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow? Am J Hematol 2020;95:E210-3. [PMID: 32419212 DOI: 10.1002/ajh.25870] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
420 Valenzuela-Almada MO, Putman MS, Duarte-García A. The protective effect of rheumatic disease agents in COVID-19. Best Pract Res Clin Rheumatol 2021;35:101659. [PMID: 33526326 DOI: 10.1016/j.berh.2021.101659] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
421 Kim BH, Yoo MC. Intracranial Hemorrhage Due to Potential Rupture of an Arteriovenous Malformation after BNT162b2 COVID-19 mRNA Vaccination in a Young Korean Woman: Case Report. Vaccines 2022;10:362. [DOI: 10.3390/vaccines10030362] [Reference Citation Analysis]
422 Yan X, Li F, Wang X, Yan J, Zhu F, Tang S, Deng Y, Wang H, Chen R, Yu Z, Li Y, Shang J, Zeng L, Zhao J, Guan C, Liu Q, Chen H, Gong W, Huang X, Zhang YJ, Liu J, Dong X, Zheng W, Nie S, Li D. Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study. J Med Virol 2020;92:2573-81. [PMID: 32458459 DOI: 10.1002/jmv.26061] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 25.5] [Reference Citation Analysis]
423 van Eeden C, Khan L, Osman MS, Cohen Tervaert JW. Natural Killer Cell Dysfunction and Its Role in COVID-19. Int J Mol Sci 2020;21:E6351. [PMID: 32883007 DOI: 10.3390/ijms21176351] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
424 Liang J, Nong S, Jiang L, Chi X, Bi D, Cao J, Mo L, Luo X, Huang H. Correlations of disease severity and age with hematology parameter variations in patients with COVID-19 pre- and post-treatment. J Clin Lab Anal 2021;35:e23609. [PMID: 33222271 DOI: 10.1002/jcla.23609] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
425 Addeo A, Friedlaender A. Cancer and COVID-19: Unmasking their ties. Cancer Treat Rev 2020;88:102041. [PMID: 32516704 DOI: 10.1016/j.ctrv.2020.102041] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
426 Mutinelli-Szymanski P, Hude I, Merle E, Lombardi Y, Seris P, Abtahi M, Azeroual L, Bourgain C, Ensergueix G, Katerinis I, Kolko A, Kolta A, Maheas C, Mehrbanian S, Morel P, Ossman R, de Préneuf H, Roux A, Saltiel C, Vendé F, Verhoeven AS, Viron B, Laplanche S, Le Monnier A, Ridel C, Ureña-Torres P, Touzot M. Neutrophil:lymphocyte ratio predicts short-term outcome of COVID-19 in haemodialysis patients. Clin Kidney J 2021;14:124-31. [PMID: 33558835 DOI: 10.1093/ckj/sfaa194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
427 Ardura M, Hartley D, Dandoy C, Lehmann L, Jaglowski S, Auletta JJ; Transplant-Associated Learning Network Team (TALNT). Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices. Biol Blood Marrow Transplant 2020;26:e147-60. [PMID: 32339662 DOI: 10.1016/j.bbmt.2020.04.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
428 Gautam SS, Gautam CS, Garg VK, Singh H. Combining hydroxychloroquine and minocycline: potential role in moderate to severe COVID-19 infection. Expert Rev Clin Pharmacol 2020;13:1183-90. [PMID: 33008280 DOI: 10.1080/17512433.2020.1832889] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
429 Akhavizadegan H, Hosamirudsari H, Alizadeh M, Alimohamadi Y, Karbakhsh Davari M, Akbarpour S, Nakhostin-Ansari A, Foroughi A, Mansuri F, Faraji N, Nasiri Z. Can laboratory tests at the time of admission guide us to the prognosis of patients with COVID-19? J Prev Med Hyg 2021;62:E321-5. [PMID: 34604572 DOI: 10.15167/2421-4248/jpmh2021.62.2.1700] [Reference Citation Analysis]
430 Liu T, Liu S, Li T, Zhang J. Thymosin a1 use is not associated with reduced COVID-19 mortality. Am J Emerg Med 2021:S0735-6757(21)00329-6. [PMID: 33896653 DOI: 10.1016/j.ajem.2021.04.043] [Reference Citation Analysis]
431 Willows S, Alam SB, Sandhu JK, Kulka M. A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis. Biochem Cell Biol 2021;99:173-94. [PMID: 33027600 DOI: 10.1139/bcb-2020-0341] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
432 Alsudir SA, Almalik A, Alhasan AH. Catalogue of self-targeting nano-medical inventions to accelerate clinical trials. Biomater Sci 2021;9:3898-910. [PMID: 33912874 DOI: 10.1039/d1bm00235j] [Reference Citation Analysis]
433 Yadav AK, Verma D, Kumar A, Kumar P, Solanki PR. The perspectives of biomarker-based electrochemical immunosensors, artificial intelligence and the Internet of Medical Things toward COVID-19 diagnosis and management. Mater Today Chem 2021;20:100443. [PMID: 33615086 DOI: 10.1016/j.mtchem.2021.100443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
434 Hasan A, Al-Ozairi E, Al-Baqsumi Z, Ahmad R, Al-Mulla F. Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches. Immunotargets Ther 2021;10:63-85. [PMID: 33728277 DOI: 10.2147/ITT.S280706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
435 Senra H. Bidirectional associations and common inflammatory biomarkers in COVID-19 and mental health disorders: A window of opportunity for future research? Brain Behav Immun Health 2021;13:100237. [PMID: 33681826 DOI: 10.1016/j.bbih.2021.100237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
436 Chen F, Chen W, Chen J, Xu D, Xie W, Wang X, Xie Y. Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases. Ann Hepatol. 2021;21:100267. [PMID: 33053426 DOI: 10.1016/j.aohep.2020.09.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
437 Zeng H, Wang S, Chen L, Shen Z. Biologics for Psoriasis During the COVID-19 Pandemic. Front Med (Lausanne) 2021;8:759568. [PMID: 34938746 DOI: 10.3389/fmed.2021.759568] [Reference Citation Analysis]
438 Mösbauer K, Fritsch VN, Adrian L, Bernhardt J, Gruhlke MCH, Slusarenko AJ, Niemeyer D, Antelmann H. The Effect of Allicin on the Proteome of SARS-CoV-2 Infected Calu-3 Cells. Front Microbiol 2021;12:746795. [PMID: 34777295 DOI: 10.3389/fmicb.2021.746795] [Reference Citation Analysis]
439 Nie L, Liu Y, Weng Y, Zheng Y, Cai L, Kou G, Xiong Z, Liu L. Lymphocytes screening on admission is essential for predicting in-hospital clinical outcome in COVID-19 patients: A retrospective cohort study. Int J Lab Hematol 2021. [PMID: 34192413 DOI: 10.1111/ijlh.13640] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
440 [DOI: 10.1101/2020.05.11.20098673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
441 Spuch C, López-garcía M, Rivera-baltanás T, Cabrera-alvargonzález JJ, Gadh S, Rodrigues-amorim D, Álvarez-estévez T, Mora A, Iglesias-martínez-almeida M, Freiría-martínez L, Pérez-rodríguez M, Pérez-gonzález A, López-domínguez A, Longueira-suarez MR, Sousa-domínguez A, Araújo-ameijeiras A, Mosquera-rodríguez D, Crespo M, Vila-fernández D, Regueiro B, Olivares JM. Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients. Front Pharmacol 2022;13:850583. [DOI: 10.3389/fphar.2022.850583] [Reference Citation Analysis]
442 Zhang S, Wang C, Lin M, Deng Q, Ye Y, Li Z, Qiu L, Wang Z. Analysis of the Virus Contamination and Disinfection Effect in Isolation Ward of Patients With COVID-19. Front Public Health 2020;8:486. [PMID: 32984255 DOI: 10.3389/fpubh.2020.00486] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
443 Wang K, Luo J, Tan F, Liu J, Ni Z, Liu D, Tian P, Li W. Acute Pancreatitis as the Initial Manifestation in 2 Cases of COVID-19 in Wuhan, China. Open Forum Infect Dis. 2020;7:ofaa324. [PMID: 32959016 DOI: 10.1093/ofid/ofaa324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
444 Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, Levantovsky R, Malle L, Moreira A, Park MD, Pia L, Risson E, Saffern M, Salomé B, Esai Selvan M, Spindler MP, Tan J, van der Heide V, Gregory JK, Alexandropoulos K, Bhardwaj N, Brown BD, Greenbaum B, Gümüş ZH, Homann D, Horowitz A, Kamphorst AO, Curotto de Lafaille MA, Mehandru S, Merad M, Samstein RM; Sinai Immunology Review Project. Immunology of COVID-19: Current State of the Science. Immunity 2020;52:910-41. [PMID: 32505227 DOI: 10.1016/j.immuni.2020.05.002] [Cited by in Crossref: 731] [Cited by in F6Publishing: 635] [Article Influence: 365.5] [Reference Citation Analysis]
445 Hatami F, Valizadeh N, Ansari Ramandi MM. Emerging mechanisms for the new coronavirus-related myocardial injury and ischemia: A review of the literature. Anatol J Cardiol 2020;24:7-12. [PMID: 32628143 DOI: 10.14744/AnatolJCardiol.2020.68166] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
446 Kalicińska E, Szymczak D, Andrasiak I, Bogucka-Fedorczuk A, Zińczuk A, Szymański W, Biernat M, Rymko M, Semeńczuk G, Jabłonowska P, Rybka J, Simon K, Wróbel T. Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study. Transl Oncol 2021;14:100943. [PMID: 33204385 DOI: 10.1016/j.tranon.2020.100943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
447 Frater JL, Wang T, Lee Y. Laboratory hematologic features of COVID-19 associated liver injury: A systematic review. WJMA 2021;9:192-206. [DOI: 10.13105/wjma.v9.i2.192] [Reference Citation Analysis]
448 Sigel K, Swartz T, Golden E, Paranjpe I, Somani S, Richter F, De Freitas JK, Miotto R, Zhao S, Polak P, Mutetwa T, Factor S, Mehandru S, Mullen M, Cossarini F, Bottinger E, Fayad Z, Merad M, Gnjatic S, Aberg J, Charney A, Nadkarni G, Glicksberg BS. Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City. Clin Infect Dis 2020;71:2933-8. [PMID: 32594164 DOI: 10.1093/cid/ciaa880] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 60.0] [Reference Citation Analysis]
449 Hadid T, Kafri Z, Al-Katib A. Coagulation and anticoagulation in COVID-19. Blood Rev 2021;47:100761. [PMID: 33067035 DOI: 10.1016/j.blre.2020.100761] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
450 Ortiz-Prado E, Simbaña-Rivera K, Gómez-Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, Muslin C, Jaramillo AMG, Barba-Ostria C, Cevallos-Robalino D, Sanches-SanMiguel H, Unigarro L, Zalakeviciute R, Gadian N, López-Cortés A. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis 2020;98:115094. [PMID: 32623267 DOI: 10.1016/j.diagmicrobio.2020.115094] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 49.5] [Reference Citation Analysis]
451 Nitulescu GM, Paunescu H, Moschos SA, Petrakis D, Nitulescu G, Ion GND, Spandidos DA, Nikolouzakis TK, Drakoulis N, Tsatsakis A. Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review). Int J Mol Med 2020;46:467-88. [PMID: 32468014 DOI: 10.3892/ijmm.2020.4608] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 23.0] [Reference Citation Analysis]
452 Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol 2022. [PMID: 35354968 DOI: 10.1038/s41579-022-00713-0] [Reference Citation Analysis]
453 Li Y, Liu S, Zhang S, Ju Q, Zhang S, Yang Y, Wang H. Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies. Transfus Apher Sci 2020;59:102839. [PMID: 32561113 DOI: 10.1016/j.transci.2020.102839] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
454 Bağ Soytaş R, Ünal D, Arman P, Suzan V, Emiroğlu Gedik T, Can G, Korkmazer B, Karaali R, Börekçi Ş, Kuşkucu MA, Yavuzer H, Suna Erdinçler D, Döventaş A. Factors affecting mortality in geriatric patients hospitalized with COVID-19. Turk J Med Sci 2021;51:454-63. [PMID: 33315348 DOI: 10.3906/sag-2008-91] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
455 Alhazmi HA, Najmi A, Javed SA, Sultana S, Al Bratty M, Makeen HA, Meraya AM, Ahsan W, Mohan S, Taha MME, Khalid A. Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19. Front Immunol 2021;12:637553. [PMID: 34054806 DOI: 10.3389/fimmu.2021.637553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
456 Sharma D, Zhao F. Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19. NPJ Regen Med 2021;6:37. [PMID: 34193864 DOI: 10.1038/s41536-021-00147-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
457 Yan B, Yang J, Xie Y, Tang X. Relationship between blood eosinophil levels and COVID-19 mortality. World Allergy Organ J 2021;14:100521. [PMID: 33589865 DOI: 10.1016/j.waojou.2021.100521] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
458 Ferreira AO, Polonini HC, Dijkers ECF. Postulated Adjuvant Therapeutic Strategies for COVID-19. J Pers Med 2020;10:E80. [PMID: 32764275 DOI: 10.3390/jpm10030080] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
459 Kim DM, Kim Y, Seo JW, Lee J, Park U, Ha NY, Koh J, Park H, Lee JW, Ro HJ, Yun NR, Kim DY, Yoon SH, Na YS, Moon DS, Lim SC, Kim CM, Jeon K, Kang JG, Jang NY, Jeong H, Kim J, Cheon S, Sohn KM, Moon JY, Kym S, Han SR, Lee MS, Kim HJ, Park WY, Choi JY, Shin HW, Kim HY, Cho CH, Jeon YK, Kim YS, Cho NH. Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19. Cell Rep 2021;37:109798. [PMID: 34587481 DOI: 10.1016/j.celrep.2021.109798] [Reference Citation Analysis]
460 Kewan T, Covut F, Al-Jaghbeer MJ, Rose L, Gopalakrishna KV, Akbik B. Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study. EClinicalMedicine 2020;24:100418. [PMID: 32766537 DOI: 10.1016/j.eclinm.2020.100418] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 40.0] [Reference Citation Analysis]
461 Ghaith MM, Albanghali MA, Aldairi AF, Iqbal MS, Almaimani RA, AlQuthami K, Alqasmi MH, Almaimani W, El-Readi MZ, Alghamdi A, Almasmoum HA. Potential Predictors of Poor Prognosis among Severe COVID-19 Patients: A Single-Center Study. Can J Infect Dis Med Microbiol 2021;2021:6656092. [PMID: 33884042 DOI: 10.1155/2021/6656092] [Reference Citation Analysis]
462 Chaari A, Bendriss G, Zakaria D, McVeigh C. Importance of Dietary Changes During the Coronavirus Pandemic: How to Upgrade Your Immune Response. Front Public Health 2020;8:476. [PMID: 32984253 DOI: 10.3389/fpubh.2020.00476] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
463 Soraya GV, Ulhaq ZS. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis. Med Clin (Engl Ed) 2020;155:143-51. [PMID: 32864456 DOI: 10.1016/j.medcle.2020.05.004] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
464 Kalyon S, Gültop F, Şimşek F, Adaş M. Relationships of the neutrophil-lymphocyte and CRP-albumin ratios with the duration of hospitalization and fatality in geriatric patients with COVID-19. J Int Med Res 2021;49:3000605211046112. [PMID: 34581218 DOI: 10.1177/03000605211046112] [Reference Citation Analysis]
465 Beltrán-García J, Osca-Verdegal R, Pallardó FV, Ferreres J, Rodríguez M, Mulet S, Ferrando-Sánchez C, Carbonell N, García-Giménez JL. Sepsis and Coronavirus Disease 2019: Common Features and Anti-Inflammatory Therapeutic Approaches. Crit Care Med 2020;48:1841-4. [PMID: 32826431 DOI: 10.1097/CCM.0000000000004625] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
466 Zhang S, Wang X, Zhang H, Xu A, Fei G, Jiang X, Tu J, Qu G, Xu X, Li Y. The absence of coronavirus in expressed prostatic secretion in COVID-19 patients in Wuhan city. Reprod Toxicol 2020;96:90-4. [PMID: 32534021 DOI: 10.1016/j.reprotox.2020.06.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
467 Xu R, Hou K, Zhang K, Xu H, Zhang N, Fu H, Xie L, Sun R, Wen L, Liu H, Yang Z, Yang M, Guo Y. Performance of Two Risk-Stratification Models in Hospitalized Patients With Coronavirus Disease. Front Med (Lausanne) 2020;7:518. [PMID: 32923449 DOI: 10.3389/fmed.2020.00518] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
468 Gaborit B, Vanhove B, Vibet MA, Le Thuaut A, Lacombe K, Dubee V, Ader F, Ferre V, Vicaut E, Orain J, Le Bras M, Omnes A, Berly L, Jobert A, Morineau-Le Houssine P, Botturi K, Josien R, Flet L, Degauque N, Brouard S, Duvaux O, Poinas A, Raffi F; POLYCOR study group. Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial. Trials 2021;22:199. [PMID: 33750432 DOI: 10.1186/s13063-021-05132-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
469 Aliter KF, Al-Horani RA. Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients. Curr Pharm Des 2021;27:866-75. [PMID: 33001004 DOI: 10.2174/1381612826666201001125604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
470 Banerjee A, Santra D, Maiti S. Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development. J Transl Med 2020;18:281. [PMID: 32650788 DOI: 10.1186/s12967-020-02435-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
471 Sender V, Hentrich K, Henriques-Normark B. Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae. Front Cell Infect Microbiol 2021;11:643326. [PMID: 33828999 DOI: 10.3389/fcimb.2021.643326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
472 Stasi A, Castellano G, Ranieri E, Infante B, Stallone G, Gesualdo L, Netti GS. SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure. J Clin Med 2020;9:E4057. [PMID: 33334050 DOI: 10.3390/jcm9124057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
473 Azimzadeh M, Möhn N, Ghane Ezabadi S, Moghimi Esfandabadi Z, Soleimani A, Ranjbar E, Jahromi M, Seyedebrahimi R, Skripuletz T, Moharrami Kasmaie F. The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic. Biomolecules 2021;11:1372. [PMID: 34572585 DOI: 10.3390/biom11091372] [Reference Citation Analysis]
474 Rabaan AA, Al-Ahmed SH, Garout MA, Al-Qaaneh AM, Sule AA, Tirupathi R, Mutair AA, Alhumaid S, Hasan A, Dhawan M, Tiwari R, Sharun K, Mohapatra RK, Mitra S, Emran TB, Bilal M, Singh R, Alyami SA, Moni MA, Dhama K. Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses. Pathogens 2021;10:565. [PMID: 34066983 DOI: 10.3390/pathogens10050565] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
475 Stojkovic-Filipovic J, Bosic M. Treatment of COVID 19-Repurposing drugs commonly used in dermatology. Dermatol Ther 2020;33:e13829. [PMID: 32542964 DOI: 10.1111/dth.13829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
476 Signorini C, Pignatti P, Coccini T. How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn. Life (Basel) 2021;11:182. [PMID: 33669011 DOI: 10.3390/life11030182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
477 Morris G, Bortolasci CC, Puri BK, Olive L, Marx W, O'Neil A, Athan E, Carvalho A, Maes M, Walder K, Berk M. Preventing the development of severe COVID-19 by modifying immunothrombosis. Life Sci 2021;264:118617. [PMID: 33096114 DOI: 10.1016/j.lfs.2020.118617] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
478 Presnyakova MV, Galova EA, Sosnina LN, Popovicheva AN, Lyubavina NA, Kostina OV, Kuznetsova VL, Karyakin NN. Disturbances of the hemostasis system and expression of inflammatory reaction in patients with new coronaviral pneumonia. Klin Lab Diagn 2020;65:744-9. [PMID: 33373505 DOI: 10.18821/0869-2084-2020-65-12-744-749] [Reference Citation Analysis]
479 Peng KP. Association between COVID-19 and headache: What evidence and history tell us. Cephalalgia 2020;40:1403-5. [PMID: 33146041 DOI: 10.1177/0333102420965969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
480 Wang SC, Wang YF. Cardiovascular protective properties of oxytocin against COVID-19. Life Sci 2021;270:119130. [PMID: 33513400 DOI: 10.1016/j.lfs.2021.119130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
481 Young BE, Ong SWX, Ng LFP, Anderson DE, Chia WN, Chia PY, Ang LW, Mak TM, Kalimuddin S, Chai LYA, Pada S, Tan SY, Sun L, Parthasarathy P, Fong SW, Chan YH, Tan CW, Lee B, Rötzschke O, Ding Y, Tambyah P, Low JGH, Cui L, Barkham T, Lin RTP, Leo YS, Renia L, Wang LF, Lye DC; Singapore 2019 Novel Coronavirus Outbreak Research team. Viral dynamics and immune correlates of COVID-19 disease severity.Clin Infect Dis. 2020;. [PMID: 32856707 DOI: 10.1093/cid/ciaa1280] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 17.5] [Reference Citation Analysis]
482 Zhang Z, Ai G, Chen L, Liu S, Gong C, Zhu X, Zhang C, Qin H, Hu J, Huang J. Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis. BMC Infect Dis 2021;21:738. [PMID: 34344353 DOI: 10.1186/s12879-021-06457-1] [Reference Citation Analysis]
483 Coronado-Vázquez V, Ramírez-Durán MDV, Gómez-Salgado J, Dorado-Rabaneda MS, Benito-Alonso E, Holgado-Juan M, Bronchalo-González C. Evolution of a Cohort of COVID-19 Infection Suspects Followed-Up from Primary Health Care. J Pers Med 2021;11:459. [PMID: 34073666 DOI: 10.3390/jpm11060459] [Reference Citation Analysis]
484 Korkmaz C, Demircioglu S. The Association of Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios and Hematological Parameters with Diagnosis, Stages, Extrapulmonary Involvement, Pulmonary Hypertension, Response to Treatment, and Prognosis in Patients with Sarcoidosis. Can Respir J 2020;2020:1696450. [PMID: 33062080 DOI: 10.1155/2020/1696450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
485 Sosa JA. Welcome New Associate Editor Sanziana Roman of the USA to the World Journal of Surgery. World J Surg 2020;44:1. [PMID: 31720792 DOI: 10.1007/s00268-019-05279-2] [Reference Citation Analysis]
486 Varma A, Dergaa I, Mohammed AR, Abubaker M, Al Naama A, Mohammed S, Rafique MA, Manu L, Vedasalam S, Parveze P, Hammouda O, Ammar A. Covid-19 and diabetes in primary care - How do hematological parameters present in this cohort? Expert Rev Endocrinol Metab 2021;16:147-53. [PMID: 33818239 DOI: 10.1080/17446651.2021.1909472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
487 Fang S, Wang H, Lu L, Jia Y, Xia Z. Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study. Int Immunopharmacol 2020;89:107070. [PMID: 33039965 DOI: 10.1016/j.intimp.2020.107070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
488 Chinnadurai R, Ogedengbe O, Agarwal P, Money-Coomes S, Abdurrahman AZ, Mohammed S, Kalra PA, Rothwell N, Pradhan S. Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study. BMC Geriatr 2020;20:409. [PMID: 33066750 DOI: 10.1186/s12877-020-01803-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 14.0] [Reference Citation Analysis]
489 Putri DU, Wang CH, Tseng PC, Lee WS, Chen FL, Kuo HP, Lee CH, Lin CF. Profiles of Peripheral Immune Cells of Uncomplicated COVID-19 Cases with Distinct Viral RNA Shedding Periods. Viruses 2021;13:514. [PMID: 33808906 DOI: 10.3390/v13030514] [Reference Citation Analysis]
490 İnandıklıoğlu N, Akkoc T. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2. Adv Exp Med Biol 2020;1288:5-12. [PMID: 32514817 DOI: 10.1007/5584_2020_549] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
491 Zhou J, Sun Y, Huang W, Ye K. Altered Blood Cell Traits Underlie a Major Genetic Locus of Severe COVID-19. J Gerontol A Biol Sci Med Sci 2021;76:e147-54. [PMID: 33530099 DOI: 10.1093/gerona/glab035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
492 Mo S, Dai L, Wang Y, Song B, Yang Z, Gu W. Comprehensive Analysis of the Systemic Transcriptomic Alternations and Inflammatory Response during the Occurrence and Progress of COVID-19. Oxid Med Cell Longev 2021;2021:9998697. [PMID: 34457122 DOI: 10.1155/2021/9998697] [Reference Citation Analysis]
493 Kabak M, Çil B, Hocanlı I. Relationship between leukocyte, neutrophil, lymphocyte, platelet counts, and neutrophil to lymphocyte ratio and polymerase chain reaction positivity. Int Immunopharmacol 2021;93:107390. [PMID: 33529907 DOI: 10.1016/j.intimp.2021.107390] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
494 Mazzoni A, Salvati L, Maggi L, Annunziato F, Cosmi L. Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion. Semin Immunol 2021;:101508. [PMID: 34728121 DOI: 10.1016/j.smim.2021.101508] [Reference Citation Analysis]
495 Fernandes Q, Inchakalody VP, Merhi M, Mestiri S, Taib N, Moustafa Abo El-Ella D, Bedhiafi T, Raza A, Al-Zaidan L, Mohsen MO, Yousuf Al-Nesf MA, Hssain AA, Yassine HM, Bachmann MF, Uddin S, Dermime S. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann Med 2022;54:524-40. [PMID: 35132910 DOI: 10.1080/07853890.2022.2031274] [Reference Citation Analysis]
496 Rahman MA, Shanjana Y, Tushar MI, Mahmud T, Rahman GMS, Milan ZH, Sultana T, Chowdhury AMLH, Bhuiyan MA, Islam MR, Reza HM. Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh. PLoS One 2021;16:e0255379. [PMID: 34314447 DOI: 10.1371/journal.pone.0255379] [Reference Citation Analysis]
497 Guner R, Kayaaslan B, Hasanoglu I, Aypak A, Bodur H, Ates I, Akinci E, Erdem D, Eser F, Izdes S, Kalem AK, Bastug A, Karalezli A, Surel AA, Ayhan M, Karaahmetoglu S, Turan IO, Arguder E, Ozdemir B, Mutlu MN, Bilir YA, Sarıcaoglu EM, Gokcinar D, Gunay S, Dinc B, Gemcioglu E, Bilmez R, Aydos O, Asilturk D, Inan O, Buzgan T. Development and validation of nomogram to predict severe illness requiring intensive care follow up in hospitalized COVID-19 cases. BMC Infect Dis 2021;21:1004. [PMID: 34563117 DOI: 10.1186/s12879-021-06656-w] [Reference Citation Analysis]
498 Brown AE, Croxford SE, Nash S, Khawam J, Kirwan P, Kall M, Bradshaw D, Sabin C, Miller RF, Post FA, Harding R, Collins S, Waters L, Asboe D, Chadwick DR, Delpech V, Sullivan AK. COVID-19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID-19 pandemic in England. HIV Med 2021. [PMID: 34528739 DOI: 10.1111/hiv.13167] [Reference Citation Analysis]
499 Hachim MY, Hachim IY, Naeem KB, Hannawi H, Al Salmi I, Hannawi S. C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysis. Transl Med Commun 2020;5:14. [PMID: 32923679 DOI: 10.1186/s41231-020-00066-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
500 Busetto GM, Porreca A, Del Giudice F, Maggi M, D'Agostino D, Romagnoli D, Musi G, Lucarelli G, Palmer K, Colonna di Paliano A, Muto M, Hurle R, Terracciano D, de Cobelli O, Sciarra A, De Berardinis E, Ferro M. SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features? Urol Int 2020;104:510-22. [PMID: 32516772 DOI: 10.1159/000509065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
501 Mo P, Deng L, Liu X, Gao S, Liang K, Luo M, Chen T, Song S, Ma Z, Chen X, Fan J, Wang F, Xiong Y, Zhang Y. Risk factors for delayed negative conversion of SARS-CoV-2 in patients with COVID-19 pneumonia: a retrospective cohort study. Epidemiol Infect 2020;148:e293. [PMID: 33256876 DOI: 10.1017/S0950268820002940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
502 Wang B, Luo Q, Zhang W, Yu S, Cheng X, Wang L, Chen X, Chen Y. The Involvement of Chronic Kidney Disease and Acute Kidney Injury in Disease Severity and Mortality in Patients with COVID-19: A Meta-Analysis. Kidney Blood Press Res 2021;46:17-30. [PMID: 33352576 DOI: 10.1159/000512211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
503 Biterge Süt B. Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13. Life Sci 2020;258:118170. [PMID: 32735883 DOI: 10.1016/j.lfs.2020.118170] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
504 Azouz NP, Klingler AM, Callahan V, Akhrymuk IV, Elez K, Raich L, Henry BM, Benoit JL, Benoit SW, Noé F, Kehn-Hall K, Rothenberg ME. Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2. Pathog Immun 2021;6:55-74. [PMID: 33969249 DOI: 10.20411/pai.v6i1.408] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
505 Zhao Y, Nie HX, Hu K, Wu XJ, Zhang YT, Wang MM, Wang T, Zheng ZS, Li XC, Zeng SL. Abnormal immunity of non-survivors with COVID-19: predictors for mortality. Infect Dis Poverty 2020;9:108. [PMID: 32746940 DOI: 10.1186/s40249-020-00723-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 17.0] [Reference Citation Analysis]
506 Berretta AA, Silveira MAD, Cóndor Capcha JM, De Jong D. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19. Biomed Pharmacother 2020;131:110622. [PMID: 32890967 DOI: 10.1016/j.biopha.2020.110622] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 20.5] [Reference Citation Analysis]
507 Bhari VK, Kumar D, Kumar S, Mishra R. SARS-CoV-2 cell receptor gene ACE2 -mediated immunomodulation in breast cancer subtypes. Biochem Biophys Rep 2020;24:100844. [PMID: 33178900 DOI: 10.1016/j.bbrep.2020.100844] [Reference Citation Analysis]
508 Zhang Y, Guo X, Li C, Kou Z, Lin L, Yao M, Pang B, Zhang X, Duan Q, Tian X, Xing Y, Jiang X. Transcriptome Analysis of Peripheral Blood Mononuclear Cells in SARS-CoV-2 Naïve and Recovered Individuals Vaccinated With Inactivated Vaccine. Front Cell Infect Microbiol 2022;11:821828. [DOI: 10.3389/fcimb.2021.821828] [Reference Citation Analysis]
509 Tang B, Zhu J, Cong Y, Yang W, Kong C, Chen W, Wang Y, Zeng Y, Ji J. The Landscape of Coronavirus Disease 2019 (COVID-19) and Integrated Analysis SARS-CoV-2 Receptors and Potential Inhibitors in Lung Adenocarcinoma Patients. Front Cell Dev Biol 2020;8:577032. [PMID: 33195212 DOI: 10.3389/fcell.2020.577032] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
510 Zabetakis I, Lordan R, Norton C, Tsoupras A. COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation. Nutrients. 2020;12. [PMID: 32438620 DOI: 10.3390/nu12051466] [Cited by in Crossref: 159] [Cited by in F6Publishing: 145] [Article Influence: 79.5] [Reference Citation Analysis]
511 Skinner HD. Mining the past to treat the present, ever mindful of the future: Low-dose radiotherapy and COVID-19 pneumonia. Cancer 2020;126:5017-21. [PMID: 32985700 DOI: 10.1002/cncr.33201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
512 Ramos da Silva S, Ju E, Meng W, Paniz Mondolfi AE, Dacic S, Green A, Bryce C, Grimes Z, Fowkes M, Sordillo EM, Cordon-Cardo C, Guo H, Gao SJ. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019. J Infect Dis 2021;223:1842-54. [PMID: 33837392 DOI: 10.1093/infdis/jiab195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
513 Admou B. [Relevant immunologic markers in COVID-19]. Pan Afr Med J 2021;39:40. [PMID: 34422163 DOI: 10.11604/pamj.2021.39.40.23481] [Reference Citation Analysis]
514 Cortés-Vieyra R, Gutiérrez-Castellanos S, Álvarez-Aguilar C, Baizabal-Aguirre VM, Nuñez-Anita RE, Rocha-López AG, Gómez-García A. Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease. Viruses 2021;13:1675. [PMID: 34578258 DOI: 10.3390/v13091675] [Reference Citation Analysis]
515 Ciaccio M, Agnello L. Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19). Diagnosis (Berl) 2020;7:365-72. [PMID: 32589600 DOI: 10.1515/dx-2020-0057] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
516 Duan YQ, Xia MH, Ren L, Zhang YF, Ao QL, Xu SP, Kuang D, Liu Q, Yan B, Zhou YW, Chu Q, Liu L, Yang XP, Wang GP. Deficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients. Curr Med Sci 2020;40:618-24. [PMID: 32767259 DOI: 10.1007/s11596-020-2225-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
517 Iwamura APD, Tavares da Silva MR, Hümmelgen AL, Soeiro Pereira PV, Falcai A, Grumach AS, Goudouris E, Neto AC, Prando C. Immunity and inflammatory biomarkers in COVID-19: A systematic review. Rev Med Virol 2021;31:e2199. [PMID: 34260778 DOI: 10.1002/rmv.2199] [Reference Citation Analysis]
518 Zheng X, Luo S, Sun Y, Han M, Liu J, Sun L, Zhang L, Ling P, Ding Y, Jin T, Liu Z, Weng J. Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study. National Science Review 2020;7:1527-39. [DOI: 10.1093/nsr/nwaa141] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
519 Tso FY, Lidenge SJ, Poppe LK, Peña PB, Privatt SR, Bennett SJ, Ngowi JR, Mwaiselage J, Belshan M, Siedlik JA, Raine MA, Ochoa JB, Garcia-Diaz J, Nossaman B, Buckner L, Roberts WM, Dean MJ, Ochoa AC, West JT, Wood C. Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma. PLoS One 2021;16:e0247640. [PMID: 33661923 DOI: 10.1371/journal.pone.0247640] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
520 Varghese PM, Tsolaki AG, Yasmin H, Shastri A, Ferluga J, Vatish M, Madan T, Kishore U. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies. Immunobiology 2020;225:152008. [PMID: 33130519 DOI: 10.1016/j.imbio.2020.152008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
521 Rehman H, Ahmad MI. COVID-19: a wreak havoc across the globe. Arch Physiol Biochem 2020;:1-13. [PMID: 32730095 DOI: 10.1080/13813455.2020.1797105] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
522 Wang C, Zhang H, Cao X, Deng R, Ye Y, Fu Z, Gou L, Shao F, Li J, Fu W, Zhang X, Ding X, Xiao J, Wu C, Li T, Qi H, Li C, Lu Z. Red cell distribution width (RDW): a prognostic indicator of severe COVID-19. Ann Transl Med 2020;8:1230. [PMID: 33178762 DOI: 10.21037/atm-20-6090] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
523 Tanner T, Wahezi DM. Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19. Paediatr Respir Rev. 2020;35:81-87. [PMID: 32792288 DOI: 10.1016/j.prrv.2020.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
524 Sütlüoğlu H, Özdemir Ö. May mesenchymal stem cell transplantation be a solution for COVID-19 induced cytokine storm? World J Transplant 2021; 11(8): 344-355 [PMID: 34447671 DOI: 10.5500/wjt.v11.i8.344] [Reference Citation Analysis]
525 Sheng CC, Sahoo D, Dugar S, Prada RA, Wang TKM, Abou Hassan OK, Brennan D, Culver DA, Rajendram P, Duggal A, Lincoff AM, Nissen SE, Menon V, Cremer PC. Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study). Clin Cardiol 2020;43:1055-63. [PMID: 32830894 DOI: 10.1002/clc.23451] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
526 Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe A, Abbondanza D, Fleming SJ, Subramanian A, Montoro DT, Jagadeesh KA, Dey KK, Sen P, Slyper M, Pita-Juárez YH, Phillips D, Bloom-Ackerman Z, Barkas N, Ganna A, Gomez J, Normandin E, Naderi P, Popov YV, Raju SS, Niezen S, Tsai LT, Siddle KJ, Sud M, Tran VM, Vellarikkal SK, Amir-Zilberstein L, Atri DS, Beechem J, Brook OR, Chen J, Divakar P, Dorceus P, Engreitz JM, Essene A, Fitzgerald DM, Fropf R, Gazal S, Gould J, Grzyb J, Harvey T, Hecht J, Hether T, Jane-Valbuena J, Leney-Greene M, Ma H, McCabe C, McLoughlin DE, Miller EM, Muus C, Niemi M, Padera R, Pan L, Pant D, Pe'er C, Pfiffner-Borges J, Pinto CJ, Plaisted J, Reeves J, Ross M, Rudy M, Rueckert EH, Siciliano M, Sturm A, Todres E, Waghray A, Warren S, Zhang S, Zollinger DR, Cosimi L, Gupta RM, Hacohen N, Hide W, Price AL, Rajagopal J, Tata PR, Riedel S, Szabo G, Tickle TL, Hung D, Sabeti PC, Novak R, Rogers R, Ingber DE, Gordon Jiang Z, Juric D, Babadi M, Farhi SL, Stone JR, Vlachos IS, Solomon IH, Ashenberg O, Porter CBM, Li B, Shalek AK, Villani AC, Rozenblatt-Rosen O, Regev A. A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2. bioRxiv 2021:2021. [PMID: 33655247 DOI: 10.1101/2021.02.25.430130] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
527 Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F. Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy. Infect Drug Resist 2020;13:2485-93. [PMID: 32801787 DOI: 10.2147/IDR.S258639] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 16.5] [Reference Citation Analysis]
528 Aljouie AF, Almazroa A, Bokhari Y, Alawad M, Mahmoud E, Alawad E, Alsehawi A, Rashid M, Alomair L, Almozaai S, Albesher B, Alomaish H, Daghistani R, Alharbi NK, Alaamery M, Bosaeed M, Alshaalan H. Early Prediction of COVID-19 Ventilation Requirement and Mortality from Routinely Collected Baseline Chest Radiographs, Laboratory, and Clinical Data with Machine Learning. J Multidiscip Healthc 2021;14:2017-33. [PMID: 34354361 DOI: 10.2147/JMDH.S322431] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
529 Çakmak V, Yılmaz A, Sarı T, Çakmak P, Özen M, Herek D, Oskay A. Evaluation of the chest computed tomography and hemogram data in patients with COVID-19: the importance of thymus. Turk J Med Sci 2021;51:991-1000. [PMID: 33641314 DOI: 10.3906/sag-2007-306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
530 Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, Abediazar S, Shoja MM, Ardalan M, Zununi Vahed S. Covid-19 and kidney injury: Pathophysiology and molecular mechanisms. Rev Med Virol 2021;31:e2176. [PMID: 33022818 DOI: 10.1002/rmv.2176] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
531 Reyes Valdivia A, Gandarias Zúñiga C, Riambau V. Vascular Life During the COVID-19 Pandemic Reminds Us to Prepare for the Unexpected. Eur J Vasc Endovasc Surg 2020;60:154-5. [PMID: 32446539 DOI: 10.1016/j.ejvs.2020.04.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
532 Gutiérrez-Zarate D, Rosas-Sánchez K, Flores-Carrillo JC, Medrano-Ahumada S, Martínez-Franco M. Early management of critically ill patients with COVID-19. J Am Coll Emerg Physicians Open 2020;1:1418-26. [PMID: 33392546 DOI: 10.1002/emp2.12294] [Reference Citation Analysis]
533 Hernandez-Cedeño M, Venegas-Rodriguez R, Peña-Ruiz R, Bequet-Romero M, Santana-Sanchez R, Penton-Arias E, Martinez-Donato G, Guillén-Nieto G, Dominguez-Horta MDC. CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients. Cell Stress Chaperones 2021;26:515-25. [PMID: 33629254 DOI: 10.1007/s12192-021-01197-2] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
534 Guilger-Casagrande M, de Barros CT, Antunes VAN, de Araujo DR, Lima R. Perspectives and Challenges in the Fight Against COVID-19: The Role of Genetic Variability. Front Cell Infect Microbiol 2021;11:598875. [PMID: 33791232 DOI: 10.3389/fcimb.2021.598875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
535 Liu L, Zheng Y, Cai L, Wu W, Tang S, Ding Y, Liu W, Kou G, Xiong Z, Wang S, Zheng S. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19. Int J Lab Hematol 2021;43:329-35. [PMID: 33099889 DOI: 10.1111/ijlh.13374] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
536 Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res 2020;21:224. [PMID: 32854739 DOI: 10.1186/s12931-020-01479-w] [Cited by in Crossref: 112] [Cited by in F6Publishing: 82] [Article Influence: 56.0] [Reference Citation Analysis]
537 Wu M, Zou ZY, Chen YH, Wang C, Feng Y, Liu ZF. Severe COVID-19-associated sepsis is different from classical sepsis induced by pulmonary infection with carbapenem-resistant klebsiella pneumonia (CrKP). Chin J Traumatol 2021:S1008-1275(21)00182-6. [PMID: 34815141 DOI: 10.1016/j.cjtee.2021.11.001] [Reference Citation Analysis]
538 Bai C, Chotirmall SH, Rello J, Alba GA, Ginns LC, Krishnan JA, Rogers R, Bendstrup E, Burgel PR, Chalmers JD, Chua A, Crothers KA, Duggal A, Kim YW, Laffey JG, Luna CM, Niederman MS, Raghu G, Ramirez JA, Riera J, Roca O, Tamae-Kakazu M, Torres A, Watkins RR, Barrecheguren M, Belliato M, Chami HA, Chen R, Cortes-Puentes GA, Delacruz C, Hayes MM, Heunks LMA, Holets SR, Hough CL, Jagpal S, Jeon K, Johkoh T, Lee MM, Liebler J, McElvaney GN, Moskowitz A, Oeckler RA, Ojanguren I, O'Regan A, Pletz MW, Rhee CK, Schultz MJ, Storti E, Strange C, Thomson CC, Torriani FJ, Wang X, Wuyts W, Xu T, Yang D, Zhang Z, Wilson KC. Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020). Eur Respir Rev 2020;29:200287. [PMID: 33020069 DOI: 10.1183/16000617.0287-2020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 16.0] [Reference Citation Analysis]
539 Niedźwiedzka-Rystwej P, Grywalska E, Hrynkiewicz R, Bębnowska D, Wołącewicz M, Majchrzak A, Parczewski M. Interplay between Neutrophils, NETs and T-Cells in SARS-CoV-2 Infection-A Missing Piece of the Puzzle in the COVID-19 Pathogenesis? Cells 2021;10:1817. [PMID: 34359987 DOI: 10.3390/cells10071817] [Reference Citation Analysis]
540 Huang Y, Li S, Huang S, Tu J, Chen X, Xiao L, Liu B, Yuan X. Comprehensive and Integrative Analysis of Two Novel SARS-CoV-2 Entry Associated Proteases CTSB and CTSL in Healthy Individuals and Cancer Patients. Front Bioeng Biotechnol 2022;10:780751. [DOI: 10.3389/fbioe.2022.780751] [Reference Citation Analysis]
541 Klocperk A, Parackova Z, Dissou J, Malcova H, Pavlicek P, Vymazal T, Dolezalova P, Sediva A. Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19. Front Immunol 2020;11:1665. [PMID: 32719688 DOI: 10.3389/fimmu.2020.01665] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
542 Zheng W, Wu H, Wang T, Zhan S, Liu X. Quercetin for COVID-19 and DENGUE co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and DENV. Brief Bioinform 2021:bbab199. [PMID: 34058750 DOI: 10.1093/bib/bbab199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
543 Zhang H, Ai JW, Yang W, Zhou X, He F, Xie S, Zeng W, Li Y, Yu Y, Gou X, Li Y, Wang X, Su H, Zhu Z, Xu T, Zhang W. Metatranscriptomic Characterization of Coronavirus Disease 2019 Identified a Host Transcriptional Classifier Associated With Immune Signaling. Clin Infect Dis 2021;73:376-85. [PMID: 32463434 DOI: 10.1093/cid/ciaa663] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
544 Boulle A, Davies MA, Hussey H, Ismail M, Morden E, Vundle Z, Zweigenthal V, Mahomed H, Paleker M, Pienaar D, Tembo Y, Lawrence C, Isaacs W, Mathema H, Allen D, Allie T, Bam JL, Buddiga K, Dane P, Heekes A, Matlapeng B, Mutemaringa T, Muzarabani L, Phelanyane F, Pienaar R, Rode C, Smith M, Tiffin N, Zinyakatira N, Cragg C, Marais F, Mudaly V, Voget J, Davids J, Roodt F, van Zyl Smit N, Vermeulen A, Adams K, Audley G, Bateman K, Beckwith P, Bernon M, Blom D, Boloko L, Botha J, Boutall A, Burmeister S, Cairncross L, Calligaro G, Coccia C, Corin C, Daroowala R, Dave JA, De Bruyn E, De Villiers M, Deetlefs M, Dlamini S, Du Toit T, Endres W, Europa T, Fieggan G, Figaji A, Frankenfeld P, Gatley E, Gina P, Govender E, Grobler R, Gule MV, Hanekom C, Held M, Heynes A, Hlatswayo S, Hodkinson B, Holtzhausen J, Hoosain S, Jacobs A, Kahn M, Kahn T, Khamajeet A, Khan J, Khan R, Khwitshana A, Knight L, Kooverjee S, Krogscheepers R, Jacque Kruger J, Kuhn S, Laubscher K, Lazarus J, Le Roux J, Lee Jones S, Levin D, Maartens G, Majola T, Manganyi R, Marais D, Marais S, Maritz F, Maughan D, Mazondwa S, Mbanga L, Mbatani N, Mbena B, Meintjes G, Mendelson M, Möller E, Moore A, Ndebele B, Nortje M, Ntusi N, Nyengane F, Ofoegbu C, Papavarnavas N, Peter J, Pickard H, Pluke K, Raubenheimer PJ, Robertson G, Rozmiarek J, Sayed A, Scriba M, Sekhukhune H, Singh P, Smith E, Soldati V, Stek C, van den Berg R, van der Merwe LR, Venter P, Vermooten B, Viljoen G, Viranna S, Vogel J, Vundla N, Wasserman S, Zitha E, Lomas-Marais V, Lombard A, Stuve K, Viljoen W, Basson V, Le Roux S, Linden-Mars E, Victor L, Wates M, Zwanepoel E, Ebrahim N, Lahri S, Mnguni A, Crede T, de Man M, Evans K, Hendrikse C, Naude J, Parak M, Szymanski P, Van Koningsbruggen C, Abrahams R, Allwood B, Botha C, Henndrik Botha M, Broadhurst A, Claasen D, Daniel C, Dawood R, du Preez M, Du Toit N, Erasmus K, Koegelenberg CFN, Gabriel S, Hugo S, Jardine T, Johannes C, Karamchand S, Lalla U, Langenegger E, Louw E, Mashigo B, Mhlana N, Mnqwazi C, Moodley A, Moodley D, Moolla S, Mowlana A, Nortje A, Olivier E, Parker A, Paulsen C, Prozesky H, Rood J, Sabela T, Schrueder N, Sithole N, Sithole S, Taljaard JJ, Titus G, Van Der Merwe T, van Schalkwyk M, Vazi L, Viljoen AJ, Yazied Chothia M, Naidoo V, Alan Wallis L, Abbass M, Arendse J, Armien R, Bailey R, Bello M, Carelse R, Forgus S, Kalawe N, Kariem S, Kotze M, Lucas J, McClaughlin J, Murie K, Najjaar L, Petersen L, Porter J, Shaw M, Stapar D, Williams M, Aldum L, Berkowitz N, Girran R, Lee K, Naidoo L, Neumuller C, Anderson K, Begg K, Boerlage L, Cornell M, de Waal R, Dudley L, English R, Euvrard J, Groenewald P, Jacob N, Jaspan H, Kalk E, Levitt N, Malaba T, Nyakato P, Patten G, Schneider H, Shung King M, Tsondai P, Van Duuren J, van Schaik N, Blumberg L, Cohen C, Govender N, Jassat W, Kufa T, McCarthy K, Morris L, Hsiao NY, Marais R, Ambler J, Ngwenya O, Osei-Yeboah R, Johnson L, Kassanjee R, Tamuhla T. Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis 2020:ciaa1198. [PMID: 32860699 DOI: 10.1093/cid/ciaa1198] [Cited by in Crossref: 57] [Cited by in F6Publishing: 104] [Article Influence: 28.5] [Reference Citation Analysis]
545 García-Salido A, García-Teresa MÁ, Leoz-Gordillo I, Martínez de Azagra-Garde A, Cabrero-Hernández M, Ramirez-Orellana M. Innate cell response in severe SARS-CoV-2 infection in children: Expression analysis of CD64, CD18 and CD11a. Med Intensiva (Engl Ed) 2020. [PMID: 33994613 DOI: 10.1016/j.medin.2020.09.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
546 [DOI: 10.1101/2020.04.15.20066266] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
547 Ishay Y, Potruch A, Schwartz A, Berg M, Jamil K, Agus S, Ilan Y. A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage. Biomed Pharmacother 2021;143:112228. [PMID: 34649354 DOI: 10.1016/j.biopha.2021.112228] [Reference Citation Analysis]
548 Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, Lu H, Liu J, Yang J, Dong Y, Pan D, Shu C, Li J, Wei J, Huang Y, Peng L, Wu M, Zhang R, Wu B, Li Y, Cai L, Li G, Zhang T, Wu G. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol 2020;21:904-13. [PMID: 32479787 DOI: 10.1016/S1470-2045(20)30310-7] [Cited by in Crossref: 212] [Cited by in F6Publishing: 139] [Article Influence: 106.0] [Reference Citation Analysis]
549 Ni Y, Alu A, Lei H, Wang Y, Wu M, Wei X. Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19. Mol Biomed 2021;2:1. [PMID: 34766001 DOI: 10.1186/s43556-020-00015-y] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
550 Kaur K, Ko MW, Ohanian N, Cook J, Jewett A. Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells. Sci Rep 2020;10:20363. [PMID: 33230147 DOI: 10.1038/s41598-020-76702-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
551 Chen J, Jiang Q, Xia X, Liu K, Yu Z, Tao W, Gong W, Han JJ. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging Cell. 2020;19. [PMID: 32558150 DOI: 10.1111/acel.13168] [Cited by in Crossref: 127] [Cited by in F6Publishing: 143] [Article Influence: 63.5] [Reference Citation Analysis]
552 Bou Khalil R. Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia. Med Hypotheses 2020;142:109798. [PMID: 32413699 DOI: 10.1016/j.mehy.2020.109798] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
553 Asghar MS, Ahmed I, Alvi H, Iqbal S, Khan I, Alvi RS, Saeed Z, Irfan S, Akhtar M, Fatima I. Correlation of refractory hypoxemia with biochemical markers and clinical outcomes of COVID-19 patients in a developing country: A retrospective observational study: Running head: Predictors of hypoxemia in COVID-19. J Community Hosp Intern Med Perspect 2021;11:9-16. [PMID: 33552406 DOI: 10.1080/20009666.2020.1835214] [Reference Citation Analysis]
554 Degarege A, Naveed Z, Kabayundo J, Brett-major D. Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis. Pathogens 2022;11:563. [DOI: 10.3390/pathogens11050563] [Reference Citation Analysis]
555 Muthuvattur Pallath M, Ahirwar AK, Chandra Tripathi S, Asia P, Sakarde A, Gopal N. COVID-19 and nutritional deficiency: a review of existing knowledge. Horm Mol Biol Clin Investig 2021;42:77-85. [PMID: 33544528 DOI: 10.1515/hmbci-2020-0074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
556 Atri D, Siddiqi HK, Lang J, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the Cardiologist: A current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies. JACC Basic Transl Sci. 2020;. [PMID: 32292848 DOI: 10.1016/j.jacbts.2020.04.002] [Cited by in Crossref: 107] [Cited by in F6Publishing: 92] [Article Influence: 53.5] [Reference Citation Analysis]
557 Timofeeva A, Sedykh S, Nevinsky G. Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities. Vaccines 2022;10:384. [DOI: 10.3390/vaccines10030384] [Reference Citation Analysis]
558 Putowski Z, Szczepańska A, Czok M, Krzych ŁJ. Veno-Venous Extracorporeal Membrane Oxygenation in COVID-19-Where Are We Now? Int J Environ Res Public Health 2021;18:1173. [PMID: 33525739 DOI: 10.3390/ijerph18031173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
559 Gómez-Carballa A, Rivero-Calle I, Pardo-Seco J, Gómez-Rial J, Rivero-Velasco C, Rodríguez-Núñez N, Barbeito-Castiñeiras G, Pérez-Freixo H, Cebey-López M, Barral-Arca R, Rodriguez-Tenreiro C, Dacosta-Urbieta A, Bello X, Pischedda S, Currás-Tuala MJ, Viz-Lasheras S, Martinón-Torres F, Salas A; GEN-COVID study group. A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity. Environ Res 2022;210:112890. [PMID: 35202626 DOI: 10.1016/j.envres.2022.112890] [Reference Citation Analysis]
560 Dhamne MC, Benny R, Singh R, Pande A, Agarwal P, Wagh S, Oak P, Lakhotia A, Godge Y, Bolegave V, Doshi D, Patidar Y, Venkatachalam A, Pujara B, Borse S, Makhija P, Khadilkar S. Guillian--Barre' Syndrome in Patients with SARS-CoV-2: A Multicentric Study from Maharashtra, India. Ann Indian Acad Neurol 2021;24:339-46. [PMID: 34446994 DOI: 10.4103/aian.AIAN_1303_20] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
561 Jiménez-Cortegana C, Liró J, Palazón-Carrión N, Salamanca E, Sojo-Dorado J, de la Cruz-Merino L, Pascual Á, Rodríguez-Baño J, Sánchez-Margalet V. Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19. Viral Immunol 2021;34:639-45. [PMID: 34529510 DOI: 10.1089/vim.2021.0044] [Reference Citation Analysis]
562 Dejani NN, Elshabrawy HA, Bezerra Filho CDSM, de Sousa DP. Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives. Biomolecules 2021;11:1254. [PMID: 34439920 DOI: 10.3390/biom11081254] [Reference Citation Analysis]
563 Mann ER, Menon M, Knight SB, Konkel JE, Jagger C, Shaw TN, Krishnan S, Rattray M, Ustianowski A, Bakerly ND, Dark P, Lord G, Simpson A, Felton T, Ho LP, Feldmann M, Grainger JR, Hussell T; NIHR Respiratory TRC,., CIRCO,. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19. Sci Immunol 2020;5:eabd6197. [PMID: 32943497 DOI: 10.1126/sciimmunol.abd6197] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 35.5] [Reference Citation Analysis]
564 Davoodi L, Abedi SM, Salehifar E, Alizadeh-Navaei R, Rouhanizadeh H, Khorasani G, Hosseinimehr SJ. Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial. Int J Clin Pract 2020;74:e13600. [PMID: 32603531 DOI: 10.1111/ijcp.13600] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
565 Stella A, Lamkanfi M, Portincasa P. Familial Mediterranean Fever and COVID-19: Friends or Foes? Front Immunol 2020;11:574593. [PMID: 33072117 DOI: 10.3389/fimmu.2020.574593] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
566 Hoiland RL, Stukas S, Cooper J, Thiara S, Chen LYC, Biggs CM, Hay K, Lee AYY, Shojania K, Abdulla A, Wellington CL, Sekhon MS. Amelioration of COVID-19-related cytokine storm syndrome: parallels to chimeric antigen receptor-T cell cytokine release syndrome. Br J Haematol 2020;190:e150-4. [PMID: 32584416 DOI: 10.1111/bjh.16961] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
567 Rabaan AA, Al-Ahmed SH, Muhammad J, Khan A, Sule AA, Tirupathi R, Mutair AA, Alhumaid S, Al-Omari A, Dhawan M, Tiwari R, Sharun K, Mohapatra RK, Mitra S, Bilal M, Alyami SA, Emran TB, Moni MA, Dhama K. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm. Vaccines (Basel) 2021;9:436. [PMID: 33946736 DOI: 10.3390/vaccines9050436] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
568 [DOI: 10.1101/2020.07.20.20157891] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
569 Williams ME, Fielding BC. Insult to Injury-Potential Contribution of Coronavirus Disease-19 to Neuroinflammation and the Development of HIV-Associated Neurocognitive Disorders. AIDS Res Hum Retroviruses 2021;37:601-9. [PMID: 32993321 DOI: 10.1089/AID.2020.0136] [Reference Citation Analysis]
570 Colmenero J, Rodríguez-Perálvarez M, Salcedo M, Arias-Milla A, Muñoz-Serrano A, Graus J, Nuño J, Gastaca M, Bustamante-Schneider J, Cachero A, Lladó L, Caballero A, Fernández-Yunquera A, Loinaz C, Fernández I, Fondevila C, Navasa M, Iñarrairaegui M, Castells L, Pascual S, Ramírez P, Vinaixa C, González-Dieguez ML, González-Grande R, Hierro L, Nogueras F, Otero A, Álamo JM, Blanco-Fernández G, Fábrega E, García-Pajares F, Montero JL, Tomé S, De la Rosa G, Pons JA. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol 2021;74:148-55. [PMID: 32750442 DOI: 10.1016/j.jhep.2020.07.040] [Cited by in Crossref: 76] [Cited by in F6Publishing: 83] [Article Influence: 38.0] [Reference Citation Analysis]
571 Caruso FP, Scala G, Cerulo L, Ceccarelli M. A review of COVID-19 biomarkers and drug targets: resources and tools. Brief Bioinform 2021;22:701-13. [PMID: 33279954 DOI: 10.1093/bib/bbaa328] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
572 Peter AE, Sandeep BV, Rao BG, Kalpana VL. Nanotechnology to the Rescue: Treatment Perspective for the Immune Dysregulation Observed in COVID-19. Front Nanotechnol 2021;3:644023. [DOI: 10.3389/fnano.2021.644023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
573 Cotugno N, Ruggiero A, Bonfante F, Petrara MR, Zicari S, Pascucci GR, Zangari P, De Ioris MA, Santilli V, Manno EC, Amodio D, Bortolami A, Pagliari M, Concato C, Linardos G, Campana A, Donà D, Giaquinto C, Brodin P, Rossi P, De Rossi A, Palma P; CACTUS Study Team. Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies. Cell Rep 2021;34:108852. [PMID: 33730580 DOI: 10.1016/j.celrep.2021.108852] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
574 Picchianti Diamanti A, Rosado MM, Nicastri E, Sesti G, Pioli C, Laganà B. Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines. Front Immunol 2021;12:708848. [PMID: 34659200 DOI: 10.3389/fimmu.2021.708848] [Reference Citation Analysis]
575 Chiok K, Hutchison K, Miller LG, Bose S, Miura TA. Proinflammatory responses in SARS-CoV-2 infected and soluble spike glycoprotein S1 subunit activated human macrophages. bioRxiv 2021:2021. [PMID: 34159334 DOI: 10.1101/2021.06.14.448426] [Reference Citation Analysis]
576 Diamond MS, Kanneganti TD. Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol 2022;23:165-76. [PMID: 35105981 DOI: 10.1038/s41590-021-01091-0] [Reference Citation Analysis]
577 Rogers CJ, Harman RJ, Bunnell BA, Schreiber MA, Xiang C, Wang FS, Santidrian AF, Minev BR. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. J Transl Med. 2020;18:203. [PMID: 32423449 DOI: 10.1186/s12967-020-02380-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 19.0] [Reference Citation Analysis]
578 Calabrò L, Rossi G, Covre A, Morra A, Maio M. COVID and Lung Cancer. Curr Oncol Rep 2021;23:134. [PMID: 34677721 DOI: 10.1007/s11912-021-01125-8] [Reference Citation Analysis]
579 Spoerl S, Kremer AN, Aigner M, Eisenhauer N, Koch P, Meretuk L, Löffler P, Tenbusch M, Maier C, Überla K, Heinzerling L, Frey B, Lutzny-Geier G, Winkler TH, Krönke G, Vetter M, Bruns H, Neurath MF, Mackensen A, Kremer AE, Völkl S. Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection. Eur J Immunol 2021;51:1436-48. [PMID: 33784417 DOI: 10.1002/eji.202049135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
580 Rasmi Y, Mosa OF, Alipour S, Heidari N, Javanmard F, Golchin A, Gholizadeh-ghaleh Aziz S. Significance of Cardiac Troponins as an Identification Tool in COVID-19 Patients Using Biosensors: An Update. Front Mol Biosci 2022;9:821155. [DOI: 10.3389/fmolb.2022.821155] [Reference Citation Analysis]
581 Ricci D, Etna MP, Rizzo F, Sandini S, Severa M, Coccia EM. Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators. Int J Mol Sci 2021;22:7017. [PMID: 34209845 DOI: 10.3390/ijms22137017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
582 Katsiari M, Mavroidi A, Palla E, Zourla K, Alonistiotis T, Ntorlis K, Nikolaou C, Vrioni G, Tsakris A. Possible COVID-19-Associated Pulmonary Aspergillosis due to Aspergillus niger in Greece. Antibiotics 2022;11:300. [DOI: 10.3390/antibiotics11030300] [Reference Citation Analysis]
583 Claude-Rosny E. COVID-19 therapy and prevention. Discoveries (Craiova) 2020;8:e113. [PMID: 33094148 DOI: 10.15190/d.2020.10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
584 Heimfarth L, Serafini MR, Martins-Filho PR, Quintans JSS, Quintans-Júnior LJ. Drug repurposing and cytokine management in response to COVID-19: A review. Int Immunopharmacol 2020;88:106947. [PMID: 32919216 DOI: 10.1016/j.intimp.2020.106947] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
585 Rammohan A. Post-transplant immunosuppression and COVID-19: From a double whammy to a mixed blessing. World J Transplant 2020; 10(9): 267-276 [PMID: 32995321 DOI: 10.5500/wjt.v10.i9.267] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
586 Hoang T, Tran Thi Anh T. Comparison of Comorbidities in Relation to Critical Conditions among Coronavirus Disease 2019 Patients: A Network Meta-Analysis. Infect Chemother 2021;53:13-28. [PMID: 34409779 DOI: 10.3947/ic.2020.0136] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
587 Maniaci A, Iannella G, Vicini C, Pavone P, Nunnari G, Falsaperla R, Di Mauro P, Ferlito S, Cocuzza S. A Case of COVID-19 with Late-Onset Rash and Transient Loss of Taste and Smell in a 15-Year-Old Boy. Am J Case Rep 2020;21:e925813. [PMID: 32814757 DOI: 10.12659/AJCR.925813] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
588 Ahmed F, Jo DH, Lee SH. Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity? Front Immunol 2020;11:586765. [PMID: 33365027 DOI: 10.3389/fimmu.2020.586765] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
589 Tomera K, kittah J. Famotidine with Celecoxib Adjuvant Therapy on Hospitalized COVID-19 Patients: A Case Series. SSRN Journal. [DOI: 10.2139/ssrn.3646583] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
590 Laudanski K. Humanized Mice as a Tool to Study Sepsis-More Than Meets the Eye. Int J Mol Sci 2021;22:2403. [PMID: 33673691 DOI: 10.3390/ijms22052403] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
591 Ramphul K, Mejias SG, Ramphul Y. Headache may not be linked with severity of coronavirus disease 2019 (COVID-19). World J Emerg Med 2020;11:274. [PMID: 33014228 DOI: 10.5847/wjem.j.1920-8642.2020.04.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
592 Ciaglia E, Lopardo V, Montella F, Sellitto C, Manzo V, De Bellis E, Iannaccone T, Franci G, Zannella C, Pagliano P, Di Pietro P, Carrizzo A, Vecchione C, Conti V, Filippelli A, Puca AA. BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19. J Gerontol A Biol Sci Med Sci 2021:glab208. [PMID: 34396395 DOI: 10.1093/gerona/glab208] [Reference Citation Analysis]
593 Skevaki C, Fragkou PC, Cheng C, Xie M, Renz H. Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus. J Infect 2020;81:205-12. [PMID: 32579986 DOI: 10.1016/j.jinf.2020.06.039] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 16.5] [Reference Citation Analysis]
594 Alzoughool F, Alanagreh L, Abumweis S, Atoum M. Cerebrovascular comorbidity, high blood levels of C-reactive protein and D-dimer are associated with disease outcomes in COVID-19 patients. Clin Hemorheol Microcirc 2021;77:311-22. [PMID: 33185593 DOI: 10.3233/CH-201002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
595 Rahmani-Kukia N, Abbasi A. Physiological and Immunological Causes of the Susceptibility of Chronic Inflammatory Patients to COVID-19 Infection: Focus on Diabetes. Front Endocrinol (Lausanne) 2021;12:576412. [PMID: 33746897 DOI: 10.3389/fendo.2021.576412] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
596 Li C, Luo F, Liu C, Xiong N, Xu Z, Zhang W, Yang M, Wang Y, Liu D, Yu C, Zeng J, Zhang L, Li D, Liu Y, Feng M, Liu R, Mei J, Deng S, Zeng Z, He Y, Liu H, Shi Z, Duan M, Kang D, Liao J, Li W, Liu L. Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial. Ann Med 2021;53:391-401. [PMID: 33620016 DOI: 10.1080/07853890.2021.1890329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
597 Cheng FY, Joshi H, Tandon P, Freeman R, Reich DL, Mazumdar M, Kohli-Seth R, Levin M, Timsina P, Kia A. Using Machine Learning to Predict ICU Transfer in Hospitalized COVID-19 Patients. J Clin Med 2020;9:E1668. [PMID: 32492874 DOI: 10.3390/jcm9061668] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 22.5] [Reference Citation Analysis]
598 Benetos A, Lai TP, Toupance S, Labat C, Verhulst S, Perret-Guillaume C, Gautier S, Ungeheuer MN, Levy D, Susser E, Aviv A. A Mechanism for Severity of Disease in Older Patients with COVID-19: The Nexus between Telomere Length and Lymphopenia. medRxiv 2020:2020. [PMID: 33024983 DOI: 10.1101/2020.10.01.20205393] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
599 Verhoef PA, Kannan S, Sturgill JL, Tucker EW, Morris PE, Miller AC, Sexton TR, Koyner JL, Hejal R, Brakenridge SC, Moldawer LL, Hotchkiss RS, Blood TM, Mazer MB, Bolesta S, Alexander SA, Armaignac DL, Shein SL, Jones C, Hoemann CD, Doctor A, Friess SH, Parker RI, Rotta AT, Remy KE. Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research. Crit Care Explor 2021;3:e0374. [PMID: 33786450 DOI: 10.1097/CCE.0000000000000374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
600 Patel HN, Syed A, Lobel JS, Galler R, Georges J, Carmody M, Puumala M. Cerebellar infarction requiring surgical decompression in patient with COVID 19 pathological analysis and brief review. Interdiscip Neurosurg 2020;22:100850. [PMID: 32835021 DOI: 10.1016/j.inat.2020.100850] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
601 Bagherimoghaddam A, Rafatpanah H, Mansouritorghabeh H. Elevated levels of C3 , C4 , and CH50 of the complement system in ICU and non‐ICU patients with COVID ‐19. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.519] [Reference Citation Analysis]
602 Rongioletti F, Ferreli C, Sena P, Caputo V, Atzori L. Clinicopathologic correlations of COVID-19-related cutaneous manifestations with special emphasis on histopathologic patterns. Clin Dermatol 2021;39:149-62. [PMID: 33972045 DOI: 10.1016/j.clindermatol.2020.12.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
603 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032. [PMID: 32651579 DOI: 10.1038/s41591-020-0968-3] [Cited by in Crossref: 770] [Cited by in F6Publishing: 675] [Article Influence: 385.0] [Reference Citation Analysis]
604 Zhou K, Sun Y, Li L, Zang Z, Wang J, Li J, Liang J, Zhang F, Zhang Q, Ge W, Chen H, Sun X, Yue L, Wu X, Shen B, Xu J, Zhu H, Chen S, Yang H, Huang S, Peng M, Lv D, Zhang C, Zhao H, Hong L, Zhou Z, Chen H, Dong X, Tu C, Li M, Zhu Y, Chen B, Li SZ, Guo T. Eleven routine clinical features predict COVID-19 severity uncovered by machine learning of longitudinal measurements. Comput Struct Biotechnol J 2021;19:3640-9. [PMID: 34188785 DOI: 10.1016/j.csbj.2021.06.022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
605 Lebeau G, Vagner D, Frumence É, Ah-Pine F, Guillot X, Nobécourt E, Raffray L, Gasque P. Deciphering SARS-CoV-2 Virologic and Immunologic Features. Int J Mol Sci 2020;21:E5932. [PMID: 32824753 DOI: 10.3390/ijms21165932] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
606 Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Vardavas AI, Porter AL. Common contributing factors to COVID-19 and inflammatory bowel disease. Toxicol Rep 2021;8:1616-37. [PMID: 34485092 DOI: 10.1016/j.toxrep.2021.08.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
607 Fijačko N, Masterson Creber R, Gosak L, Kocbek P, Cilar L, Creber P, Štiglic G. A Review of Mortality Risk Prediction Models in Smartphone Applications. J Med Syst 2021;45:107. [PMID: 34735603 DOI: 10.1007/s10916-021-01776-x] [Reference Citation Analysis]
608 Zhang JY, Wang XM, Xing X, Xu Z, Zhang C, Song JW, Fan X, Xia P, Fu JL, Wang SY, Xu RN, Dai XP, Shi L, Huang L, Jiang TJ, Shi M, Zhang Y, Zumla A, Maeurer M, Bai F, Wang FS. Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol. 2020;21:1107-1118. [PMID: 32788748 DOI: 10.1038/s41590-020-0762-x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 135] [Article Influence: 77.5] [Reference Citation Analysis]
609 Letícia de Oliveira Toledo S, Sousa Nogueira L, das Graças Carvalho M, Romana Alves Rios D, de Barros Pinheiro M. COVID-19: Review and hematologic impact. Clin Chim Acta 2020;510:170-6. [PMID: 32659224 DOI: 10.1016/j.cca.2020.07.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
610 Janiuk K, Jabłońska E, Garley M. Significance of NETs Formation in COVID-19. Cells 2021;10:151. [PMID: 33466589 DOI: 10.3390/cells10010151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
611 Al-Yamani MJ, Imam Rabbani S, Mohammed Basheeruddin Asdaq S, Imran M, Kanan Alshammari M, Aqeel AlShammari N, Hussain Alshahrani A, Ali Mohammed Harshan M, Yahya A Hurubi M, Mubaraki AA, Alamri AS, Alsanie WF, Alhomrani M. EPIDEMIOLOGICAL DETERMINANTS FOR THE SPREAD OF COVID-19 IN RIYADH PROVINCE OF SAUDI ARABIA. Saudi J Biol Sci 2021. [PMID: 34955667 DOI: 10.1016/j.sjbs.2021.12.032] [Reference Citation Analysis]
612 Kumar M, Taki K, Gahlot R, Sharma A, Dhangar K. A chronicle of SARS-CoV-2: Part-I - Epidemiology, diagnosis, prognosis, transmission and treatment. Sci Total Environ 2020;734:139278. [PMID: 32434058 DOI: 10.1016/j.scitotenv.2020.139278] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 23.5] [Reference Citation Analysis]
613 Berger JR, Brandstadter R, Bar-Or A. COVID-19 and MS disease-modifying therapies. Neurol Neuroimmunol Neuroinflamm 2020;7:e761. [PMID: 32414755 DOI: 10.1212/NXI.0000000000000761] [Cited by in Crossref: 50] [Cited by in F6Publishing: 27] [Article Influence: 25.0] [Reference Citation Analysis]
614 Anand G, Perry AM, Cummings CL, Raymond E, Clemens RA, Steed AL. Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-Dependent Inflammation. J Immunol 2021:ji2001407. [PMID: 34078711 DOI: 10.4049/jimmunol.2001407] [Reference Citation Analysis]
615 Deng YP, Xie W, Liu T, Wang SY, Wang MR, Zan YX, Meng XB, Deng YQ, Xiong HR, Fu XD. Association of Hypertension with Severity and Mortality in Hospitalized Patients with COVID-19 in Wuhan, China: A Single-centered, Retrospective Study. Arq Bras Cardiol 2021:S0066-782X2021005010205. [PMID: 34287571 DOI: 10.36660/abc.20200733] [Reference Citation Analysis]
616 Ozen M, Yilmaz A, Cakmak V, Beyoglu R, Oskay A, Seyit M, Senol H. D-Dimer as a potential biomarker for disease severity in COVID-19. Am J Emerg Med 2021;40:55-9. [PMID: 33348224 DOI: 10.1016/j.ajem.2020.12.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
617 Leelayuwatanakul N, Kongpolprom N, Sriprasart T, Phoophiboon V, Thanthitaweewat V, Thawanaphong S, Sirichana W, Chirakalwasan N, Kawkitinarong K, Sittipunt C, Putcharoen O, Paitoonpong L, Suwanpimolkul G, Jantarabenjakul W, Srisawat N, Pachinburavan M. Multimodality treatment in immunocompromised patients with severe COVID-19: the role of IL-6 inhibitor, intravenous immunoglobulin, and haemoperfusion. Respirol Case Rep 2021;9:e0733. [PMID: 33732466 DOI: 10.1002/rcr2.733] [Reference Citation Analysis]
618 Khinda J, Janjua NZ, Cheng S, van den Heuvel ER, Bhatti P, Darvishian M. Association between markers of immune response at hospital admission and COVID-19 disease severity and mortality: A meta-analysis and meta-regression. J Med Virol 2021;93:1078-98. [PMID: 32776551 DOI: 10.1002/jmv.26411] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
619 Luo L, Fu M, Li Y, Hu S, Luo J, Chen Z, Yu J, Li W, Dong R, Yang Y, Tu L, Xu X. The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis. Clin Cardiol 2020;43:1478-93. [PMID: 33026120 DOI: 10.1002/clc.23465] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
620 Guerra I, Algaba A, Jiménez L, Mar Aller M, Garza D, Bonillo D, Molina Esteban LM, Bermejo F. Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain. Inflamm Bowel Dis 2021;27:25-33. [PMID: 32830267 DOI: 10.1093/ibd/izaa221] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
621 Jafarzadeh A, Jafarzadeh S, Nozari P, Mokhtari P, Nemati M. Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms. Scand J Immunol 2021;93:e12967. [PMID: 32875598 DOI: 10.1111/sji.12967] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
622 He X, Zhang D, Zhang L, Zheng X, Zhang G, Pan K, Yu H, Zhang L, Hu X. Neurological and psychiatric presentations associated with COVID-19. Eur Arch Psychiatry Clin Neurosci 2021. [PMID: 33710424 DOI: 10.1007/s00406-021-01244-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
623 Xu Q, Wang T, Lu W. Therapeutic potential of anticoagulant therapy in association with cytokine storm inhibition in severe cases of COVID-19: A case report. Open Life Sci 2021;16:809-14. [PMID: 34485700 DOI: 10.1515/biol-2021-0088] [Reference Citation Analysis]
624 Cai L, Zhou X, Wang M, Mei H, Ai L, Mu S, Zhao X, Chen W, Hu Y, Wang H. Predictive Nomogram for Severe COVID-19 and Identification of Mortality-Related Immune Features. J Allergy Clin Immunol Pract 2021;9:177-184.e3. [PMID: 33160092 DOI: 10.1016/j.jaip.2020.10.043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
625 Chu CF, Sabath F, Fibi-Smetana S, Sun S, Öllinger R, Noeßner E, Chao YY, Rinke L, Winheim E, Rad R, Krug AB, Taher L, Zielinski CE. Convalescent COVID-19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities. Front Immunol 2021;12:601080. [PMID: 34867933 DOI: 10.3389/fimmu.2021.601080] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
626 Chen TY, Farghaly S, Cham S, Tatem LL, Sin JH, Rauda R, Ribisi M, Sumrani N. COVID-19 pneumonia in kidney transplant recipients: Focus on immunosuppression management. Transpl Infect Dis 2020;22:e13378. [PMID: 32573882 DOI: 10.1111/tid.13378] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
627 Wollina U. Challenges of COVID-19 pandemic for dermatology. Dermatol Ther 2020;33:e13430. [PMID: 32314460 DOI: 10.1111/dth.13430] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
628 Kanakan A, Mishra N, Srinivasa Vasudevan J, Sahni S, Khan A, Sharma S, Pandey R. Threading the Pieces Together: Integrative Perspective on SARS-CoV-2. Pathogens 2020;9:E912. [PMID: 33158051 DOI: 10.3390/pathogens9110912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
629 Araya S, Wordofa M, Mamo MA, Tsegay YG, Hordofa A, Negesso AE, Fasil T, Berhanu B, Begashaw H, Atlaw A, Niguse T, Cheru M, Tamir Z. The Magnitude of Hematological Abnormalities Among COVID-19 Patients in Addis Ababa, Ethiopia. J Multidiscip Healthc 2021;14:545-54. [PMID: 33688198 DOI: 10.2147/JMDH.S295432] [Reference Citation Analysis]
630 Wang ZH, Lin YW, Wei XB, Li F, Liao XL, Yuan HQ, Huang DZ, Qin TH, Geng H, Wang SH. Predictive Value of Prognostic Nutritional Index on COVID-19 Severity. Front Nutr 2020;7:582736. [PMID: 33521032 DOI: 10.3389/fnut.2020.582736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
631 Fan Y, Wang Y, Yu S, Chang J, Yan Y, Wang Y, Bian Y. Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review. Chin Med 2021;16:67. [PMID: 34321065 DOI: 10.1186/s13020-021-00478-3] [Reference Citation Analysis]
632 Melgaço JG, Azamor T, Ano Bom APD. Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection? Cell Immunol 2020;353:104114. [PMID: 32361409 DOI: 10.1016/j.cellimm.2020.104114] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
633 Ali KM, Ali AM, Tawfeeq HM, Figueredo GP, Rostam HM. Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019. J Med Virol 2021;93:4532-6. [PMID: 33830538 DOI: 10.1002/jmv.27002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
634 Petrara MR, Bonfante F, Costenaro P, Cantarutti A, Carmona F, Ruffoni E, Di Chiara C, Zanchetta M, Barzon L, Donà D, Da Dalt L, Bortolami A, Pagliari M, Plebani M, Rossi P, Cotugno N, Palma P, Giaquinto C, De Rossi A. Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults. Front Immunol 2021;12:741796. [PMID: 34659235 DOI: 10.3389/fimmu.2021.741796] [Reference Citation Analysis]
635 Skalny AV, Aschner M, Tinkov AA. Zinc. Adv Food Nutr Res 2021;96:251-310. [PMID: 34112355 DOI: 10.1016/bs.afnr.2021.01.003] [Reference Citation Analysis]
636 Kilic G, Bulut O, Jaeger M, Ter Horst R, Koeken VACM, Moorlag SJCFM, Mourits VP, de Bree C, Domínguez-Andrés J, Joosten LAB, Netea MG. The Immunological Factors Predisposing to Severe Covid-19 Are Already Present in Healthy Elderly and Men. Front Immunol 2021;12:720090. [PMID: 34434199 DOI: 10.3389/fimmu.2021.720090] [Reference Citation Analysis]
637 Guillon A, Hiemstra PS, Si-Tahar M. Pulmonary immune responses against SARS-CoV-2 infection: harmful or not? Intensive Care Med 2020;46:1897-900. [PMID: 32681297 DOI: 10.1007/s00134-020-06170-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
638 Sadeghi-Haddad-Zavareh M, Bayani M, Shokri M, Ebrahimpour S, Babazadeh A, Mehraeen R, Moudi E, Rostami A, Barary M, Hosseini A, Bijani A, Javanian M. C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients. Interdiscip Perspect Infect Dis 2021;2021:5557582. [PMID: 33968148 DOI: 10.1155/2021/5557582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
639 Naqvi HR, Mutreja G, Hashim M, Singh A, Nawazuzzoha M, Naqvi DF, Siddiqui MA, Shakeel A, Chaudhary AA, Naqvi AR. Global assessment of tropospheric and ground air pollutants and its correlation with COVID-19. Atmos Pollut Res 2021;12:101172. [PMID: 34421319 DOI: 10.1016/j.apr.2021.101172] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
640 Blagova O, Varionchik N, Zaidenov V, Savina P, Sarkisova N. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19. Eur J Immunol 2021;51:893-902. [PMID: 33368288 DOI: 10.1002/eji.202048930] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
641 Chou EH, Wang CH, Chou FY, Tsai CL, Wolfshohl J, Garrett J, Bhakta T, Shedd A, Hassani D, Risch R, d'Etienne J, Ogola GO, Lu TC, Ma MH. Development and validation of a prediction model for estimating one-month mortality of adult COVID-19 patients presenting at emergency department with suspected pneumonia: a multicenter analysis. Intern Emerg Med 2021. [PMID: 34813010 DOI: 10.1007/s11739-021-02882-x] [Reference Citation Analysis]
642 Verma HK, Bhaskar L. SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted. World J Gastroenterol 2021; 27(45): 7855-7858 [PMID: 34963747 DOI: 10.3748/wjg.v27.i45.7855] [Reference Citation Analysis]
643 Coloretti I, Berlot G, Busani S, De Rosa FG, Donati A, Forfori F, Grasselli G, Mirabella L, Tascini C, Viale P, Girardis M. Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus. J Clin Med 2021;10:3500. [PMID: 34441796 DOI: 10.3390/jcm10163500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
644 Vigón L, García-Pérez J, Rodríguez-Mora S, Torres M, Mateos E, Castillo de la Osa M, Cervero M, Malo De Molina R, Navarro C, Murciano-Antón MA, García-Gutiérrez V, Planelles V, Alcamí J, Pérez-Olmeda M, Coiras M, López-Huertas MR. Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU. Front Immunol 2021;12:742631. [PMID: 34616404 DOI: 10.3389/fimmu.2021.742631] [Reference Citation Analysis]
645 Hong X, He J, Li P, Chen J, Zou B, Li Z, Jia Y, Liu Y, Yang L, Li J. Evidence of SARS-CoV-2 infection in gallbladder and aggravating cholecystitis to septic shock: a case report. Ann Transl Med 2021;9:1631. [PMID: 34926675 DOI: 10.21037/atm-21-4778] [Reference Citation Analysis]
646 Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, Wang F. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis. Research (Wash D C) 2020;2020:2402961. [PMID: 32377638 DOI: 10.34133/2020/2402961] [Cited by in Crossref: 71] [Cited by in F6Publishing: 89] [Article Influence: 35.5] [Reference Citation Analysis]
647 Kim DM, Seo JW, Kim Y, Park U, Ha NY, Park H, Yun NR, Kim DY, Yoon SH, Na YS, Moon DS, Lim SC, Kim CM, Kim YS, Cho NH. Eosinophil-mediated lung inflammation associated with elevated natural killer T cell response in COVID-19 patients. Korean J Intern Med 2021. [PMID: 34565131 DOI: 10.3904/kjim.2021.093] [Reference Citation Analysis]
648 Cozzi E, Faccioli E, Marinello S, Loy M, Congedi S, Calabrese F, Romagnoli M, Cattelan AM, Rea F. COVID-19 pneumonia in lung transplant recipients: Report of 2 cases. Am J Transplant. 2020;. [PMID: 32400074 DOI: 10.1111/ajt.15993] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
649 Guihot A, Litvinova E, Autran B, Debré P, Vieillard V. Cell-Mediated Immune Responses to COVID-19 Infection. Front Immunol 2020;11:1662. [PMID: 32719687 DOI: 10.3389/fimmu.2020.01662] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
650 Cainelli F, Dzudzor B, Lanzafame M, Goushchi A, Chhem S, Vento S. HIV and SARS-Coronavirus-2 Epidemics: Possible Interactions and Need for Studies, Especially in Africa. Front Med (Lausanne) 2020;7:216. [PMID: 32574323 DOI: 10.3389/fmed.2020.00216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
651 Yang L, Xie X, Tu Z, Fu J, Xu D, Zhou Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct Target Ther 2021;6:255. [PMID: 34234112 DOI: 10.1038/s41392-021-00679-0] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
652 Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res 2021;292:198235. [PMID: 33232783 DOI: 10.1016/j.virusres.2020.198235] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
653 Li S, Cheng CS, Zhang C, Tang GY, Tan HY, Chen HY, Wang N, Lai AY, Feng Y. Edible and Herbal Plants for the Prevention and Management of COVID-19. Front Pharmacol 2021;12:656103. [PMID: 33995078 DOI: 10.3389/fphar.2021.656103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
654 David S, Dorado G, Duarte EL, David-bosne S, Trigueiro-louro J, Rebelo-de-andrade H. COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severity. Immunogenetics. [DOI: 10.1007/s00251-022-01261-w] [Reference Citation Analysis]
655 Rauch-Kröhnert U, Riess H. [Anticoagulation in coronavirus disease 2019 (COVID-19): confirmed and controversial aspects]. Internist (Berl) 2022. [PMID: 35290499 DOI: 10.1007/s00108-022-01296-x] [Reference Citation Analysis]
656 Wu ZH, Yang DL. A meta-analysis of the impact of COVID-19 on liver dysfunction. Eur J Med Res. 2020;25:54. [PMID: 33148326 DOI: 10.1186/s40001-020-00454-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
657 Nainu F, Abidin RS, Bahar MA, Frediansyah A, Emran TB, Rabaan AA, Dhama K, Harapan H. SARS-CoV-2 reinfection and implications for vaccine development. Hum Vaccin Immunother 2020;16:3061-73. [PMID: 33393854 DOI: 10.1080/21645515.2020.1830683] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
658 Zingaropoli MA, Perri V, Pasculli P, Cogliati Dezza F, Nijhawan P, Savelloni G, La Torre G, D'Agostino C, Mengoni F, Lichtner M, Ciardi MR, Mastroianni CM. Major reduction of NKT cells in patients with severe COVID-19 pneumonia. Clin Immunol. 2021;222:108630. [PMID: 33189887 DOI: 10.1016/j.clim.2020.108630] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
659 Jiménez-cortegana C, Sánchez-jiménez F, Pérez-pérez A, Álvarez N, Sousa A, Cantón-bulnes L, Vilariño-garcía T, Fuentes S, Martín S, Jiménez M, León-justel A, de la Cruz-merino L, Garnacho-montero J, Sánchez-margalet V. Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19. Front Immunol 2022;12:801410. [DOI: 10.3389/fimmu.2021.801410] [Reference Citation Analysis]
660 Rusu I, Turlacu M, Micheu MM. Acute myocardial injury in patients with COVID-19: Possible mechanisms and clinical implications. World J Clin Cases 2022; 10(3): 762-776 [DOI: 10.12998/wjcc.v10.i3.762] [Reference Citation Analysis]
661 Mercola J, Grant WB, Wagner CL. Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity. Nutrients 2020;12:E3361. [PMID: 33142828 DOI: 10.3390/nu12113361] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 20.5] [Reference Citation Analysis]
662 Megha KB, Joseph X, Akhil V, Mohanan PV. Cascade of immune mechanism and consequences of inflammatory disorders. Phytomedicine 2021;91:153712. [PMID: 34511264 DOI: 10.1016/j.phymed.2021.153712] [Reference Citation Analysis]
663 Carretero Gómez J, Mafé Nogueroles MC, Garrachón Vallo F, Escudero Álvarez E, Maciá Botejara E, Miramontes González JP; en representación del grupo de Diabetes, Obesidad y Nutrición de la Sociedad Española de Medicina Interna (SEMI). [Inflammation, malnutrition, and SARS-CoV-2 infection: a disastrous combination]. Rev Clin Esp (Barc) 2020;220:511-7. [PMID: 32863403 DOI: 10.1016/j.rce.2020.07.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
664 Sayah W, Berkane I, Guermache I, Sabri M, Lakhal FZ, Yasmine Rahali S, Djidjeli A, Lamara Mahammed L, Merah F, Belaid B, Berkani L, Lazli NZ, Kheddouci L, Kadi A, Ouali M, Khellafi R, Mekideche D, Kheliouen A, Hamidi RM, Ayoub S, Raaf NB, Derrar F, Gharnaout M, Allam I, Djidjik R. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19. Cytokine 2021;141:155428. [PMID: 33550165 DOI: 10.1016/j.cyto.2021.155428] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
665 Alonso-Bellido IM, Bachiller S, Vázquez G, Cruz-Hernández L, Martínez E, Ruiz-Mateos E, Deierborg T, Venero JL, Real LM, Ruiz R. The Other Side of SARS-CoV-2 Infection: Neurological Sequelae in Patients. Front Aging Neurosci 2021;13:632673. [PMID: 33889082 DOI: 10.3389/fnagi.2021.632673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
666 Zhou Y, Yang Q, Chi J, Dong B, Lv W, Shen L, Wang Y. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. Int J Infect Dis 2020;99:47-56. [PMID: 32721533 DOI: 10.1016/j.ijid.2020.07.029] [Cited by in Crossref: 83] [Cited by in F6Publishing: 67] [Article Influence: 41.5] [Reference Citation Analysis]
667 Dabbish AM, Yonis N, Salama M, Essa MM, Qoronfleh MW. Inflammatory pathways and potential therapies for COVID-19: A mini review. Eur J Inflamm 2021;19:205873922110029. [DOI: 10.1177/20587392211002986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
668 Krajewski R, Gołębiowska J, Makuch S, Mazur G, Agrawal S. Update on serologic testing in COVID-19. Clin Chim Acta 2020;510:746-50. [PMID: 32946795 DOI: 10.1016/j.cca.2020.09.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
669 Maguire D, Woods M, Richards C, Dolan R, Veitch JW, Sim WMJ, Kemmett OEH, Milton DC, Randall SLW, Bui LD, Goldmann N, Cameron A, Laird B, Talwar D, Godber I, Davidson A, McMillan DC. Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection. J Transl Med 2020;18:354. [PMID: 32933530 DOI: 10.1186/s12967-020-02524-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
670 Wang R, Hume AJ, Beermann ML, Simone-Roach C, Lindstrom-Vautrin J, Le Suer J, Huang J, Olejnik J, Villacorta-Martin C, Bullitt E, Hinds A, Ghaedi M, Rollins S, Werder RB, Abo KM, Wilson AA, Mühlberger E, Kotton DN, Hawkins FJ. Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection. Am J Physiol Lung Cell Mol Physiol 2022. [PMID: 35020534 DOI: 10.1152/ajplung.00397.2021] [Reference Citation Analysis]
671 Kazancioglu S, Yilmaz FM, Bastug A, Sakallı A, Ozbay BO, Buyuktarakci C, Bodur H, Yilmaz G. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19. Viral Immunol 2021;34:342-51. [PMID: 33264073 DOI: 10.1089/vim.2020.0166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
672 Meng M, Zhao Q, Kumar R, Bai C, Deng Y, Wan B. Impact of cardiovascular and metabolic diseases on the severity of COVID-19: a systematic review and meta-analysis. Aging (Albany NY) 2020;12:23409-21. [PMID: 33199670 DOI: 10.18632/aging.103991] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
673 Memish ZA, Faqihi F, Alharthy A, Alqahtani SA, Karakitsos D. Plasma exchange in the treatment of complex COVID-19-related critical illness: controversies and perspectives. Int J Antimicrob Agents 2021;57:106273. [PMID: 33370568 DOI: 10.1016/j.ijantimicag.2020.106273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
674 Gonzalez-llinares J, Font-julián CI, Orduña-malea E. Universidades en Google: hacia un modelo de análisis multinivel del posicionamiento web académico. Rev esp doc cient 2020;43:260. [DOI: 10.3989/redc.2020.2.1691] [Reference Citation Analysis]
675 Hernandez JJ, Beaty DE, Fruhwirth LL, Lopes Chaves AP, Riordan NH. Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells. J Transl Med 2021;19:149. [PMID: 33853637 DOI: 10.1186/s12967-021-02813-6] [Reference Citation Analysis]
676 Robinson PC, Liew DFL, Tanner HL, Grainger JR, Dwek RA, Reisler RB, Steinman L, Feldmann M, Ho LP, Hussell T, Moss P, Richards D, Zitzmann N. COVID-19 therapeutics: Challenges and directions for the future. Proc Natl Acad Sci U S A 2022;119:e2119893119. [PMID: 35385354 DOI: 10.1073/pnas.2119893119] [Reference Citation Analysis]
677 Garg S, Garg M, Prabhakar N, Malhotra P, Agarwal R. Unraveling the mystery of Covid-19 cytokine storm: From skin to organ systems. Dermatol Ther 2020;33:e13859. [PMID: 32559324 DOI: 10.1111/dth.13859] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
678 Hosseinzadeh R, Goharrizi MASB, Bahardoust M, Alvanegh AG, Ataee MR, Bagheri M, Navidiyan ES, Zijoud SRH, Heiat M. Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19)? Clin Hypertens 2021;27:3. [PMID: 33451360 DOI: 10.1186/s40885-021-00161-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
679 de Almeida-Pititto B, Dualib PM, Zajdenverg L, Dantas JR, de Souza FD, Rodacki M, Bertoluci MC; Brazilian Diabetes Society Study Group (SBD). Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis. Diabetol Metab Syndr 2020;12:75. [PMID: 32874207 DOI: 10.1186/s13098-020-00586-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 22.5] [Reference Citation Analysis]
680 Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, Viganò M, Giovannelli G, Pirro F, Montisano DA, Appollonio I, Ferrarese C. Guillain-Barré syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm 2020;7:e741. [PMID: 32350026 DOI: 10.1212/NXI.0000000000000741] [Cited by in Crossref: 180] [Cited by in F6Publishing: 108] [Article Influence: 90.0] [Reference Citation Analysis]
681 Uversky VN, Elrashdy F, Aljadawi A, Ali SM, Khan RH, Redwan EM. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How? J Neurosci Res 2021;99:750-77. [PMID: 33217763 DOI: 10.1002/jnr.24752] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
682 Bhatta A. Choice of Food: A Preventive Measure during Covid-19 Outbreak. Europasian J Med Sci 2020;2:85-9. [DOI: 10.46405/ejms.v2i1.49] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
683 Fraiman P, Godeiro Junior C, Moro E, Cavallieri F, Zedde M. COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management. Front Neurol 2020;11:574694. [PMID: 33250845 DOI: 10.3389/fneur.2020.574694] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
684 Buso R, Cinetto F, Dell'Edera A, Veneran N, Facchini C, Biscaro V, Schiavon S, Vian E, Grossi U, Zanus G, Giobbia M, Scarpa R, Agostini C, Rattazzi M, Felice C. Comparison between Dexamethasone and Methylprednisolone Therapy in Patients with COVID-19 Pneumonia Admitted to Non-Intensive Medical Units. J Clin Med 2021;10:5812. [PMID: 34945108 DOI: 10.3390/jcm10245812] [Reference Citation Analysis]
685 Hafezi B, Chan L, Knapp JP, Karimi N, Alizadeh K, Mehrani Y, Bridle BW, Karimi K. Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells. Cells 2021;10:1761. [PMID: 34359931 DOI: 10.3390/cells10071761] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
686 Wu M, Ma L, Xue L, Zhu Q, Zhou S, Dai J, Yan W, Zhang J, Wang S. Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age. Genomics 2021;113:3449-60. [PMID: 34418496 DOI: 10.1016/j.ygeno.2021.08.012] [Reference Citation Analysis]
687 Wang M, Yu D, Shang Y, Zhang X, Yang Y, Zhao S, Su D, Liu L, Wang Q, Ren J, Li Y, Chen H. Predictive Score of Risk Associated with Progression of Patients with COVID-19 Pneumonia in Wuhan, China: the ALA Score. Arab J Sci Eng 2021;:1-9. [PMID: 34221844 DOI: 10.1007/s13369-021-05808-z] [Reference Citation Analysis]
688 Halaji M, Heiat M, Faraji N, Ranjbar R. Epidemiology of COVID-19: An updated review. J Res Med Sci 2021;26:82. [PMID: 34759999 DOI: 10.4103/jrms.JRMS_506_20] [Reference Citation Analysis]
689 Farrag MA, Amer HM, Bhat R, Hamed ME, Aziz IM, Mubarak A, Dawoud TM, Almalki SG, Alghofaili F, Alnemare AK, Al-Baradi RS, Alosaimi B, Alturaiki W. SARS-CoV-2: An Overview of Virus Genetics, Transmission, and Immunopathogenesis. Int J Environ Res Public Health 2021;18:6312. [PMID: 34200934 DOI: 10.3390/ijerph18126312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
690 Bao J, Li C, Zhang K, Kang H, Chen W, Gu B. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19. Clin Chim Acta 2020;509:180-94. [PMID: 32511971 DOI: 10.1016/j.cca.2020.06.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 17.0] [Reference Citation Analysis]
691 Tian S, Zheng N, Zu X, Wu G, Zhong J, Zhang J, Sheng L, Liu W, Wang C, Ge G, Han J, Zhao J, Li H, Zhang W. Integrated hepatic single-cell RNA sequencing and untargeted metabolomics reveals the immune and metabolic modulation of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia. Phytomedicine 2022;97:153922. [PMID: 35032732 DOI: 10.1016/j.phymed.2021.153922] [Reference Citation Analysis]
692 Firstenberg MS, Stahel PF, Hanna J, Kotaru C, Crossno J Jr, Forrester J. Successful COVID-19 rescue therapy by extra-corporeal membrane oxygenation (ECMO) for respiratory failure: a case report. Patient Saf Surg 2020;14:20. [PMID: 32395179 DOI: 10.1186/s13037-020-00245-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
693 Simon Junior H, Sakano TMS, Rodrigues RM, Eisencraft AP, Carvalho VEL, Schvartsman C, Reis AGADC. Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view. J Pediatr (Rio J). 2021;97:140-159. [PMID: 32946801 DOI: 10.1016/j.jped.2020.08.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
694 Maibach MA, Allam A, Hilty MP, Perez Gonzalez NA, Buehler PK, Wendel Garcia PD, Brugger SD, Ganter CC, Krauthammer M, Schuepbach RA, Bartussek J; CoViD-19 ICU-Research Group Zurich., RISC-19-ICU Investigators. How to Synchronize Longitudinal Patient Data With the Underlying Disease Progression: A Pilot Study Using the Biomarker CRP for Timing COVID-19. Front Med (Lausanne) 2021;8:607594. [PMID: 34307391 DOI: 10.3389/fmed.2021.607594] [Reference Citation Analysis]
695 Zhou Z, Huang C, Zhou Z, Huang Z, Su L, Kang S, Chen X, Chen Q, He S, Rong X, Xiao F, Chen J, Chen S. Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes. iScience 2021;24:102187. [PMID: 33615195 DOI: 10.1016/j.isci.2021.102187] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
696 Jegede O, Anand Raman A, Tiongson B, Garlapati PR, Hershberger J, Gayam V. Clinical characteristics, hospital course, and outcomes among COVID-19 positive patients with mental illness in a community hospital in New York City. International Journal of Mental Health 2021;50:4-15. [DOI: 10.1080/00207411.2020.1845567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
697 [DOI: 10.1101/2020.04.23.20076612] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
698 Singh K, Singh S. Blood Urea Nitrogen/Albumin Ratio and Mortality Risk in Patients with COVID-19. Indian Journal of Critical Care Medicine 2022;26:624-9. [DOI: 10.5005/jp-journals-10071-24150] [Reference Citation Analysis]
699 Zhou J, Zhang J, Zhou J, Yi H, Lin Z, Liu Y, Zhu M, Wang H, Zhang W, Xu H, Jiang H, Xiang Z, Qu Z, Yang Y, Lu L, Guo S, Fu H, Adcock IM, Wei Y, Yao X. Clinical characteristics of re-positive COVID-19 patients in Huangshi, China: A retrospective cohort study. PLoS One 2020;15:e0241896. [PMID: 33147282 DOI: 10.1371/journal.pone.0241896] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
700 Renn A, Fu Y, Hu X, Hall MD, Simeonov A. Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2. Trends Pharmacol Sci 2020;41:815-29. [PMID: 32829936 DOI: 10.1016/j.tips.2020.07.004] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 24.0] [Reference Citation Analysis]
701 Bleyzac N, Goutelle S, Bourguignon L, Tod M. Azithromycin for COVID-19: More Than Just an Antimicrobial? Clin Drug Investig. 2020;40:683-686. [PMID: 32533455 DOI: 10.1007/s40261-020-00933-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 16.0] [Reference Citation Analysis]
702 Al-nimer MS, Merza TA, Mohammed‎ ‎YMY, Mohammed ‎A. Blood Cells Indices are Determinants of the COVID-19 Outcome: A Cross-Sectional Study from ‎Kurdistan Region-Iraq. ELECTRON J GEN MED 2021;18:em304. [DOI: 10.29333/ejgm/11013] [Reference Citation Analysis]
703 Wu YF, Yu WJ, Jiang YH, Chen Y, Zhang B, Zhen RB, Zhang JT, Wang YP, Li Q, Xu F, Shi YJ, Li XP. COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report. World J Clin Cases 2021; 9(19): 5266-5269 [PMID: 34307577 DOI: 10.12998/wjcc.v9.i19.5266] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
704 De Vito D, Ciaula AD, Palmieri VO, Trerotoli P, Larocca AMV, Montagna MT, Portincasa P. Reduced COVID-19 mortality linked with early antibodies against SARS-CoV-2, irrespective of age. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.02.010] [Reference Citation Analysis]
705 Lusczek ER, Ingraham NE, Karam B, Proper J, Siegel L, Helgeson E, Lotfi-Emran S, Zolfaghari EJ, Jones E, Usher M, Chipman J, Dudley RA, Benson B, Melton GB, Charles A, Lupei MI, Tignanelli CJ. Characterizing COVID-19 Clinical Phenotypes and Associated Comorbidities and Complication Profiles. medRxiv 2020:2020. [PMID: 32995813 DOI: 10.1101/2020.09.12.20193391] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
706 Kothari A, Singh V, Nath UK, Kumar S, Rai V, Kaushal K, Omar BJ, Pandey A, Jain N. Immune Dysfunction and Multiple Treatment Modalities for the SARS-CoV-2 Pandemic: Races of Uncontrolled Running Sweat? Biology (Basel) 2020;9:E243. [PMID: 32846906 DOI: 10.3390/biology9090243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
707 Zayed M, Iohara K. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019. Cell Transplant 2020;29:963689720952089. [PMID: 32830527 DOI: 10.1177/0963689720952089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
708 Schulz-Kuhnt A, Wirtz S, Neurath MF, Atreya I. Regulation of Human Innate Lymphoid Cells in the Context of Mucosal Inflammation. Front Immunol 2020;11:1062. [PMID: 32655549 DOI: 10.3389/fimmu.2020.01062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
709 Skalny AV, Lima TRR, Ke T, Zhou JC, Bornhorst J, Alekseenko SI, Aaseth J, Anesti O, Sarigiannis DA, Tsatsakis A, Aschner M, Tinkov AA. Toxic metal exposure as a possible risk factor for COVID-19 and other respiratory infectious diseases. Food Chem Toxicol 2020;146:111809. [PMID: 33069759 DOI: 10.1016/j.fct.2020.111809] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
710 Schönrich G, Raftery MJ, Samstag Y. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression. Adv Biol Regul 2020;77:100741. [PMID: 32773102 DOI: 10.1016/j.jbior.2020.100741] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 31.5] [Reference Citation Analysis]
711 Boechat JL, Chora I, Morais A, Delgado L. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives. Pulmonology 2021;27:423-37. [PMID: 33867315 DOI: 10.1016/j.pulmoe.2021.03.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
712 Fraga-Silva TFC, Maruyama SR, Sorgi CA, Russo EMS, Fernandes APM, de Barros Cardoso CR, Faccioli LH, Dias-Baruffi M, Bonato VLD. COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes. Front Immunol 2020;11:599736. [PMID: 33584667 DOI: 10.3389/fimmu.2020.599736] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
713 Liu X, Zhou H, Zhou Y, Wu X, Zhao Y, Lu Y, Tan W, Yuan M, Ding X, Zou J, Li R, Liu H, Ewing RM, Hu Y, Nie H, Wang Y. Risk factors associated with disease severity and length of hospital stay in COVID-19 patients. J Infect 2020;81:e95-7. [PMID: 32305490 DOI: 10.1016/j.jinf.2020.04.008] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 30.0] [Reference Citation Analysis]
714 Fang Y, Zhou J, Ding X, Ling G, Yu S. Pulmonary fibrosis in critical ill patients recovered from COVID-19 pneumonia: Preliminary experience. Am J Emerg Med 2020;38:2134-8. [PMID: 33071084 DOI: 10.1016/j.ajem.2020.05.120] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
715 Chu R, van Eeden C, Suresh S, Sligl WI, Osman M, Cohen Tervaert JW. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis. Int J Mol Sci 2021;22:2967. [PMID: 33803997 DOI: 10.3390/ijms22062967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
716 Hammad R, Elshafei A, Khidr EG, El-Husseiny AA, Gomaa MH, Kotb HG, Eltrawy HH, Farhoud H. Copeptin: a neuroendocrine biomarker of COVID-19 severity. Biomark Med 2022. [PMID: 35350852 DOI: 10.2217/bmm-2021-1100] [Reference Citation Analysis]
717 Danilenko V, Devyatkin A, Marsova M, Shibilova M, Ilyasov R, Shmyrev V. Common Inflammatory Mechanisms in COVID-19 and Parkinson's Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention. J Inflamm Res 2021;14:6349-81. [PMID: 34876830 DOI: 10.2147/JIR.S333887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
718 Kang CK, Han GC, Kim M, Kim G, Shin HM, Song KH, Choe PG, Park WB, Kim ES, Kim HB, Kim NJ, Kim HR, Oh MD. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity. Int J Infect Dis 2020;97:313-21. [PMID: 32492530 DOI: 10.1016/j.ijid.2020.05.106] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
719 Gaitzsch E, Passerini V, Khatamzas E, Strobl CD, Muenchhoff M, Scherer C, Osterman A, Heide M, Reischer A, Subklewe M, Leutbecher A, Tast B, Ruhle A, Weiglein T, Stecher SS, Stemmler HJ, Dreyling M, Girl P, Georgi E, Wölfel R, Mateyka L, D'Ippolito E, Schober K, Busch DH, Kager J, Spinner CD, Treiber M, Rasch S, Lahmer T, Iakoubov R, Schneider J, Protzer U, Winter C, Ruland J, Quante M, Keppler OT, von Bergwelt-Baildon M, Hellmuth J, Weigert O. COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma. Hemasphere 2021;5:e603. [PMID: 34235400 DOI: 10.1097/HS9.0000000000000603] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
720 Mahallawi WH, Fakher MH, Alsarani MA, Aljohani RH, Al-Mutabgani SA, Ibrahim NA. A Single Dose of SARS-CoV-2 Vaccine Primes a Strong Humoral Immune Response in COVID-19-Recovered Patients. Viral Immunol 2021. [PMID: 34747643 DOI: 10.1089/vim.2021.0108] [Reference Citation Analysis]
721 Hue S, Beldi-Ferchiou A, Bendib I, Surenaud M, Fourati S, Frapard T, Rivoal S, Razazi K, Carteaux G, Delfau-Larue MH, Mekontso-Dessap A, Audureau E, de Prost N. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2020;202:1509-19. [PMID: 32866033 DOI: 10.1164/rccm.202005-1885OC] [Cited by in Crossref: 48] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
722 Chi Y, Ge Y, Wu B, Zhang W, Wu T, Wen T, Liu J, Guo X, Huang C, Jiao Y, Zhu F, Zhu B, Cui L. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China. J Infect Dis. 2020;222:746-754. [PMID: 32563194 DOI: 10.1093/infdis/jiaa363] [Cited by in Crossref: 89] [Cited by in F6Publishing: 88] [Article Influence: 44.5] [Reference Citation Analysis]
723 [DOI: 10.1101/2020.05.01.20078360] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
724 Cao W, Liu X, Hong K, Ma Z, Zhang Y, Lin L, Han Y, Xiong Y, Liu Z, Ruan L, Li T. High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China. Front Immunol 2021;12:627844. [PMID: 33679771 DOI: 10.3389/fimmu.2021.627844] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
725 Macciò A, Oppi S, Madeddu C. COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied? J Ovarian Res 2021;14:28. [PMID: 33550983 DOI: 10.1186/s13048-021-00772-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
726 Naeimi R, Ghasemi-Kasman M. Update on cerebrovascular manifestations of COVID-19. Neurol Sci 2020;41:3423-35. [PMID: 33083934 DOI: 10.1007/s10072-020-04837-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
727 Salama C, Kaplan-Lewis E, Durrance R, Wong L, Arumugam V, Fabbri M. Tocilizumab for Severe and Critical COVID-19 Pneumonia in Queens, NYC. Infect Dis Clin Pract (Baltim Md) 2021;29:e215-20. [PMID: 34276173 DOI: 10.1097/IPC.0000000000000988] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
728 Park JG, Kang MK, Lee YR, Song JE, Kim NY, Kweon YO, Tak WY, Jang SY, Lee C, Kim BS, Hwang JS, Jang BK, Bae J, Lee JY, Suh JI, Park SY, Chung WJ; Daegu-Gyeongbuk Liver Study Group (DGLSG). Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: a retrospective multicentre cohort study. BMJ Open 2020;10:e041989. [PMID: 33184086 DOI: 10.1136/bmjopen-2020-041989] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
729 Roy K, Agarwal S, Banerjee R, Paul MK, Purbey PK. COVID-19 and gut immunomodulation. World J Gastroenterol 2021; 27(46): 7925-7942 [DOI: 10.3748/wjg.v27.i46.7925] [Reference Citation Analysis]
730 Neurath MF. COVID-19 and immunomodulation in IBD. Gut 2020;69:1335-42. [PMID: 32303609 DOI: 10.1136/gutjnl-2020-321269] [Cited by in Crossref: 108] [Cited by in F6Publishing: 102] [Article Influence: 54.0] [Reference Citation Analysis]
731 Bhattacharjee S, Banerjee M. Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review. SN Compr Clin Med 2020;:1-11. [PMID: 32984764 DOI: 10.1007/s42399-020-00521-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 23.0] [Reference Citation Analysis]
732 Kerget B, Kerget F, Koçak AO, Kızıltunç A, Araz Ö, Uçar EY, Akgün M. Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19? Lung 2020;198:777-84. [PMID: 32918573 DOI: 10.1007/s00408-020-00393-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
733 Dwijayanti R. Experience and Insight Author in Preventing and Curbing the Novel Coronavirus (Covid19) Outbreak. JKL 2020;12:79. [DOI: 10.20473/jkl.v12i1si.2020.79-88] [Reference Citation Analysis]
734 Nicastro E, Verdoni L, Bettini LR, Zuin G, Balduzzi A, Montini G, Biondi A, D'Antiga L. COVID-19 in Immunosuppressed Children. Front Pediatr 2021;9:629240. [PMID: 33996683 DOI: 10.3389/fped.2021.629240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
735 Liu F, Liu H, Yu WY, Liu Z, Zhang X, Wang Y, Miao LB, Li ZY, Huang JS, Bao JF. The Associations of Lymphocyte Ratio and Neutrophil Ratio on Liver Dysfunction in COVID-19 Patients. Front Immunol 2021;12:717461. [PMID: 34552588 DOI: 10.3389/fimmu.2021.717461] [Reference Citation Analysis]
736 Suwanwongse K, Shabarek N. Hyperpyrexia in patients with COVID-19. J Med Virol 2020;92:2857-62. [PMID: 32519768 DOI: 10.1002/jmv.26154] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6]<